Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,A1BG,Alpha-1B-glycoprotein,2309,270,0.98 [0.48-1.99],0.9588460934434944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,2243,264,0.90 [0.71-1.13],0.3483466938529174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,2636,313,0.85 [0.71-1.02],0.0828267354036674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,2242,265,1.40 [1.00-1.97],0.0504343424790447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABHD14B,Protein ABHD14B,2634,319,0.90 [0.75-1.08],0.2502344072578952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,2636,313,0.94 [0.81-1.10],0.4473118050648891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABO,Histo-blood group ABO system transferase,2315,273,1.02 [0.94-1.10],0.6286632887494361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABRAXAS2,BRISC complex subunit Abraxas 2,2242,265,0.98 [0.81-1.18],0.8376487661453859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2579,308,1.02 [0.91-1.15],0.7387700509905171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2271,266,1.05 [0.89-1.24],0.5507113779540715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2304,270,0.88 [0.77-1.01],0.0673891664958501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAN,Aggrecan core protein,2631,315,0.94 [0.66-1.33],0.7234281844184041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE,Angiotensin-converting enzyme,2315,273,1.41 [0.94-2.13],0.0959929106018381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE2,Angiotensin-converting enzyme 2,2616,315,0.94 [0.81-1.10],0.4489295538058977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACHE,Acetylcholinesterase,2268,265,0.96 [0.70-1.33],0.8163396521669779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOT13,Acyl-coenzyme A thioesterase 13,2307,271,0.95 [0.86-1.05],0.3070399327898595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2658,316,0.90 [0.74-1.10],0.3170802931242213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,2244,268,0.81 [0.62-1.06],0.120074042125597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,2676,320,1.57 [1.19-2.07],0.0015586958662372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP6,Lysophosphatidic acid phosphatase type 6,2673,318,0.95 [0.82-1.11],0.5060199335877409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRBP,Acrosin-binding protein,2297,268,0.96 [0.71-1.30],0.780910328926444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,2244,268,1.15 [1.04-1.27],0.0067821165025328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,2242,265,1.04 [0.73-1.48],0.8366251824122182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",2616,315,1.37 [1.13-1.67],0.001229843209762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN2,Alpha-actinin-2,2242,265,1.08 [0.90-1.29],0.4012198871352139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,2601,309,0.98 [0.71-1.35],0.8876296294878134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2637,320,2.23 [1.63-3.06],6.417105055701541e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY1,Aminoacylase-1,2658,316,0.93 [0.80-1.07],0.2913035241161374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2242,265,1.20 [1.00-1.45],0.0505148483349094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACYP1,Acylphosphatase-1,2263,263,0.85 [0.71-1.02],0.0742867729440762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,2692,319,1.03 [0.79-1.36],0.8131822884969551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,2642,314,1.93 [1.61-2.33],2.8256935802880945e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2244,268,1.42 [1.04-1.94],0.0291551447504899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2616,315,1.30 [0.95-1.77],0.1005803839456854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2641,320,1.46 [1.12-1.90],0.0047037707277881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2692,319,1.28 [0.95-1.72],0.1056973427018812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2675,319,1.37 [0.99-1.89],0.0586765964508411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2307,271,2.25 [1.65-3.07],3.270910678537476e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2244,268,1.12 [0.76-1.67],0.5638534520096782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2695,322,0.86 [0.59-1.27],0.4549698362650971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2636,313,0.90 [0.72-1.14],0.3837981110071583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2616,315,0.90 [0.65-1.24],0.5052199461735938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2244,268,0.98 [0.70-1.37],0.8977988441393684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2658,318,0.96 [0.78-1.18],0.6672822448457099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,2316,272,1.22 [0.91-1.62],0.1794152422238233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL4,ADAMTS-like protein 4,2243,264,0.87 [0.54-1.42],0.5799087338555777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL5,ADAMTS-like protein 5,2304,270,1.00 [0.75-1.34],0.9929968874828176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2579,308,0.92 [0.66-1.29],0.6393009261149215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADD1,Alpha-adducin,2268,265,0.87 [0.73-1.03],0.1033537625795753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,2637,320,2.00 [1.52-2.63],7.856493934739294e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,2268,265,1.16 [0.89-1.52],0.2735092454477686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE1,Adhesion G protein-coupled receptor E1,2307,271,1.06 [0.87-1.30],0.5616219807430296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,2674,318,2.15 [1.58-2.92],1.0932557712429004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,2685,322,2.31 [1.78-2.99],2.4226922827365665e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRF5,Adhesion G protein-coupled receptor F5,2304,270,1.07 [0.68-1.67],0.7722103083502716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,2636,313,1.21 [1.12-1.32],4.038964804869029e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,2658,316,0.46 [0.32-0.65],1.589263902070445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRV1,Adhesion G-protein coupled receptor V1,2244,266,1.08 [0.92-1.27],0.3592894502848733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,2268,265,0.83 [0.72-0.95],0.0074704292256749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2616,315,0.83 [0.74-0.93],0.0011937135911252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADIPOQ,Adiponectin,2309,270,1.12 [0.95-1.31],0.1693730575425878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,2676,318,2.18 [1.52-3.13],2.522367020722332e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADRA2A,Alpha-2A adrenergic receptor,2242,265,0.87 [0.71-1.07],0.1912453343618274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFAP1,Actin filament-associated protein 1,2268,265,1.00 [0.87-1.16],0.9836678156685292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,2309,270,0.31 [0.19-0.49],1.1818091928374815e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,2633,319,0.66 [0.56-0.78],5.339949846019838e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGBL2,Cytosolic carboxypeptidase 2,2244,266,1.01 [0.89-1.13],0.9290907507580868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGER,Advanced glycosylation end product-specific receptor,2659,316,1.05 [0.83-1.33],0.6704250178697578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,2570,307,1.25 [1.13-1.37],6.333362180919574e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,2574,308,1.11 [0.94-1.32],0.2009532511949348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,2674,318,1.65 [1.31-2.08],2.641306718124396e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,2692,319,1.11 [0.92-1.34],0.2805925117238759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGT,Angiotensinogen,2315,273,0.89 [0.54-1.48],0.6579586177265402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGXT,Serine--pyruvate aminotransferase,2658,316,1.05 [0.93-1.19],0.3899703009111992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,2658,316,0.81 [0.69-0.94],0.0054213391420202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,2243,264,0.78 [0.53-1.13],0.1854934692063587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,2243,264,1.30 [0.92-1.83],0.1315548133757371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2297,268,0.85 [0.69-1.05],0.1382922504512198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSG,Alpha-2-HS-glycoprotein,2315,273,0.85 [0.57-1.26],0.4057203069397029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,2663,320,0.85 [0.76-0.96],0.006135073936725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIDA,"Axin interactor, dorsalization-associated protein",2262,271,1.01 [0.88-1.16],0.9107245716325388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1,Allograft inflammatory factor 1,2579,308,0.90 [0.74-1.09],0.2705632157571189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1L,Allograft inflammatory factor 1-like,2243,264,1.06 [0.85-1.31],0.6047568880157786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2633,313,0.98 [0.89-1.07],0.6335785878476652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,2658,316,0.78 [0.67-0.92],0.002841926412473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK2,"Adenylate kinase 2, mitochondrial",2300,272,0.98 [0.88-1.09],0.7160753907988049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,2268,265,0.77 [0.41-1.45],0.4243535320623135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B1,Aldo-keto reductase family 1 member B1,2579,308,0.97 [0.84-1.11],0.6218078826534157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B10,Aldo-keto reductase family 1 member B10,2262,271,1.00 [0.87-1.16],0.9560783423213686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1C4,Aldo-keto reductase family 1 member C4,2616,315,1.18 [0.97-1.43],0.0943500370255716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,2244,268,0.92 [0.78-1.09],0.3459461597361219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT1S1,Proline-rich AKT1 substrate 1,2589,310,0.92 [0.79-1.07],0.2792195121685165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT2,RAC-beta serine/threonine-protein kinase,2304,274,0.97 [0.89-1.07],0.5845693326724756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT3,RAC-gamma serine/threonine-protein kinase,2563,307,0.95 [0.80-1.14],0.5953872236222951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,2695,322,2.22 [1.41-3.49],0.0005507763286359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,2670,320,0.76 [0.65-0.90],0.0012687728196147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",2297,268,1.03 [0.83-1.28],0.7790334038576852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2661,320,1.01 [0.90-1.13],0.9102399086611218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2304,274,1.11 [0.87-1.41],0.4130646107521697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALMS1,Alstrom syndrome protein 1,2271,266,1.00 [0.76-1.32],0.9940214772031192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,2244,268,1.10 [1.01-1.20],0.033083390576478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",2636,313,1.11 [1.01-1.22],0.0291102440307147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBN,Ameloblastin,2601,309,0.93 [0.64-1.34],0.6832214096953679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,2674,318,4.19 [2.70-6.50],1.8400548720775363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2316,272,0.89 [0.57-1.41],0.6263045490425658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMFR,E3 ubiquitin-protein ligase AMFR,2589,310,0.98 [0.83-1.16],0.8264150356633699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO1,Amphoterin-induced protein 1,2262,271,0.80 [0.61-1.05],0.1145790980525217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,2636,313,1.71 [1.14-2.57],0.0089623026065275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMN,Protein amnionless,2601,309,0.90 [0.73-1.11],0.3146740324219577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,2268,265,0.56 [0.41-0.76],0.0001862263409878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOTL2,Angiomotin-like protein 2,2288,266,0.97 [0.75-1.25],0.8198912842506452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMPD3,AMP deaminase 3,2300,272,1.02 [0.87-1.20],0.7764131758579403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,2184,263,0.90 [0.72-1.13],0.3520062766498679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2A,Pancreatic alpha-amylase,2573,306,0.97 [0.80-1.17],0.7345970696740476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2B,Alpha-amylase 2B,2495,297,0.93 [0.76-1.13],0.4394045990912364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,2656,316,1.49 [1.13-1.98],0.0049614653162469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT1,Angiopoietin-1,2650,315,1.00 [0.89-1.13],0.9433916231117554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,2676,318,1.43 [1.11-1.85],0.0055921727861492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,2616,312,1.37 [0.98-1.91],0.0676378852374633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL2,Angiopoietin-related protein 2,2663,318,0.99 [0.78-1.26],0.943128603148946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,2661,316,0.72 [0.55-0.94],0.0174376957296286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,2672,317,1.64 [1.33-2.03],4.823714691712283e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,2676,318,1.33 [1.04-1.69],0.0220472766317101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANK2,Ankyrin-2,2242,265,0.91 [0.75-1.10],0.3162717576904414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2244,268,0.92 [0.80-1.06],0.265396895591893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRA2,Ankyrin repeat family A protein 2,2224,264,1.04 [0.84-1.28],0.7168683244136256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,2579,308,0.73 [0.60-0.89],0.0017851340308382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2243,264,0.72 [0.49-1.04],0.0825760696017447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,2661,317,1.50 [1.08-2.09],0.0168006617321311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA1,Annexin A1,2256,264,0.83 [0.63-1.10],0.1981152881319868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,2589,310,1.15 [1.03-1.28],0.0118713916269286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,2659,319,0.86 [0.75-1.00],0.0457974224385458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,2211,262,0.95 [0.80-1.12],0.5248604725152372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA3,Annexin A3,2675,319,0.91 [0.79-1.05],0.2087584592264706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,2645,315,0.86 [0.75-0.99],0.0376526973264792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,2581,309,1.76 [1.40-2.20],1.124577940721931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],2601,309,0.92 [0.75-1.13],0.4268252316651063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,2668,319,3.63 [2.68-4.93],1.1406997791455252e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP1G2,AP-1 complex subunit gamma-like 2,2297,268,0.97 [0.84-1.12],0.7043570197469093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP2B1,AP-2 complex subunit beta,2262,271,1.00 [0.79-1.27],0.9961373648406238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3B1,AP-3 complex subunit beta-1,2307,271,0.97 [0.83-1.13],0.6801419918742072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3S2,AP-3 complex subunit sigma-2,2300,272,1.02 [0.81-1.30],0.8514267696282809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2636,313,0.97 [0.78-1.20],0.7552746040729152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,2283,269,0.72 [0.50-1.03],0.0682380065724453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2670,318,0.83 [0.70-0.99],0.0425807659107562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,2658,316,0.77 [0.64-0.94],0.0083143195950077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,2309,270,0.44 [0.26-0.74],0.0018420320316658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,2315,273,1.29 [1.04-1.60],0.0197371030248817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,2309,270,2.46 [1.86-3.26],2.8384742568560856e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOB,Apolipoprotein B-100,2315,273,0.72 [0.44-1.20],0.2073557595311638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,2243,264,0.74 [0.57-0.97],0.0296773948974761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,2304,270,0.49 [0.36-0.65],1.2248796287394633e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,2216,259,0.70 [0.49-0.99],0.0463411925106755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,2309,270,0.59 [0.47-0.75],1.4207682900625844e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOF,Apolipoprotein F,2315,273,1.27 [0.92-1.76],0.1465960805999316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,2670,320,1.14 [0.90-1.46],0.2763584033295077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,2315,273,0.89 [0.72-1.09],0.2505362073968374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,2666,317,0.65 [0.47-0.90],0.0103066013635568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APP,Amyloid-beta precursor protein,2669,320,1.00 [0.86-1.16],0.9833186797338976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APPL2,DCC-interacting protein 13-beta,2268,265,0.95 [0.86-1.06],0.3658908923137658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,2639,320,0.87 [0.71-1.08],0.2071629471846076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARAF,Serine/threonine-protein kinase A-Raf,2271,266,1.11 [0.94-1.31],0.2012731217833336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,2636,313,2.15 [1.78-2.59],1.4334216883393664e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARF6,ADP-ribosylation factor 6,2307,271,0.98 [0.88-1.09],0.6763525263398633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARFIP1,Arfaptin-1,2304,274,0.96 [0.81-1.14],0.6380864713831496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,2622,315,0.80 [0.66-0.97],0.0199187730632805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG2,"Arginase-2, mitochondrial",2297,268,1.07 [0.82-1.42],0.6108956943036734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP1,Rho GTPase-activating protein 1,2579,308,0.82 [0.66-1.02],0.0756373372005314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP25,Rho GTPase-activating protein 25,2579,308,0.91 [0.77-1.08],0.2971223156003468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP30,Rho GTPase-activating protein 30,2271,266,1.09 [0.81-1.47],0.5517856803293197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP45,Rho GTPase-activating protein 45,2268,265,0.93 [0.80-1.07],0.3145992755125939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP5,Rho GTPase-activating protein 5,2224,264,1.05 [0.90-1.21],0.55988142359618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,2300,272,0.95 [0.83-1.08],0.4280120206393969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,2304,274,0.92 [0.81-1.04],0.1801914323910058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,2664,320,0.94 [0.86-1.04],0.2283267924788362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,2244,266,1.13 [0.97-1.31],0.123191413768491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID3A,AT-rich interactive domain-containing protein 3A,2244,266,0.87 [0.63-1.21],0.4159357503184834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID4B,AT-rich interactive domain-containing protein 4B,2589,310,0.87 [0.67-1.13],0.288315282777617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL13B,ADP-ribosylation factor-like protein 13B,2242,265,0.99 [0.83-1.17],0.8884227876807251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2242,265,0.85 [0.63-1.16],0.3101896368434655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,2244,266,0.94 [0.75-1.18],0.5880114584841887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,2601,309,1.09 [0.85-1.39],0.4869199701039295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2242,265,0.98 [0.77-1.25],0.8492210720464929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSA,Arylsulfatase A,2670,320,0.89 [0.72-1.10],0.2723858948337142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSB,Arylsulfatase B,2636,313,0.92 [0.77-1.10],0.3397363529396842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,2668,319,1.66 [1.30-2.13],6.110711258561319e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART5,Ecto-ADP-ribosyltransferase 5,2244,266,1.01 [0.84-1.22],0.9318456430820417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARTN,Artemin,2601,309,0.97 [0.76-1.25],0.8275481457909156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH1,Acid ceramidase,2303,271,1.07 [0.84-1.38],0.5758903629763515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH2,Neutral ceramidase,2641,320,0.93 [0.78-1.10],0.4056342269774978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,2641,320,1.48 [1.10-1.99],0.0099216224304702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,2315,273,1.74 [1.15-2.62],0.0082816098143283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPN,Asporin,2304,270,1.42 [0.96-2.10],0.0752165696440642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPSCR1,Tether containing UBX domain for GLUT4,2304,274,0.90 [0.75-1.08],0.2655607513270818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,2243,264,0.94 [0.83-1.06],0.304444015715545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,2242,265,1.03 [0.89-1.18],0.7061587066940616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,2589,310,1.11 [0.97-1.26],0.1387814410174997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,2224,264,0.73 [0.51-1.05],0.0908975693011866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG16L1,Autophagy-related protein 16-1,2307,271,0.95 [0.83-1.09],0.5003066398933789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,2579,308,0.83 [0.70-0.99],0.0339644355033042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,2658,318,1.00 [0.86-1.15],0.9582528859543642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2242,265,1.27 [1.02-1.57],0.0291510293101323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2242,265,1.04 [0.72-1.52],0.821925462187075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2242,265,1.15 [0.87-1.54],0.3264070111906231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B4,Protein ATP1B4,2224,264,1.17 [0.90-1.52],0.2441524785219802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,2242,265,0.97 [0.79-1.19],0.7690961150518341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",2242,265,1.04 [0.81-1.33],0.784332599657227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5IF1,"ATPase inhibitor, mitochondrial",2674,318,1.00 [0.92-1.10],0.9540903411403532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",2589,310,1.05 [0.85-1.29],0.673855677113951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6AP2,Renin receptor,2579,308,1.18 [0.93-1.50],0.1848634080362698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,2636,313,1.10 [0.77-1.57],0.611615352896352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,2584,309,0.80 [0.69-0.94],0.0070481476555857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G1,V-type proton ATPase subunit G 1,2243,264,0.98 [0.83-1.16],0.8091574808581353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G2,V-type proton ATPase subunit G 2,2242,265,0.90 [0.78-1.03],0.1369911131296724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2307,271,2.07 [1.51-2.84],6.491350792670251e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRN,"Attractin, Isoform 2",2309,270,0.62 [0.31-1.22],0.1618314005744122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN10,Ataxin-10,2589,310,1.01 [0.88-1.17],0.8351541213082623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2,Ataxin-2,2244,266,0.97 [0.87-1.07],0.5240155875480171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2L,Ataxin-2-like protein,2304,274,0.91 [0.71-1.15],0.4127496716080499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN3,Ataxin-3,2300,272,0.85 [0.71-1.03],0.1049911659952029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXIN1,Axin-1,2664,320,0.92 [0.83-1.02],0.1275909566483759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,2668,319,1.59 [1.14-2.23],0.0067425730333084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZI2,5-azacytidine-induced protein 2,2304,274,0.88 [0.71-1.09],0.2465660862703428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZU1,Azurocidin,2590,309,0.95 [0.84-1.08],0.4411288777127331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,2309,270,1.87 [1.33-2.63],0.0003500773197892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2242,265,0.88 [0.50-1.58],0.6769317014554477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2243,264,3.03 [2.21-4.16],5.638671086035029e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2674,318,2.11 [1.52-2.93],7.708265649061655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",2670,320,1.23 [0.82-1.85],0.3149412553299953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BABAM1,BRISC and BRCA1-A complex member 1,2244,268,0.97 [0.62-1.52],0.8834110280756131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,2664,320,0.90 [0.78-1.03],0.1350904925999272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG3,BAG family molecular chaperone regulator 3,2637,320,0.82 [0.66-1.02],0.0751495780705384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG4,BAG family molecular chaperone regulator 4,2244,268,0.87 [0.68-1.11],0.2628394156838921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG6,Large proline-rich protein BAG6,2616,315,0.89 [0.68-1.16],0.3862777925706143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2579,308,1.13 [0.98-1.30],0.0864698519121153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2579,308,1.63 [1.27-2.09],0.0001213212276945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BANK1,B-cell scaffold protein with ankyrin repeats,2664,320,0.92 [0.84-1.01],0.0833353277610139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAP18,Chromatin complexes subunit BAP18,2300,272,0.83 [0.70-1.00],0.0519918506829837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BATF,Basic leucine zipper transcriptional factor ATF-like,2262,271,0.95 [0.81-1.11],0.4962328189079986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAX,Apoptosis regulator BAX,2583,309,1.02 [0.92-1.14],0.6853951132134057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,2670,320,1.85 [1.26-2.74],0.0019131352429144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,2641,320,0.48 [0.37-0.63],9.401628508220585e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2304,270,0.68 [0.46-1.02],0.0650058014103946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2244,266,0.71 [0.53-0.95],0.0196181088051066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCHE,Cholinesterase,2272,270,0.90 [0.61-1.32],0.5810012303445731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,2307,271,1.10 [0.88-1.37],0.3905036511042591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L1,Bcl-2-like protein 1,2300,272,0.95 [0.85-1.07],0.4179757028362424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2664,320,1.66 [1.28-2.17],0.0001741864363865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,2244,268,1.03 [0.86-1.24],0.7481247773166277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,2224,264,0.94 [0.78-1.15],0.557148460669125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,2297,268,0.96 [0.72-1.26],0.7491957499687831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCR,Breakpoint cluster region protein,2664,320,0.95 [0.86-1.06],0.383705761201363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BDNF,Brain-derived neurotrophic factor,2316,272,1.00 [0.87-1.15],0.9609579245210568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BECN1,Beclin-1,2243,264,0.89 [0.72-1.10],0.2823823120263364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,2224,264,0.99 [0.76-1.29],0.9518343933913856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,2316,272,0.69 [0.62-0.78],2.1062109935110926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGN,Biglycan,2577,308,1.01 [0.93-1.10],0.7409264964373479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHLHE40,Class E basic helix-loop-helix protein 40,2244,266,1.08 [0.92-1.27],0.3451077764255295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2242,265,0.83 [0.51-1.34],0.4506514562500771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BID,BH3-interacting domain death agonist,2664,320,0.88 [0.76-1.03],0.1047637609636362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIN2,Bridging integrator 2,2670,320,0.92 [0.82-1.02],0.1216540894408848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,2579,308,0.93 [0.79-1.09],0.3722823572873707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,2695,322,0.74 [0.55-0.99],0.0459562020653903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLNK,B-cell linker protein,2244,268,0.90 [0.68-1.20],0.4845703243782667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2244,266,0.95 [0.81-1.11],0.5027877982990101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2300,272,0.81 [0.60-1.09],0.156817810304792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLVRB,Flavin reductase,2670,320,0.87 [0.75-1.01],0.0720221299402558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,2268,265,1.35 [0.92-1.99],0.1197731705918277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP4,Bone morphogenetic protein 4,2637,320,1.09 [0.90-1.32],0.3812766370291263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP6,Bone morphogenetic protein 6,2615,315,0.85 [0.66-1.10],0.2255527329622998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,2268,265,2.17 [1.39-3.39],0.0006617276726694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2304,270,0.80 [0.55-1.16],0.2365244355408675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2244,268,1.00 [0.77-1.31],0.9718599251125366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,2616,315,2.80 [1.87-4.18],5.152575168432474e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,2244,266,0.87 [0.69-1.09],0.2209566289501018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,2243,264,0.77 [0.61-0.95],0.0171219515964325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFA2,BPI fold-containing family A member 2,2174,257,1.08 [0.98-1.20],0.1210161733140116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB1,BPI fold-containing family B member 1,2660,318,1.00 [0.86-1.16],0.9864274092421924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,2301,270,0.75 [0.63-0.90],0.0017903495664642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRAP,BRCA1-associated protein,2285,269,0.98 [0.88-1.09],0.737158137416904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD1,Bromodomain-containing protein 1,2271,266,1.14 [0.78-1.67],0.4876469492089753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD2,Bromodomain-containing protein 2,2244,266,0.74 [0.50-1.10],0.1332108365221006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD3,Bromodomain-containing protein 3,2242,265,0.97 [0.74-1.29],0.8455405762289687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRDT,Bromodomain testis-specific protein,2242,265,0.93 [0.68-1.28],0.6647251525505853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,2589,310,1.06 [0.86-1.32],0.5661298882086405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRME1,Break repair meiotic recombinase recruitment factor 1,2244,266,0.92 [0.67-1.28],0.6336278925394777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRSK2,Serine/threonine-protein kinase BRSK2,2304,274,1.11 [0.81-1.53],0.5032265076787893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,2686,319,2.05 [1.33-3.16],0.0010771230096119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSND,Barttin,2224,264,1.21 [0.89-1.65],0.2187311492512474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2678,319,1.21 [0.95-1.53],0.1244236766370569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST2,Bone marrow stromal antigen 2,2678,319,1.18 [0.99-1.40],0.0571624387636437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTC,Probetacellulin,2579,308,0.95 [0.82-1.09],0.4787914140778541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTD,Biotinidase,2309,270,1.56 [0.89-2.74],0.1224940193690482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTLA,B- and T-lymphocyte attenuator,2224,264,0.98 [0.86-1.12],0.8085747075302939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN1A1,Butyrophilin subfamily 1 member A1,2294,268,1.04 [0.77-1.39],0.8156961878066357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,2674,318,2.52 [1.87-3.40],1.079707829645807e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,2664,320,1.22 [0.94-1.59],0.1297354466426875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTNL10,Butyrophilin-like protein 10,2224,264,1.05 [0.77-1.43],0.7603044938039611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,2589,310,0.84 [0.74-0.97],0.0156210741135463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1GALT1C1,C1GALT1-specific chaperone 1,2242,265,0.97 [0.68-1.39],0.8776966085518926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,2677,318,1.57 [1.02-2.42],0.0406566289400096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2304,274,1.04 [0.87-1.23],0.6731240359097749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,2244,268,0.73 [0.55-0.97],0.0310930623897664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2668,319,1.32 [1.10-1.59],0.0030256164397798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2268,265,0.70 [0.51-0.97],0.0309003474671215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2304,274,0.98 [0.66-1.44],0.9145344935924112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2265,264,0.80 [0.64-1.01],0.0559062805204726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,2309,270,0.39 [0.19-0.82],0.0135952214863607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,2302,270,1.02 [0.57-1.83],0.9431265953554612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1S,Complement C1s subcomponent,2309,270,0.64 [0.37-1.11],0.1147109301616237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,2666,317,2.85 [1.72-4.72],4.8385846267276245e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2CD2L,Phospholipid transfer protein C2CD2L,2584,309,1.04 [0.81-1.32],0.7601429143047806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2orf69,UPF0565 protein C2orf69,2262,271,1.02 [0.82-1.27],0.8414695045016897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C3,Complement C3,2194,258,0.82 [0.61-1.09],0.1777276280153975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C4BPB,C4b-binding protein beta chain,2658,318,0.99 [0.77-1.26],0.9339132427169804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C5,Complement C5,2309,270,0.99 [0.45-2.14],0.9724276010649158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,2257,267,2.21 [1.59-3.07],2.2366316281426724e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7orf50,Uncharacterized protein C7orf50,2300,272,0.83 [0.47-1.46],0.512304206908593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,2309,270,0.88 [0.60-1.28],0.4974337981920914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9,Complement component C9,2315,273,1.08 [0.90-1.29],0.4157863491011037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9orf40,Uncharacterized protein C9orf40,2307,271,0.88 [0.77-1.02],0.0972432190085751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA1,Carbonic anhydrase 1,2618,313,0.84 [0.71-1.00],0.0503419847155482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA11,Carbonic anhydrase-related protein 11,2579,308,1.11 [0.85-1.46],0.4331908153614292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,2636,313,2.26 [1.76-2.91],2.0519683836943672e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA13,Carbonic anhydrase 13,2635,312,0.96 [0.87-1.05],0.3925908078551811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,2676,318,1.44 [1.12-1.85],0.0040382294295386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,2660,320,0.84 [0.73-0.97],0.0152838313428922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,2692,321,1.03 [0.88-1.21],0.7309474418597346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,2695,322,1.62 [1.11-2.36],0.0120133371223507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",2616,315,0.91 [0.82-1.01],0.0808707155879616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA6,Carbonic anhydrase 6,2659,314,0.91 [0.77-1.06],0.213806784873271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA7,Carbonic anhydrase 7,2271,266,0.96 [0.67-1.38],0.8389013976534665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA8,Carbonic anhydrase-related protein,2244,268,1.03 [0.65-1.65],0.8886258441819518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,2676,318,1.56 [1.33-1.84],6.993374036149887e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CABP2,Calcium-binding protein 2,2262,271,1.08 [0.90-1.30],0.3944486619683421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2244,266,0.78 [0.51-1.18],0.2313589704658591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2242,265,1.04 [0.85-1.27],0.6919324573060652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2244,266,1.00 [0.82-1.22],0.997598954546627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2304,274,0.96 [0.84-1.10],0.5866415775824232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACYBP,Calcyclin-binding protein,2266,263,0.94 [0.84-1.05],0.2826651004978793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CADPS,Calcium-dependent secretion activator 1,2262,271,0.91 [0.67-1.25],0.5727489623918556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,2636,313,1.12 [0.90-1.40],0.3073912115615388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,2589,310,1.64 [1.21-2.23],0.0015214875032009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,2636,319,1.28 [1.12-1.46],0.0002854230145749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,2300,272,1.28 [0.98-1.66],0.0661874285066687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2668,318,0.93 [0.84-1.02],0.1278376104538313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2243,264,0.94 [0.80-1.11],0.4864040742672988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALY,Neuron-specific vesicular protein calcyon,2242,265,0.84 [0.59-1.19],0.3217718659622727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2579,308,1.08 [0.86-1.36],0.4915258556141146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2262,271,1.15 [0.93-1.41],0.20099569714043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2304,274,0.94 [0.84-1.05],0.2849705125584211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CANT1,Soluble calcium-activated nucleotidase 1,2648,315,1.29 [0.80-2.07],0.3007971697265189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,2636,315,1.07 [0.91-1.26],0.383058779942833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPN3,Calpain-3,2297,268,0.86 [0.62-1.20],0.3770238544061942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPS,Calcyphosin,2300,272,0.98 [0.87-1.11],0.7857477848068417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,2589,310,0.76 [0.62-0.93],0.0084565727020085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASC3,Protein CASC3,2262,271,0.94 [0.72-1.24],0.6654895015611646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP1,Caspase-1,2589,310,0.89 [0.76-1.03],0.1056000847615013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,2589,310,0.85 [0.74-0.98],0.0258866708095138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP2,Caspase-2,2664,320,0.89 [0.77-1.03],0.1288153667326101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP3,Caspase-3,2695,322,0.94 [0.84-1.05],0.2706731596630827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP4,Caspase-4,2271,266,0.98 [0.92-1.05],0.6262053202586626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP7,Caspase-7,2300,272,0.92 [0.80-1.06],0.2410767776064931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP8,Caspase-8,2671,318,0.93 [0.79-1.09],0.3519269196287048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP9,Caspase-9,2244,268,0.86 [0.70-1.06],0.1497929100558695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASQ2,Calsequestrin-2,2242,265,1.07 [0.81-1.40],0.6469558998054856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAT,Catalase,2280,267,0.81 [0.66-1.01],0.0625814956897816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,2656,314,1.24 [1.10-1.40],0.0003519690190365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN1,Cerebellin-1,2244,266,1.02 [0.88-1.17],0.800614410453115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,2676,318,0.76 [0.57-1.01],0.0613475426668544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBS,Cystathionine beta-synthase,2243,264,0.84 [0.68-1.05],0.1187228715381304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBX2,Chromobox protein homolog 2,2242,265,1.02 [0.75-1.40],0.8767171943650321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2641,320,0.88 [0.77-1.02],0.0852432420804701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,2300,272,1.11 [0.92-1.35],0.2634526129181191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC134,Coiled-coil domain-containing protein 134,2297,268,1.09 [0.85-1.40],0.479294428312091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC28A,Coiled-coil domain-containing protein 28A,2262,271,1.32 [0.89-1.96],0.1620788901585818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC50,Coiled-coil domain-containing protein 50,2304,274,1.00 [0.85-1.17],0.9956996349604432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC80,Coiled-coil domain-containing protein 80,2658,316,1.31 [1.00-1.71],0.0536525962798751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2243,264,1.01 [0.85-1.21],0.911201027900723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,2692,319,1.73 [1.34-2.24],2.6026930305677428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL13,C-C motif chemokine 13,2686,318,1.02 [0.89-1.18],0.7546902342789716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,2656,316,1.48 [1.19-1.84],0.0004981582744974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,2695,322,1.68 [1.38-2.04],1.370661066284025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,2695,322,1.11 [0.92-1.33],0.2720228776322353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL17,C-C motif chemokine 17,2663,317,0.94 [0.85-1.05],0.2710275778169093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL18,C-C motif chemokine 18,2631,313,0.96 [0.83-1.11],0.5431952851781525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL19,C-C motif chemokine 19,2678,319,1.00 [0.92-1.08],0.9588842111870324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL2,C-C motif chemokine 2,2637,320,1.07 [0.88-1.29],0.4995044884950961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL20,C-C motif chemokine 20,2692,319,1.06 [0.95-1.18],0.2937755199578967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,2674,318,1.49 [1.23-1.82],6.619449564206709e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL22,C-C motif chemokine 22,2643,316,0.88 [0.73-1.06],0.1645229421763495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL23,C-C motif chemokine 23,2674,318,0.92 [0.74-1.15],0.4755982425942247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL24,C-C motif chemokine 24,2672,317,0.98 [0.87-1.10],0.6978705025216858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,2692,319,1.74 [1.43-2.12],4.1691963137352016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL26,C-C motif chemokine 26,2664,320,0.93 [0.83-1.03],0.1601077609014963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL27,C-C motif chemokine 27,2658,316,0.92 [0.79-1.08],0.3058727845488899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,2660,320,1.21 [1.04-1.42],0.0147837030959654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL3,C-C motif chemokine 3,2664,320,1.11 [0.99-1.24],0.081556426573087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL4,C-C motif chemokine 4,2669,318,1.05 [0.90-1.22],0.5455975676615479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL5,C-C motif chemokine 5,2668,319,0.98 [0.89-1.08],0.6872770977772202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,2664,320,1.09 [0.91-1.30],0.3446773301323894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL8,C-C motif chemokine 8,2674,318,1.07 [0.91-1.26],0.4150093993362498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,2634,313,0.87 [0.76-1.00],0.0446230554573664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN2,CCN family member 2,2661,316,1.04 [0.87-1.24],0.674837163427598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,2689,322,1.23 [0.94-1.60],0.125774824293512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,2676,318,1.68 [1.34-2.10],6.372235551079593e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,2670,320,1.56 [1.22-2.01],0.0004745988979097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCND2,G1/S-specific cyclin-D2,2271,266,0.94 [0.69-1.27],0.677639562715995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCNE1,G1/S-specific cyclin-E1,2244,268,0.98 [0.85-1.14],0.8201572625915755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,2641,320,0.68 [0.55-0.84],0.0004694689696367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,2579,308,0.73 [0.57-0.93],0.0114338990495818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,2307,271,1.35 [1.04-1.76],0.0268044207149208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,2670,320,1.33 [1.01-1.76],0.0453540574027032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,2613,310,1.87 [1.48-2.37],1.849788265068006e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,2692,319,1.71 [1.43-2.05],5.748806327496636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2668,319,1.38 [1.12-1.71],0.0030319842570912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,2670,320,1.70 [1.27-2.27],0.0003370090673611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,2262,271,1.02 [0.75-1.41],0.8800785127421377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD177,CD177 antigen,2663,320,0.98 [0.91-1.06],0.5842475949961696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,2658,318,0.68 [0.48-0.95],0.0249729932307223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2,T-cell surface antigen CD2,2242,265,1.15 [0.88-1.50],0.3084112325882965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,2664,320,1.69 [1.23-2.30],0.0010141854686828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,2655,319,0.95 [0.72-1.25],0.6925582979855323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,2588,309,1.45 [1.13-1.85],0.0029615230048433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD209,CD209 antigen,2676,321,1.14 [0.87-1.49],0.3464460415991415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD22,B-cell receptor CD22,2692,319,1.19 [0.96-1.48],0.1194626023323546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD226,CD226 antigen,2244,268,1.04 [0.79-1.38],0.7783535189834284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD244,Natural killer cell receptor 2B4,2692,319,1.30 [0.92-1.83],0.1385561501912581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,2316,272,0.73 [0.55-0.96],0.022320107566178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,2658,318,2.30 [1.90-2.79],3.0491488701802097e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,2641,320,1.30 [1.00-1.69],0.0458713669973864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,2663,317,2.54 [1.96-3.28],1.0476081791758597e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,2579,308,1.53 [1.18-1.97],0.001246821093554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,2658,316,0.86 [0.73-1.01],0.0607069253728376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,2268,265,1.32 [0.91-1.92],0.1448875490523554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,2678,319,1.61 [1.24-2.09],0.0003329347417539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,2668,316,1.39 [1.11-1.73],0.004157320625288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,2676,318,1.27 [1.08-1.49],0.0036361874426516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,2670,320,1.33 [1.04-1.70],0.0242383574889433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,2636,313,1.84 [1.42-2.38],3.7495454769349127e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD33,Myeloid cell surface antigen CD33,2658,318,0.95 [0.84-1.08],0.4621614148684182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD34,Hematopoietic progenitor cell antigen CD34,2671,317,1.15 [0.77-1.72],0.4902750327858942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD36,Platelet glycoprotein 4,2244,268,1.26 [0.99-1.61],0.0640159123572394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2636,313,1.17 [0.88-1.55],0.2940475699132999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3D,T-cell surface glycoprotein CD3 delta chain,2244,266,0.92 [0.62-1.35],0.6534732098892464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,2271,266,1.00 [0.70-1.43],0.9954564786754542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,2244,268,1.00 [0.88-1.14],0.9637506375881466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,2663,320,1.61 [1.20-2.17],0.0016946752343652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,2667,317,1.22 [1.02-1.47],0.0276310981216744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40LG,CD40 ligand,2692,319,0.94 [0.83-1.06],0.2875303087450674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,2644,312,1.66 [1.20-2.29],0.0020446136855151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,2672,317,1.85 [1.33-2.56],0.0002382290840968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,2674,318,1.59 [1.25-2.02],0.0001775629780859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,2569,303,1.66 [1.18-2.34],0.0035023295489002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD58,Lymphocyte function-associated antigen 3,2656,317,1.07 [0.62-1.87],0.8014333508858413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,2554,303,1.86 [1.29-2.67],0.0009083630066469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5L,CD5 antigen-like,2297,270,0.96 [0.76-1.22],0.7525246855227761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD6,T-cell differentiation antigen CD6,2686,319,0.99 [0.82-1.20],0.9249951417487572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD63,CD63 antigen,2637,320,1.06 [0.86-1.30],0.5777144744903682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD69,Early activation antigen CD69,2645,314,0.93 [0.83-1.04],0.2130943257275905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,2238,268,1.47 [1.14-1.90],0.0032963828622273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,2664,320,1.13 [0.91-1.41],0.2761788160831067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD72,B-cell differentiation antigen CD72,2268,265,1.19 [0.91-1.56],0.1920343120674261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,2678,319,2.23 [1.72-2.90],1.7969371540087395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2692,319,1.68 [1.38-2.04],2.092284898381435e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,2304,270,1.67 [1.23-2.26],0.0009092909386486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD82,CD82 antigen,2271,266,1.00 [0.76-1.31],0.9990822436284976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,2664,320,1.40 [1.08-1.82],0.0121112420088157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD84,SLAM family member 5,2664,320,0.79 [0.58-1.06],0.1140214928574341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD86,T-lymphocyte activation antigen CD86,2307,271,0.78 [0.53-1.15],0.2108935640994069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2678,319,1.30 [1.08-1.55],0.0044022891413544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,2582,304,1.50 [1.11-2.03],0.0081258431800613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,2670,320,2.13 [1.33-3.41],0.0015556713914757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,2670,320,1.23 [0.83-1.82],0.2946901260721245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,2301,270,0.72 [0.56-0.92],0.0098998261784677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDAN1,Codanin-1,2300,272,1.00 [0.64-1.57],0.9907549675044592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC123,Cell division cycle protein 123 homolog,2224,264,0.86 [0.70-1.06],0.1521544731426388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC25A,M-phase inducer phosphatase 1,2224,264,0.77 [0.54-1.08],0.1316616103394855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC26,Anaphase-promoting complex subunit CDC26,2303,270,0.93 [0.78-1.10],0.3864936405819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,2579,308,0.96 [0.81-1.14],0.6600791294755288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC37,Hsp90 co-chaperone Cdc37,2658,318,0.92 [0.81-1.03],0.15907139169131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,2307,271,0.92 [0.82-1.04],0.183671520089521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDCP1,CUB domain-containing protein 1,2641,320,1.17 [1.00-1.38],0.0556024714298714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,2571,305,2.05 [1.75-2.40],4.79896790198571e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,2673,318,1.17 [1.05-1.30],0.0042290992471527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,2658,316,1.51 [1.34-1.71],1.167770355760415e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH2,Cadherin-2,2658,316,1.02 [0.79-1.31],0.8879098883818952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH22,Cadherin-22,2271,266,1.10 [0.72-1.68],0.670555038560354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,2300,272,1.02 [0.64-1.62],0.9437459540078282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,2678,319,1.57 [1.23-2.00],0.0002913800841968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH4,Cadherin-4,2244,266,0.82 [0.62-1.10],0.1835655756674896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,2695,322,1.49 [1.09-2.04],0.0115805668079578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,2658,316,1.34 [1.05-1.72],0.0204561836734132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR1,Cadherin-related family member 1,2589,310,1.05 [0.85-1.30],0.6416277117832252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,2636,313,0.87 [0.75-1.02],0.0780248061222808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR5,Cadherin-related family member 5,2658,316,0.91 [0.70-1.17],0.4553600337768637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK1,Cyclin-dependent kinase 1,2224,264,0.87 [0.63-1.21],0.4020686663615299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2304,274,1.05 [0.86-1.28],0.6612213410658208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKL5,Cyclin-dependent kinase-like 5,2244,266,1.01 [0.78-1.29],0.9676758486053906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,2636,313,0.95 [0.87-1.04],0.2815884750446941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2636,313,0.93 [0.84-1.04],0.1959128284638839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,2636,313,1.17 [0.91-1.49],0.2237758146711385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2668,317,1.30 [0.90-1.87],0.1624125340339694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,2682,319,1.22 [0.98-1.52],0.0716624517493573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2654,318,1.07 [0.75-1.51],0.7169248522191025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2307,271,0.84 [0.73-0.96],0.013319334019037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2271,266,1.02 [0.88-1.18],0.7769754308306108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2307,271,1.06 [0.80-1.41],0.6913828717386676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2271,266,1.01 [0.77-1.32],0.9663054446781028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2664,320,1.14 [1.03-1.27],0.0142364462670454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2579,308,1.11 [0.90-1.36],0.3370161930368927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2555,308,1.19 [1.02-1.40],0.0297465063199132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2316,272,1.06 [0.80-1.40],0.6943812257562237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2616,315,1.04 [0.86-1.26],0.7006441438188544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPA,CCAAT/enhancer-binding protein alpha,2244,268,0.82 [0.56-1.20],0.3015744871813756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPB,CCAAT/enhancer-binding protein beta,2616,315,0.79 [0.61-1.03],0.0806443846335675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA2A,Chymotrypsin-like elastase family member 2A,2316,272,0.99 [0.84-1.16],0.8962377280282341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA3A,Chymotrypsin-like elastase family member 3A,2691,322,1.07 [0.93-1.23],0.3118553242631969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2268,265,0.73 [0.49-1.08],0.1185854755107894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEMIP2,Cell surface hyaluronidase,2244,268,0.91 [0.62-1.36],0.6545660406164248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,2244,266,1.01 [0.83-1.22],0.956705320235684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPF,Centromere protein F,2271,266,0.87 [0.69-1.09],0.2127343542178811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,2271,266,1.01 [0.86-1.19],0.8999291633357305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP112,Centrosomal protein of 112 kDa,2242,265,0.81 [0.59-1.12],0.2070185929999815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP152,Centrosomal protein of 152 kDa,2224,264,1.01 [0.77-1.34],0.9335450097295964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP164,Centrosomal protein of 164 kDa,2601,309,1.01 [0.87-1.18],0.8574105565383472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP170,Centrosomal protein of 170 kDa,2243,264,0.92 [0.78-1.09],0.3434839182084908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,2579,308,0.92 [0.80-1.06],0.2628158607300743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP290,Centrosomal protein of 290 kDa,2271,266,0.99 [0.79-1.24],0.951074447343267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP350,Centrosome-associated protein 350,2224,264,0.93 [0.67-1.30],0.6772361442970674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,2599,312,0.92 [0.79-1.06],0.2439509737391942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,2579,308,0.83 [0.71-0.98],0.0269878806952499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CERT,Ceramide transfer protein,2589,310,0.93 [0.79-1.10],0.4182181615657814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,2669,319,0.94 [0.85-1.03],0.176330200856166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,2636,313,1.24 [1.05-1.46],0.0109535347787117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES3,Carboxylesterase 3,2636,313,0.88 [0.76-1.02],0.0862019429928908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN2,Centrin-2,2589,310,0.92 [0.79-1.07],0.2996530129924157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN3,Centrin-3,2307,271,0.91 [0.78-1.06],0.2355041019983945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFB,Complement factor B,2270,266,1.17 [0.82-1.67],0.3886028416909799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,2579,308,1.24 [1.03-1.50],0.0249787994525988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,2309,270,0.83 [0.47-1.46],0.5183380910542303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFH,Complement factor H,2184,258,1.09 [0.64-1.86],0.7407594423426302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,2294,269,1.32 [1.06-1.66],0.0147610630723042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR4,Complement factor H-related protein 4,2306,270,1.10 [0.93-1.29],0.2639028981188879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR5,Complement factor H-related protein 5,2277,268,0.91 [0.71-1.17],0.4777503159253266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFI,Complement factor I,2309,270,0.92 [0.51-1.66],0.7895251946498026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,2309,270,0.42 [0.24-0.72],0.0016655534110158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,2670,320,1.41 [1.22-1.62],1.947005034871881e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2315,273,1.45 [1.05-2.01],0.022721662535699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGN,Cingulin,2262,271,0.74 [0.53-1.05],0.0891016309123483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2658,316,1.62 [1.32-1.98],4.341752392951152e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2579,308,0.84 [0.70-1.02],0.0719285249334658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,2268,265,0.39 [0.31-0.49],1.3939868867124791e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2300,272,1.60 [1.25-2.06],0.0002442260165094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD6,MICOS complex subunit MIC25,2297,268,1.20 [0.86-1.68],0.2831069205437514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHEK2,Serine/threonine-protein kinase Chk2,2616,315,0.91 [0.66-1.24],0.5397868052457999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,2316,272,1.17 [1.05-1.29],0.0027385484095047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,2666,317,1.55 [1.25-1.92],5.7193071385443387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,2600,308,1.18 [1.06-1.32],0.0021633209711142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHIT1,Chitotriosidase-1,2678,319,0.98 [0.92-1.04],0.4546241266664382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,2664,319,1.63 [1.21-2.19],0.0011225391745543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHM,Rab proteins geranylgeranyltransferase component A 1,2262,271,0.87 [0.71-1.06],0.175398899974235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP1A,Charged multivesicular body protein 1a,2641,320,0.98 [0.86-1.11],0.7544123498004944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP6,Charged multivesicular body protein 6,2304,270,0.85 [0.69-1.04],0.1063296220722633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHP1,Calcineurin B homologous protein 1,2244,266,0.90 [0.76-1.08],0.2772286373027984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,2672,317,1.72 [1.30-2.29],0.0001588022325611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL2,Chordin-like protein 2,2658,316,0.83 [0.67-1.02],0.0694911247020984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,2262,271,0.91 [0.66-1.25],0.5589959466877096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,2658,318,0.91 [0.77-1.07],0.2594642215922043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,2316,272,1.57 [1.26-1.95],5.679297699877354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CINP,Cyclin-dependent kinase 2-interacting protein,2271,266,0.91 [0.68-1.20],0.4877049381236115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIRBP,Cold-inducible RNA-binding protein,2307,271,0.94 [0.83-1.06],0.3155044336797311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,2262,271,0.85 [0.65-1.10],0.2203061120149603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,2681,319,2.10 [1.63-2.70],7.361554612875462e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,2316,272,1.28 [1.06-1.54],0.0092747685474803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2655,317,1.34 [1.15-1.57],0.0002365359716954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLASP1,CLIP-associating protein 1,2224,264,0.96 [0.82-1.12],0.6032596347868436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,2654,316,1.16 [1.01-1.33],0.0406726307791045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,2641,320,1.36 [1.03-1.78],0.0277025703520253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC11A,C-type lectin domain family 11 member A,2665,319,0.85 [0.70-1.03],0.1036176573888923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC12A,C-type lectin domain family 12 member A,2244,268,0.67 [0.36-1.25],0.2093589514235328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,2670,320,1.61 [1.22-2.12],0.0007833751263544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,2616,315,1.29 [0.98-1.70],0.0669160592320348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1B,C-type lectin domain family 1 member B,2678,319,0.96 [0.86-1.06],0.3960066260146246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,2262,271,1.10 [0.87-1.38],0.4259549794352958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,2257,264,0.29 [0.17-0.48],2.301296882663367e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4A,C-type lectin domain family 4 member A,2664,320,0.86 [0.66-1.11],0.2476830975512763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,2664,320,0.90 [0.74-1.10],0.3160140021522614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,2664,320,1.22 [1.06-1.41],0.0069851312809576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4G,C-type lectin domain family 4 member G,2664,320,0.97 [0.72-1.30],0.8263889614559405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4M,C-type lectin domain family 4 member M,2314,272,0.80 [0.62-1.03],0.0845062181180616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,2653,316,1.42 [1.05-1.91],0.0214443118597362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,2579,308,1.24 [1.02-1.51],0.0302006425862758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,2692,319,1.38 [1.14-1.66],0.0008671839360912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLGN,Calmegin,2262,271,1.21 [0.94-1.57],0.1453951052530457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIC5,Chloride intracellular channel protein 5,2262,271,1.02 [0.71-1.48],0.899214704850515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLINT1,Clathrin interactor 1,2224,264,1.02 [0.79-1.33],0.8790442789997494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIP2,CAP-Gly domain-containing linker protein 2,2664,320,0.95 [0.87-1.03],0.2251879175467588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,2676,318,1.92 [1.29-2.85],0.0011964410202563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLNS1A,Methylosome subunit pICln,2262,271,0.71 [0.49-1.03],0.0703524116876505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2636,319,1.01 [0.91-1.12],0.8634215912836979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPS,Colipase,2663,320,1.05 [0.93-1.19],0.3967955350622433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSPN,Claspin,2584,309,0.91 [0.67-1.24],0.5604058246451917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,2589,310,0.78 [0.63-0.97],0.0278829093155319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,2692,319,1.37 [1.11-1.69],0.0036728486978738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN3,Calsyntenin-3,2300,272,0.83 [0.57-1.20],0.3180994548319434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,2616,315,0.92 [0.73-1.16],0.4695741060567968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLU,Clusterin,2309,270,1.24 [0.78-1.96],0.3657473569954287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLUL1,Clusterin-like protein 1,2654,316,0.88 [0.71-1.08],0.2266088504575671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMC1,COX assembly mitochondrial protein homolog,2304,270,0.93 [0.82-1.06],0.2938048904553003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMIP,C-Maf-inducing protein,2297,268,0.98 [0.85-1.13],0.7835674997638349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,2668,319,1.30 [1.05-1.61],0.0157593656794054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,2244,266,0.98 [0.79-1.22],0.8844256559657878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2240,264,0.95 [0.82-1.11],0.5422884561578369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY2,Protein canopy homolog 2,2616,315,0.85 [0.70-1.03],0.0923244991934585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY4,Protein canopy homolog 4,2636,313,0.96 [0.84-1.10],0.5588381655849568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNST,Consortin,2658,316,0.96 [0.87-1.05],0.3249390450365602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTF,Ciliary neurotrophic factor,2244,266,0.83 [0.59-1.17],0.2815324233006242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,2695,322,2.02 [1.42-2.87],8.378983729644914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,2676,318,1.48 [1.20-1.84],0.000256144172046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN3,Contactin-3,2670,320,1.29 [0.93-1.79],0.1232919615893807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,2670,320,1.40 [0.93-2.10],0.109557692504818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,2665,315,0.90 [0.69-1.17],0.4138022626136877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP2,Contactin-associated protein-like 2,2664,320,1.13 [0.91-1.41],0.251868749305851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP4,Contactin-associated protein-like 4,2262,271,1.01 [0.90-1.13],0.878350960838485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COCH,Cochlin,2304,270,0.82 [0.64-1.05],0.1203272325088613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,2316,272,0.45 [0.30-0.67],0.0001043994893517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,2672,319,2.46 [1.69-3.58],2.772615399145492e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,2695,322,0.39 [0.26-0.60],1.4342312859613834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL24A1,Collagen alpha-1(XXIV) chain,2307,271,1.01 [0.83-1.23],0.9257590682515326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL28A1,Collagen alpha-1(XXVIII) chain,2262,271,1.08 [0.94-1.23],0.2692993838058212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL2A1,Collagen alpha-1(II) chain,2243,264,0.98 [0.84-1.14],0.7734457849245211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL3A1,Collagen alpha-1(III) chain,2316,272,0.83 [0.51-1.35],0.4585057355064504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,2658,316,1.79 [1.48-2.17],2.3115603584102997e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A4,Collagen alpha-4(IV) chain,2265,265,1.05 [0.83-1.33],0.6680105791815516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL5A1,Collagen alpha-1(V) chain,2268,265,1.02 [0.79-1.31],0.8796998460919586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,2695,322,1.61 [1.27-2.04],6.892262622545516e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A1,Collagen alpha-1(IX) chain,2664,320,0.83 [0.66-1.03],0.0886197698983841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A2,Collagen alpha-2(IX) chain,2271,266,0.98 [0.73-1.31],0.8796300296879656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,2663,317,1.95 [1.42-2.68],3.9499523713391273e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD1,COMM domain-containing protein 1,2243,264,0.96 [0.79-1.18],0.7172294415447729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD9,COMM domain-containing protein 9,2297,268,0.92 [0.68-1.24],0.5755530767197642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,2634,315,0.72 [0.54-0.96],0.0239364770340128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMT,Catechol O-methyltransferase,2594,313,0.92 [0.81-1.05],0.2252696708451805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPB2,Coatomer subunit beta',2242,265,0.90 [0.68-1.18],0.4418799010311079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPE,Coatomer subunit epsilon,2589,310,0.96 [0.77-1.20],0.721479998638412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2243,264,1.08 [0.80-1.46],0.6152233342534148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO1A,Coronin-1A,2609,308,0.99 [0.88-1.11],0.8855486530079413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,2244,266,1.02 [0.77-1.36],0.8778873347490983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2636,313,1.03 [0.89-1.19],0.7034188288333305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX6B1,Cytochrome c oxidase subunit 6B1,2304,270,0.92 [0.64-1.32],0.65829204873455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,2695,322,0.94 [0.83-1.07],0.3703720146316934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,2671,318,1.58 [1.40-1.78],3.935704570992405e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,2217,256,0.74 [0.57-0.97],0.0271846041694018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB1,Carboxypeptidase B,2695,322,0.98 [0.85-1.12],0.7297528311918761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB2,Carboxypeptidase B2,2304,270,0.98 [0.58-1.64],0.9370696578543284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,2653,313,1.05 [0.81-1.36],0.7141055128818603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPLX2,Complexin-2,2224,264,1.04 [0.71-1.54],0.8407644772918758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,2661,315,1.69 [1.30-2.18],6.498198602368511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2244,268,0.54 [0.34-0.86],0.0088871981694239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,2678,319,0.87 [0.74-1.01],0.0654843086913054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPQ,Carboxypeptidase Q,2314,272,1.20 [0.88-1.62],0.2508345579125743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPTP,Ceramide-1-phosphate transfer protein,2242,265,1.20 [0.87-1.65],0.2569913126235089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,2672,318,1.46 [1.14-1.87],0.0030359623457116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM1,Probable carboxypeptidase X1,2658,318,1.10 [0.96-1.26],0.1764943687561271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,2304,270,1.61 [1.05-2.46],0.0286442291662441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR1,Complement receptor type 1,2307,272,1.02 [0.75-1.38],0.9034102972496736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,2668,319,1.26 [1.04-1.54],0.0194762180345102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2579,308,0.90 [0.79-1.02],0.0929814366884042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRADD,Death domain-containing protein CRADD,2636,319,0.91 [0.79-1.04],0.1562422069505324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREB3,Cyclic AMP-responsive element-binding protein 3,2224,264,0.94 [0.74-1.19],0.588816841230541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREBZF,CREB/ATF bZIP transcription factor,2224,264,1.17 [0.74-1.88],0.5010480304452096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,2620,311,0.61 [0.48-0.76],1.978427801067157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,2268,265,1.29 [0.95-1.75],0.1041587902485879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,2672,317,1.15 [0.96-1.37],0.1351616098071252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRH,Corticoliberin,2577,308,0.91 [0.80-1.03],0.1197679343076342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,2663,317,1.56 [1.10-2.21],0.0119578980160356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHR1,Corticotropin-releasing factor receptor 1,2616,315,1.08 [0.93-1.26],0.3163829102170785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,2674,318,2.42 [1.54-3.80],0.0001199864110584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,2641,320,1.25 [0.96-1.63],0.0958104883626561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,2676,318,0.87 [0.73-1.03],0.1059138040485061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,2295,271,0.44 [0.30-0.66],5.199029776657328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRKL,Crk-like protein,2665,317,0.94 [0.85-1.03],0.1987882323957651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRLF1,Cytokine receptor-like factor 1,2674,318,1.27 [0.87-1.86],0.2141983630785355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRNN,Cornulin,2570,312,1.08 [0.94-1.25],0.2931362498250443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,2695,322,0.73 [0.54-0.98],0.0372497205875151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2641,320,1.36 [1.12-1.65],0.0019118034267888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAP,Cartilage-associated protein,2262,271,0.95 [0.73-1.22],0.6676760593622991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRX,Cone-rod homeobox protein,2616,315,0.94 [0.84-1.05],0.2491840745456204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB1,Beta-crystallin B1,2304,270,0.94 [0.78-1.12],0.4652472842714897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,2300,272,0.90 [0.78-1.06],0.2038967835075046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYGD,Gamma-crystallin D,2300,272,0.96 [0.86-1.09],0.5399057196353644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYM,Ketimine reductase mu-crystallin,2244,266,1.06 [0.90-1.25],0.4675403073719842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYZL1,Quinone oxidoreductase-like protein 1,2243,264,0.93 [0.81-1.07],0.3050718946425322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSDE1,Cold shock domain-containing protein E1,2242,265,0.98 [0.88-1.09],0.6721037238883143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,2674,318,1.70 [1.21-2.38],0.002218699103076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,2315,273,1.27 [0.98-1.66],0.0704858849791077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2,Granulocyte-macrophage colony-stimulating factor,2242,265,1.28 [0.96-1.71],0.0954821804096094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2641,320,1.14 [0.97-1.34],0.1009313854712089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RB,Cytokine receptor common subunit beta,2244,268,0.90 [0.68-1.18],0.443802049906694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3,Granulocyte colony-stimulating factor,2601,309,0.82 [0.66-1.01],0.0615455443191199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3R,Granulocyte colony-stimulating factor receptor,2244,268,0.82 [0.55-1.20],0.3000673978687372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSH1,Chorionic somatomammotropin hormone 1,2315,273,0.79 [0.53-1.19],0.2626092746219013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK1D,Casein kinase I isoform delta,2244,268,0.88 [0.72-1.08],0.232211306356673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK2A1,Casein kinase II subunit alpha,2304,274,1.02 [0.79-1.33],0.8645418752693944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,2316,272,1.30 [0.93-1.82],0.1301540620934701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,2244,266,0.74 [0.57-0.98],0.0333842796025736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSRP3,Cysteine and glycine-rich protein 3,2242,265,1.07 [0.96-1.20],0.2333292345888142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST1,Cystatin-SN,2027,243,1.02 [0.91-1.15],0.7260685510955176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,2660,319,1.71 [1.27-2.31],0.0004324038390511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,2617,318,1.18 [0.99-1.41],0.0620836264940075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST6,Cystatin-M,2583,307,1.08 [0.89-1.31],0.4418866892615571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST7,Cystatin-F,2669,318,1.00 [0.90-1.11],0.9651245010988284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,2633,312,1.01 [0.80-1.26],0.9623304155720702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,2268,266,0.83 [0.64-1.06],0.1359922463202252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTBS,Di-N-acetylchitobiase,2277,266,1.27 [0.85-1.91],0.246878181038249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTF1,Cardiotrophin-1,2616,315,0.98 [0.86-1.10],0.6890087671460146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2316,272,1.68 [1.18-2.41],0.0045233977175928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,2316,272,1.02 [0.70-1.48],0.9252892932629676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,2244,266,0.94 [0.63-1.41],0.7757813567052683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRB1,Chymotrypsinogen B,2670,320,1.00 [0.86-1.15],0.9468765790642374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,2667,317,0.91 [0.80-1.04],0.1755609109810992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRL,Chymotrypsin-like protease CTRL-1,2300,272,0.92 [0.79-1.05],0.2174224989963858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,2660,316,1.26 [1.04-1.52],0.020534491789999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSC,Dipeptidyl peptidase 1,2654,317,0.81 [0.65-1.01],0.0614727218106078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSD,Cathepsin D,2498,296,1.22 [0.98-1.51],0.0792637108918668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,2268,265,1.44 [1.18-1.76],0.0003982482755172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSF,Cathepsin F,2658,318,1.26 [0.98-1.60],0.0687270238886625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,2612,315,1.26 [1.10-1.44],0.0008162583789477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,2658,316,1.78 [1.23-2.58],0.0021314284185153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,2692,319,1.80 [1.34-2.40],7.53697672321747e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,2104,233,2.37 [1.45-3.88],0.0006240056328768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,2665,316,1.00 [0.80-1.25],0.9919685768940434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,2660,317,1.61 [1.22-2.14],0.0008148081647697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2262,271,1.32 [1.13-1.54],0.0004584671980285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CWC15,Spliceosome-associated protein CWC15 homolog,2293,269,1.02 [0.85-1.22],0.8623300302159349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,2641,320,1.48 [1.13-1.94],0.0048365885597801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,2664,320,1.22 [1.00-1.48],0.0456811674411341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL1,Growth-regulated alpha protein,2664,317,1.06 [0.95-1.17],0.3175303113373791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL10,C-X-C motif chemokine 10,2674,318,0.95 [0.82-1.11],0.5365345284438345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL11,C-X-C motif chemokine 11,2678,319,0.95 [0.83-1.08],0.4115762716227277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL12,Stromal cell-derived factor 1,2601,309,0.96 [0.75-1.23],0.747908765443446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL13,C-X-C motif chemokine 13,2678,319,1.09 [0.93-1.28],0.3070462073348284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL14,C-X-C motif chemokine 14,2601,309,1.03 [0.87-1.22],0.703638976826003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,2694,322,1.57 [1.06-2.33],0.0254466289966639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL17,C-X-C motif chemokine 17,2692,319,0.88 [0.70-1.10],0.2565519103798206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL3,C-X-C motif chemokine 3,2667,317,0.97 [0.87-1.07],0.504065271152815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL5,C-X-C motif chemokine 5,2651,315,1.02 [0.94-1.11],0.568868649623718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL6,C-X-C motif chemokine 6,2692,319,1.06 [0.93-1.21],0.3711537780483823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,2631,313,1.14 [1.01-1.29],0.0362735538318334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,2674,318,1.24 [1.07-1.43],0.0037654418293908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5A,Cytochrome b5,2224,264,0.85 [0.70-1.03],0.1033774035524136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5R2,NADH-cytochrome b5 reductase 2,2281,270,1.06 [0.87-1.29],0.5748753299668554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2242,265,0.87 [0.74-1.02],0.0850025598159566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTH3,Cytohesin-3,2224,264,1.11 [0.94-1.30],0.212849337240406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,2316,272,0.58 [0.37-0.90],0.0157517971902094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAAM1,Disheveled-associated activator of morphogenesis 1,2268,265,0.92 [0.79-1.06],0.243377318173592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAB2,Disabled homolog 2,2676,318,0.95 [0.87-1.04],0.2485513599201888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,2674,318,1.19 [0.96-1.48],0.1029131176686814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAND5,DAN domain family member 5,2244,268,1.03 [0.86-1.22],0.7676251365700428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPK2,Death-associated protein kinase 2,2244,268,0.89 [0.71-1.10],0.2858273185257206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2664,320,0.97 [0.89-1.04],0.375482691107734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",2636,319,0.86 [0.75-0.99],0.0312239945010497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBH,Dopamine beta-hydroxylase,2312,273,0.95 [0.86-1.04],0.2555567376638474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,2654,317,0.99 [0.87-1.14],0.927395963785986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBN1,Drebrin,2244,268,0.94 [0.74-1.19],0.5871343074675328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBNL,Drebrin-like protein,2674,318,0.95 [0.85-1.06],0.3304786990960174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2658,318,2.39 [1.83-3.10],8.860668455631406e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,2262,271,0.36 [0.19-0.69],0.0017855470204552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCDC2C,Doublecortin domain-containing protein 2C,2224,264,1.00 [0.82-1.21],0.9965539420842848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,2224,264,0.57 [0.37-0.86],0.0077590327599046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,2616,315,2.70 [1.83-3.97],4.832872785403314e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTD,Deoxycytidylate deaminase,2268,265,0.94 [0.83-1.07],0.3568411099098132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN1,Dynactin subunit 1,2676,318,0.87 [0.74-1.02],0.0843603962325935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN2,Dynactin subunit 2,2636,313,1.01 [0.91-1.12],0.8696949946141198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,2589,310,0.89 [0.76-1.04],0.1306717370111955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,2658,316,0.64 [0.46-0.88],0.0062193750766314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D1,DCN1-like protein 1,2244,266,0.94 [0.80-1.12],0.4976604035929132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D2,DCN1-like protein 2,2224,264,1.04 [0.90-1.20],0.6354508553445006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,2658,318,0.79 [0.67-0.93],0.0055988788295428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDA1,DET1- and DDB1-associated protein 1,2242,265,0.88 [0.62-1.26],0.4872045196885772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2636,313,0.97 [0.78-1.21],0.7867709480002156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDC,Aromatic-L-amino-acid decarboxylase,2656,314,0.92 [0.75-1.11],0.381255797720728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDHD2,Phospholipase DDHD2,2304,274,0.93 [0.78-1.11],0.4316813656406724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,2268,265,0.83 [0.71-0.97],0.01888411642524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,2678,319,1.80 [1.22-2.64],0.0027793703778241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,2316,272,0.71 [0.53-0.94],0.015757246298349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,2307,271,1.17 [0.92-1.49],0.212339425809868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,2262,271,1.19 [0.86-1.65],0.2884364332082209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX39A,ATP-dependent RNA helicase DDX39A,2244,268,1.18 [0.72-1.92],0.517630921857448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX4,Probable ATP-dependent RNA helicase DDX4,2244,268,0.85 [0.65-1.09],0.1979510754989865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX53,Probable ATP-dependent RNA helicase DDX53,2262,271,0.89 [0.64-1.24],0.4839421596588854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,2579,308,0.81 [0.67-0.98],0.0313368029572873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2664,320,0.99 [0.89-1.10],0.8411852707287735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFA1_DEFA1B,Neutrophil defensin 1,2615,314,1.15 [0.96-1.37],0.1207174005821102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,2229,267,1.18 [0.94-1.47],0.1488338691106386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB104A_DEFB104B,Beta-defensin 104,2244,266,0.92 [0.72-1.18],0.5067728134590241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB116,Beta-defensin 116,2244,266,1.05 [0.90-1.22],0.5605110435800642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB118,Beta-defensin 118,2244,266,0.96 [0.78-1.19],0.7286450333605052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB4A_DEFB4B,Beta-defensin 4A,2616,311,1.02 [0.95-1.09],0.6514417681878812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENND2B,DENN domain-containing protein 2B,2242,265,0.93 [0.71-1.22],0.5839295539840608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENR,Density-regulated protein,2244,268,0.85 [0.69-1.06],0.1511652440013278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,2692,319,0.91 [0.78-1.06],0.2197452180942316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGCR6,Protein DGCR6,2244,266,0.81 [0.58-1.13],0.2054515603547007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKA,Diacylglycerol kinase alpha,2244,268,0.96 [0.77-1.19],0.6928810702279495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,2601,309,0.73 [0.55-0.99],0.0415770389745416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHODH,Dihydroorotate dehydrogenase,2242,265,0.87 [0.65-1.16],0.3437248262505392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHPS,Deoxyhypusine synthase,2297,268,1.10 [0.84-1.44],0.4900657224677139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2300,272,1.02 [0.80-1.29],0.8830946768529709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIABLO,"Diablo homolog, mitochondrial",2653,316,0.94 [0.86-1.03],0.199783222659773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK1C,Divergent protein kinase domain 1C,2262,271,1.15 [0.88-1.52],0.3076634392897483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK2B,Divergent protein kinase domain 2B,2268,265,0.82 [0.54-1.24],0.3477517772912064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK1,Dickkopf-related protein 1,2678,319,0.99 [0.84-1.17],0.9420145488782607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,2695,322,1.42 [1.03-1.96],0.0342795643015233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,2636,319,1.69 [1.41-2.04],2.581300228708705e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKKL1,Dickkopf-like protein 1,2636,313,1.01 [0.90-1.14],0.8304293222762305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLG4,Disks large homolog 4,2300,272,0.95 [0.81-1.12],0.5401719763751306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLGAP5,Disks large-associated protein 5,2304,274,0.82 [0.60-1.12],0.2167476903342724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLK1,Protein delta homolog 1,2695,322,0.91 [0.77-1.07],0.249271853473175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,2658,318,2.75 [2.10-3.62],3.7654891128636653e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL4,Delta-like protein 4,2243,264,0.98 [0.84-1.15],0.8059357800549781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMD,Dystrophin,2243,264,1.22 [0.97-1.53],0.0930763187599325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,2243,264,0.52 [0.45-0.61],2.228030304444577e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA1,DnaJ homolog subfamily A member 1,2224,264,0.99 [0.73-1.34],0.9345925863683532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA2,DnaJ homolog subfamily A member 2,2687,319,0.95 [0.84-1.07],0.3684594907127538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA4,DnaJ homolog subfamily A member 4,2300,272,0.94 [0.80-1.10],0.4192186633737367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,2636,313,0.90 [0.80-1.01],0.074360667357905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB14,DnaJ homolog subfamily B member 14,2307,271,0.98 [0.82-1.18],0.8181110480217768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,2268,265,0.79 [0.63-0.99],0.0376286046600577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB6,DnaJ homolog subfamily B member 6,2246,262,0.95 [0.83-1.10],0.4983983662245265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB8,DnaJ homolog subfamily B member 8,2616,315,0.92 [0.75-1.13],0.4471817083746751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC21,DnaJ homolog subfamily C member 21,2300,272,0.88 [0.65-1.18],0.3878965047426982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,2243,264,0.88 [0.77-1.02],0.0888115243501238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,2307,271,0.85 [0.72-0.99],0.0368236000363189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,2660,316,0.78 [0.54-1.12],0.1820749687984238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNLZ,DNL-type zinc finger protein,2244,266,0.85 [0.71-1.01],0.0691215727289466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM1,Dynamin-1,2307,271,0.97 [0.87-1.07],0.5288572464442718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM3,Dynamin-3,2304,274,1.10 [0.90-1.35],0.3515004588118816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNMBP,Dynamin-binding protein,2641,320,0.95 [0.80-1.12],0.5205752580017325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPEP,Aspartyl aminopeptidase,2300,272,0.92 [0.76-1.12],0.4179410309290781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2667,318,0.79 [0.65-0.97],0.0218753117354605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOC2B,Double C2-like domain-containing protein beta,2262,271,0.70 [0.48-1.02],0.0654564704063859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOCK9,Dedicator of cytokinesis protein 9,2244,266,0.92 [0.81-1.03],0.1612473172128565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK1,Docking protein 1,2300,272,0.98 [0.90-1.07],0.6263971725622484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK2,Docking protein 2,2658,316,0.95 [0.88-1.04],0.265864271664229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP1,Dipeptidase 1,2636,319,0.85 [0.69-1.05],0.1315862073523598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,2636,313,1.40 [1.01-1.93],0.0432819867578541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP10,Inactive dipeptidyl peptidase 10,2664,320,1.04 [0.82-1.31],0.7587467422808464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP4,Dipeptidyl peptidase 4,2611,304,1.00 [0.72-1.38],0.990237087928278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2636,313,1.96 [1.54-2.49],4.871144222337933e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP7,Dipeptidyl peptidase 2,2641,315,1.00 [0.85-1.17],0.9903897964048216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,2695,322,1.36 [0.92-2.03],0.1278904116687735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,2670,318,1.11 [0.95-1.30],0.1972813021887391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRAXIN,Draxin,2641,320,1.18 [0.94-1.48],0.1483098411050032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRG2,Developmentally-regulated GTP-binding protein 2,2636,313,0.88 [0.74-1.06],0.1802464676098855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,2637,310,2.36 [1.85-3.00],3.1343384796574e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,2304,274,1.43 [1.08-1.90],0.0135597548842628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,2670,320,2.38 [1.77-3.20],1.0353036854253261e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG3,Desmoglein-3,2668,318,0.94 [0.72-1.23],0.6437385192717742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,2627,312,0.71 [0.59-0.87],0.0009874824231048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTD1,D-aminoacyl-tRNA deacylase 1,2268,265,0.97 [0.85-1.11],0.6702988605465636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,2293,267,1.20 [0.94-1.53],0.1515308586840773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,2262,271,0.83 [0.65-1.06],0.1427470914192812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2636,313,1.53 [1.04-2.24],0.0304508963323335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,2304,270,0.83 [0.70-0.99],0.0355111513448945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUOX2,Dual oxidase 2,2616,315,1.04 [0.90-1.20],0.6126497964239224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,2297,268,0.75 [0.57-0.99],0.043894496421605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP29,Dual specificity phosphatase 29,2262,271,0.95 [0.79-1.15],0.5866199184953507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,2589,310,0.91 [0.80-1.04],0.1731827513552057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2307,271,0.97 [0.87-1.09],0.6129779935394113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DXO,Decapping and exoribonuclease protein,2300,272,1.02 [0.78-1.33],0.8922567182075816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2297,268,0.84 [0.61-1.15],0.2841326421310679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT1,Dynein light chain Tctex-type 1,2262,271,0.92 [0.79-1.07],0.2889835434207767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,2297,268,0.75 [0.57-0.99],0.040384810441461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2641,320,0.94 [0.85-1.05],0.26159086402505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,2673,318,1.80 [1.32-2.46],0.0001942882149426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECE1,Endothelin-converting enzyme 1,2589,310,0.80 [0.60-1.05],0.1081776827808383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2304,270,1.02 [0.89-1.17],0.7666563443654897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",2243,264,1.02 [0.90-1.15],0.783800580132973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECI2,Enoyl-CoA delta isomerase 2,2242,265,0.88 [0.72-1.08],0.2156461510997214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECM1,Extracellular matrix protein 1,2250,265,0.85 [0.62-1.15],0.2942330242202252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECSCR,Endothelial cell-specific chemotaxis regulator,2244,266,0.99 [0.77-1.27],0.9346151359175804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2676,318,2.15 [1.76-2.64],1.8338303140073333e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,2664,320,1.08 [0.97-1.21],0.15509628741307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,2297,268,1.03 [0.85-1.25],0.7656595356581277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2242,265,1.13 [0.80-1.59],0.4893840688454522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDF1,Endothelial differentiation-related factor 1,2304,274,1.06 [0.89-1.27],0.5036089103249644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2616,315,1.68 [1.31-2.15],4.147993281396806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,2243,264,1.95 [1.35-2.83],0.0004229968303981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDNRB,Endothelin receptor type B,2244,268,1.08 [0.81-1.45],0.580127467023013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EEF1D,Elongation factor 1-delta,2304,270,0.93 [0.82-1.06],0.2674352384680437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2307,271,2.01 [1.43-2.82],5.29267137138028e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB2,Dynein regulatory complex protein 8,2271,266,0.87 [0.61-1.24],0.4339744886280714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2667,319,1.81 [1.36-2.39],3.540547881576567e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,2304,274,1.11 [0.82-1.50],0.5184787867560172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,2666,319,2.48 [1.90-3.25],3.126221879304078e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,2637,320,2.72 [2.16-3.43],3.321253310373155e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,2262,271,1.21 [1.02-1.42],0.0254083672463092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGF,Pro-epidermal growth factor,2660,315,0.98 [0.90-1.08],0.7435052171717302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFL7,Epidermal growth factor-like protein 7,2579,308,1.27 [0.99-1.64],0.0579895748669936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFLAM,Pikachurin,2307,271,1.02 [0.70-1.48],0.9180389978508392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,2695,322,2.49 [1.41-4.40],0.0016572998586422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGLN1,Egl nine homolog 1,2664,320,0.87 [0.72-1.06],0.1659725699730516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHBP1,EH domain-binding protein 1,2304,270,0.89 [0.76-1.05],0.1738457590956901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHD3,EH domain-containing protein 3,2243,264,0.97 [0.88-1.07],0.572463593807744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2300,272,0.92 [0.73-1.14],0.434590247289249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2297,269,0.92 [0.83-1.03],0.1616308718675178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2242,265,0.83 [0.68-1.00],0.050923690737879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2243,264,0.93 [0.69-1.24],0.6072956518330155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,2641,320,0.81 [0.68-0.97],0.0195962635468456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4E,Eukaryotic translation initiation factor 4E,2244,268,0.90 [0.79-1.03],0.1390544677515888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2658,316,0.83 [0.71-0.97],0.0224057899832702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2692,319,0.93 [0.84-1.03],0.1881106213865561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2304,274,0.87 [0.73-1.04],0.1365110623931052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5,Eukaryotic translation initiation factor 5,2242,265,0.88 [0.66-1.18],0.3947155791425094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,2601,309,0.65 [0.46-0.93],0.0194762175321206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,2304,274,0.95 [0.83-1.10],0.4901505544915394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAVL4,ELAV-like protein 4,2244,266,1.01 [0.88-1.17],0.8415944803576979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELN,Elastin,2304,270,1.11 [0.81-1.53],0.5099111823510423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,2636,313,0.82 [0.67-0.99],0.04297207691162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOB,Elongin-B,2242,265,1.12 [0.84-1.50],0.4285257374854606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,2601,309,1.07 [0.87-1.31],0.5382153425901121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENDOU,Poly(U)-specific endoribonuclease,2137,255,1.12 [0.91-1.38],0.284113410684258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,2695,322,1.79 [1.04-3.06],0.03480557821314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO1,Alpha-enolase,2664,317,0.91 [0.80-1.04],0.162450029651765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO2,Gamma-enolase,2678,319,0.93 [0.80-1.08],0.3369230736234396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,2243,264,0.69 [0.57-0.84],0.0001914765118298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOPH1,Enolase-phosphatase E1,2297,268,0.84 [0.65-1.08],0.1767807869823261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2242,265,0.69 [0.44-1.09],0.1158134224594505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPEP,Glutamyl aminopeptidase,2242,265,1.10 [0.87-1.40],0.408207765374775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2695,322,1.25 [0.87-1.80],0.2251669237381676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2674,318,0.87 [0.71-1.06],0.1655654777272934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2243,264,1.78 [1.29-2.45],0.0004983068193101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2573,302,0.93 [0.83-1.05],0.2399127142172558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENSA,Alpha-endosulfine,2297,268,0.85 [0.67-1.08],0.1878394447225937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2579,308,1.05 [0.84-1.31],0.6530742080712373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2616,315,0.83 [0.53-1.31],0.4279052756929609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2616,315,1.21 [0.81-1.82],0.3532260613696835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,2243,264,0.83 [0.69-1.00],0.0457014154727759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EP300,Histone acetyltransferase p300,2244,268,0.86 [0.59-1.24],0.4119667643495059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPB41L5,Band 4.1-like protein 5,2262,271,0.93 [0.76-1.14],0.4876389126757059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPCAM,Epithelial cell adhesion molecule,2661,316,0.98 [0.88-1.10],0.7521602149360007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPGN,Epigen,2297,268,1.04 [0.78-1.38],0.7831902576286341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,2667,318,1.14 [0.86-1.53],0.3642524034576818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA10,Ephrin type-A receptor 10,2589,310,1.01 [0.86-1.17],0.9484984041513682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,2553,306,2.43 [1.90-3.11],1.5069163641812173e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,2268,265,0.96 [0.65-1.43],0.848963296798282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,2695,322,2.77 [2.01-3.82],4.89192426630319e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,2636,319,1.37 [1.04-1.81],0.0259409207543481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHX2,Bifunctional epoxide hydrolase 2,2616,315,0.86 [0.72-1.03],0.105630804922723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPN1,Epsin-1,2271,266,1.09 [0.83-1.43],0.5399976478316932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,2664,320,1.22 [1.09-1.37],0.0007340651402045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPPK1,Epiplakin,2243,264,1.03 [0.88-1.21],0.6912432795776504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2673,318,1.34 [1.00-1.79],0.0498416011327534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,2658,318,0.86 [0.60-1.23],0.4073159172311869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,2656,317,1.76 [1.10-2.80],0.018069793867946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2658,318,2.98 [2.09-4.25],1.4247245501531155e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBIN,Erbin,2636,313,0.94 [0.85-1.03],0.1829810785209853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERC2,ERC protein 2,2262,271,1.00 [0.85-1.19],0.9566126547874936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERCC1,DNA excision repair protein ERCC-1,2224,264,0.79 [0.52-1.20],0.2617251310628946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EREG,Proepiregulin,2636,319,0.94 [0.83-1.06],0.3159758506929727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERI1,3'-5' exoribonuclease 1,2271,266,1.07 [0.76-1.51],0.6909891904699472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,2244,268,1.06 [0.82-1.37],0.674993535421708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2297,268,0.87 [0.63-1.20],0.3866821346076994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP29,Endoplasmic reticulum resident protein 29,2268,265,0.95 [0.86-1.05],0.325196483790176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP44,Endoplasmic reticulum resident protein 44,2634,313,0.74 [0.51-1.09],0.1314723172083605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2242,265,1.13 [0.85-1.48],0.4007352988756406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,2695,322,1.58 [1.20-2.07],0.0009901206232477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESM1,Endothelial cell-specific molecule 1,2663,317,0.91 [0.69-1.20],0.5189389031997453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,2224,264,1.11 [0.93-1.31],0.250613948595814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESR1,Estrogen receptor,2244,268,0.85 [0.65-1.10],0.2180268155429031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESYT2,Extended synaptotagmin-2,2300,272,1.01 [0.88-1.16],0.8945571140994966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI2B,Protein EVI2B,2224,264,0.95 [0.68-1.33],0.7531382477150176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI5,Ecotropic viral integration site 5 protein homolog,2244,268,0.94 [0.82-1.07],0.3248363307652803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVPL,Envoplakin,2271,266,1.13 [0.77-1.64],0.5395138735351683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,2242,265,0.65 [0.49-0.87],0.0041857947071182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXTL1,Exostosin-like 1,2242,265,1.07 [0.85-1.33],0.5768800746532396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EZR,Ezrin,2678,319,0.84 [0.56-1.26],0.4061074331975666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F10,Coagulation factor X,2315,273,1.13 [0.76-1.67],0.5478723868691626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,2282,268,2.03 [1.41-2.91],0.0001403487880527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11R,Junctional adhesion molecule A,2670,320,0.98 [0.82-1.17],0.8292674703528081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F12,Coagulation factor XII,2309,270,1.11 [0.83-1.48],0.4967824252799051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F13B,Coagulation factor XIII B chain,2297,270,0.66 [0.42-1.02],0.0591557855983033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,2309,270,0.39 [0.18-0.85],0.0171915060195908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,2672,317,1.16 [0.98-1.39],0.0856744228999261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,2660,318,1.77 [1.26-2.49],0.0010117516684974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F7,Coagulation factor VII,2664,319,0.98 [0.73-1.32],0.883635229982777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F9,Coagulation factor IX,2666,317,0.97 [0.55-1.69],0.9038263727987836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",2663,317,1.24 [1.12-1.37],1.6822688609373518e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",2658,316,1.19 [1.07-1.34],0.0018369279855089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",2304,270,1.33 [1.11-1.60],0.0025253579845322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",2695,322,1.55 [1.32-1.82],7.946508871745422e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,2669,317,1.01 [0.87-1.18],0.8544476637899795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP6,Gastrotropin,2613,313,0.97 [0.82-1.15],0.7577495835057162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP9,Fatty acid-binding protein 9,2664,320,0.92 [0.77-1.09],0.3238345285103083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FADD,FAS-associated death domain protein,2658,316,0.89 [0.78-1.02],0.0993629471304777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM13A,Protein FAM13A,2307,271,0.91 [0.76-1.09],0.3012331366534099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171A2,Protein FAM171A2,2304,274,0.97 [0.90-1.04],0.3921637821862419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171B,Protein FAM171B,2297,268,0.89 [0.54-1.46],0.6421578615252739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM172A,Cotranscriptional regulator FAM172A,2243,264,0.92 [0.75-1.12],0.4000503420976767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM20A,Pseudokinase FAM20A,2304,270,0.84 [0.55-1.26],0.3968892673847685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,2636,313,2.06 [1.56-2.73],3.932095558024541e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,2656,314,3.01 [2.29-3.95],2.938192196618076e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,2307,271,1.33 [1.17-1.51],1.889886014914138e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAP,Prolyl endopeptidase FAP,2695,322,1.16 [0.84-1.60],0.3645075335814262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,2262,271,0.94 [0.79-1.12],0.4683239659014889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,2690,322,1.53 [1.21-1.93],0.000364033592839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FASLG,Tumor necrosis factor ligand superfamily member 6,2692,319,1.02 [0.78-1.32],0.9033251114920612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,2316,272,0.99 [0.71-1.36],0.927475189954392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBN2,Fibrillin-2,2262,271,1.06 [0.86-1.31],0.5720473215176317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",2658,316,0.91 [0.80-1.04],0.1517833545815525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2304,270,1.05 [0.90-1.23],0.5602031971431012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAR,Immunoglobulin alpha Fc receptor,2664,320,1.04 [0.86-1.27],0.6785210236243145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2304,274,1.21 [0.78-1.87],0.3896607922339348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2670,320,1.27 [1.08-1.50],0.0040095356854033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2653,316,1.07 [0.89-1.27],0.4762472131412248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2579,308,1.03 [0.87-1.21],0.7663002750532162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2662,319,0.94 [0.78-1.15],0.5653121660897459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN1,Ficolin-1,2312,273,0.87 [0.71-1.06],0.1649958887084583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,2648,316,0.61 [0.49-0.76],1.42488582535841e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL1,Fc receptor-like protein 1,2658,316,1.07 [0.86-1.33],0.5240281375281564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,2683,317,1.27 [1.06-1.52],0.0086996133681624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL3,Fc receptor-like protein 3,2601,309,1.03 [0.86-1.22],0.7693886107695819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL5,Fc receptor-like protein 5,2670,320,1.13 [0.97-1.32],0.1274061240630313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,2664,320,1.02 [0.88-1.18],0.8018743460570684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,2579,308,1.23 [1.04-1.46],0.0139771956652241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX1,"Adrenodoxin, mitochondrial",2242,265,1.10 [0.92-1.32],0.2838080915065796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX2,"Ferredoxin-2, mitochondrial",2242,265,1.13 [0.91-1.40],0.2764123916434846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FEN1,Flap endonuclease 1,2579,308,0.86 [0.73-1.02],0.0813737587407496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FES,Tyrosine-protein kinase Fes/Fps,2579,308,0.81 [0.65-1.01],0.0605137396614749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FETUB,Fetuin-B,2666,317,0.98 [0.74-1.30],0.8942809113386238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGA,Fibrinogen alpha chain,2260,264,0.84 [0.57-1.23],0.3666088962005476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2304,274,0.96 [0.83-1.11],0.557170331763982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF12,Fibroblast growth factor 12,2244,268,0.87 [0.65-1.18],0.3761789988284727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,2244,268,0.75 [0.57-0.98],0.0351786334193655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF19,Fibroblast growth factor 19,2674,318,0.91 [0.81-1.03],0.1330257863875917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF2,Fibroblast growth factor 2,2664,320,0.98 [0.85-1.13],0.7715589165309316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF20,Fibroblast growth factor 20,2244,268,0.99 [0.75-1.31],0.9393248168195896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF21,Fibroblast growth factor 21,2673,318,0.99 [0.92-1.08],0.8605877606063761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,2668,318,1.16 [0.98-1.37],0.0751710193802923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,2244,268,1.00 [0.63-1.58],0.993453064691139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,2601,309,1.88 [1.46-2.42],7.744424654164005e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF6,Fibroblast growth factor 6,2244,268,1.03 [0.79-1.36],0.8152490513210511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF7,Fibroblast growth factor 7,2224,264,1.04 [0.90-1.20],0.6143116160483391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF9,Fibroblast growth factor 9,2221,264,1.06 [0.79-1.44],0.6828511345564803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,2658,318,0.59 [0.46-0.75],1.493691580333633e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,2316,272,0.60 [0.48-0.75],6.877287778610805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,2300,272,0.51 [0.38-0.69],1.715031783076325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR2,Fibroblast growth factor receptor 2,2658,318,1.35 [0.92-1.96],0.1210544578247694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR4,Fibroblast growth factor receptor 4,2268,265,0.97 [0.77-1.22],0.8037630438340415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,2315,273,1.38 [1.17-1.63],0.0001794294337521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGR,Tyrosine-protein kinase Fgr,2589,310,0.85 [0.72-1.02],0.0803347527440004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FH,"Fumarate hydratase, mitochondrial",2244,266,1.08 [0.95-1.22],0.2514849701944107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,2242,265,0.92 [0.72-1.19],0.5272241187660365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,2589,310,0.85 [0.73-0.98],0.0215220029828193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FIS1,Mitochondrial fission 1 protein,2662,318,0.93 [0.82-1.07],0.311157088747483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2304,274,0.97 [0.86-1.10],0.6493053950343421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2666,313,0.96 [0.88-1.05],0.4168196677728807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2641,320,0.87 [0.68-1.11],0.2549074091091944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2641,320,0.98 [0.88-1.10],0.7497292629025456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2584,309,1.04 [0.85-1.27],0.7068497697031958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBPL,FK506-binding protein-like,2307,271,0.84 [0.68-1.04],0.1050323497403054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLI1,Friend leukemia integration 1 transcription factor,2579,308,0.94 [0.86-1.04],0.2247082572463102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2641,320,1.47 [1.05-2.05],0.025741387470182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,2634,313,0.85 [0.54-1.31],0.455401108373494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,2579,308,1.02 [0.73-1.43],0.916639164275349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,2692,319,1.26 [0.95-1.68],0.1040669471596884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,2658,318,0.81 [0.62-1.06],0.1285190583749747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMNL1,Formin-like protein 1,2589,310,0.93 [0.79-1.08],0.3326926298095898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMR1,Synaptic functional regulator FMR1,2579,308,0.96 [0.72-1.27],0.7581534927032036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,2309,270,0.41 [0.27-0.63],4.395665716849109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNDC1,Fibronectin type III domain-containing protein 1,2300,272,0.81 [0.64-1.03],0.0869168016104894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2297,268,0.87 [0.59-1.28],0.4844186939170484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLH1,Glutamate carboxypeptidase 2,2244,268,0.98 [0.86-1.12],0.7679534372277562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,2647,316,1.59 [1.17-2.16],0.0029149797160284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,2678,319,1.55 [1.11-2.16],0.0092490411877006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR3,Folate receptor gamma,2652,318,0.99 [0.94-1.04],0.7764044571284052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOS,Proto-oncogene c-Fos,2221,264,0.76 [0.54-1.07],0.1208128379189976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOSB,Protein fosB,2589,310,0.91 [0.69-1.21],0.5108353314368967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXJ3,Forkhead box protein J3,2244,268,0.77 [0.59-1.02],0.0663364764317479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO1,Forkhead box protein O1,2664,320,0.98 [0.88-1.10],0.7815832531195236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO3,Forkhead box protein O3,2579,308,0.99 [0.89-1.11],0.889620581354458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD4B,FERM domain-containing protein 4B,2242,265,0.91 [0.76-1.09],0.2983498984640437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD7,FERM domain-containing protein 7,2262,271,1.19 [0.83-1.72],0.3482733364417839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRZB,Secreted frizzled-related protein 3,2634,320,0.87 [0.60-1.25],0.4440091881854169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,2243,264,1.50 [1.17-1.91],0.0011661809192031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FST,Follistatin,2672,317,0.99 [0.79-1.22],0.9002241741994315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,2243,264,1.85 [1.11-3.08],0.0178793144985708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,2660,316,1.86 [1.44-2.41],2.172280997778154e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,2296,271,0.88 [0.78-0.99],0.0295911060777393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUCA1,Tissue alpha-L-fucosidase,2680,320,1.01 [0.89-1.14],0.9216979353520024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,2268,265,0.78 [0.65-0.92],0.0039277663975284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,2658,318,0.69 [0.52-0.90],0.0064574680073277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,2571,308,0.73 [0.55-0.96],0.0239851378689342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2267,266,0.88 [0.72-1.09],0.2369529999382602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2678,319,1.22 [1.00-1.49],0.055702558708833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT8,"Alpha-(1,6)-fucosyltransferase",2641,320,0.88 [0.73-1.05],0.1417792745582109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXN,"Frataxin, mitochondrial",2676,318,0.95 [0.83-1.09],0.4871226417764033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXYD5,FXYD domain-containing ion transport regulator 5,2601,309,1.04 [0.89-1.21],0.6434830244563228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FYB1,FYN-binding protein 1,2663,320,0.94 [0.84-1.04],0.2377877058064767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD10,Frizzled-10,2262,271,1.06 [0.87-1.29],0.5526306837199877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD8,Frizzled-8,2244,266,1.01 [0.77-1.32],0.957938971875745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,2297,268,1.09 [0.86-1.37],0.4830358197613202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2271,266,0.97 [0.81-1.16],0.7203548801383988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2244,266,1.08 [0.89-1.31],0.4568231577474468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD1,Glutamate decarboxylase 1,2224,264,1.02 [0.64-1.62],0.9293857101314889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD2,Glutamate decarboxylase 2,2244,268,0.87 [0.64-1.17],0.3493673347377147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2271,266,0.85 [0.63-1.14],0.2750547470102794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2243,264,0.92 [0.73-1.15],0.4569636345630731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAGE2A,G antigen 2A,2224,264,0.93 [0.77-1.13],0.4854026515628287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,2674,318,0.99 [0.85-1.14],0.8556155212248773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2636,313,1.29 [0.92-1.81],0.1447961431509696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2676,318,0.73 [0.52-1.03],0.0738683294337511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2601,309,1.56 [1.26-1.94],5.0798599515296446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2304,270,0.74 [0.49-1.11],0.1427729626204897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,2636,313,2.31 [1.43-3.74],0.0005892441727296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAMT,Guanidinoacetate N-methyltransferase,2242,265,1.01 [0.72-1.41],0.963662254330674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2210,252,0.92 [0.59-1.44],0.714067615557503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GART,Trifunctional purine biosynthetic protein adenosine-3,2304,274,0.87 [0.53-1.44],0.5990640401998213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,2271,266,0.72 [0.55-0.94],0.0165831283359717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,2680,320,1.85 [1.26-2.72],0.001637591447525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,2242,265,0.71 [0.55-0.93],0.0122925093526621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,2300,272,1.10 [1.03-1.18],0.0072671627326094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2224,264,0.63 [0.40-1.00],0.048589221295752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2243,264,1.01 [0.86-1.17],0.9421198866706308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBA,Lysosomal acid glucosylceramidase,2262,271,1.06 [0.86-1.30],0.5809560898958657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,2296,271,0.82 [0.70-0.97],0.0208056708324163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP2,Guanylate-binding protein 2,2601,309,0.93 [0.78-1.11],0.4323303076918499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP4,Guanylate-binding protein 4,2589,310,0.90 [0.72-1.11],0.3227792017516882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP6,Guanylate-binding protein 6,2242,265,0.92 [0.68-1.23],0.5548528130240159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GC,Vitamin D-binding protein,2309,270,0.85 [0.54-1.33],0.4681042689113048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCC1,GRIP and coiled-coil domain-containing protein 1,2300,272,0.95 [0.85-1.05],0.3144034798599154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,2579,308,1.19 [1.10-1.29],1.0024460358538072e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2204,256,0.82 [0.64-1.06],0.126745077063518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCLM,Glutamate--cysteine ligase regulatory subunit,2242,265,0.86 [0.64-1.13],0.2782273163677161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2636,313,1.79 [1.35-2.36],4.463763247012501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,2695,322,2.17 [1.91-2.46],6.232915200798986e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,2658,316,1.19 [0.91-1.56],0.1993424126235627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,2589,310,1.08 [0.83-1.39],0.5672368887502919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GET3,ATPase GET3,2304,270,0.90 [0.72-1.13],0.379433740276569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFAP,Glial fibrillary acidic protein,2577,308,0.84 [0.67-1.04],0.1110340624473419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFER,FAD-linked sulfhydryl oxidase ALR,2579,308,0.90 [0.76-1.06],0.1938850932538913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2579,308,1.02 [0.94-1.12],0.6110050446398878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,2673,318,2.57 [1.91-3.45],3.5024341422154517e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,2636,313,1.13 [0.70-1.81],0.6218078311613722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,2636,318,1.51 [1.08-2.11],0.017219783628975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRAL,GDNF family receptor alpha-like,2229,266,0.89 [0.73-1.08],0.2359157347505475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGA1,ADP-ribosylation factor-binding protein GGA1,2589,310,1.01 [0.87-1.19],0.8723980793813433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGACT,Gamma-glutamylaminecyclotransferase,2304,270,0.96 [0.81-1.14],0.6333631312614972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGCT,Gamma-glutamylcyclotransferase,2302,270,0.84 [0.65-1.08],0.1762113072028412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,2618,311,0.85 [0.63-1.15],0.3016878046792821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT1,Glutathione hydrolase 1 proenzyme,2666,319,0.93 [0.77-1.12],0.4473652717046914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,2641,320,2.52 [1.77-3.59],2.967836807375607e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,2656,314,1.10 [1.04-1.16],0.0007586501007312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH2,Growth hormone variant,2579,308,1.00 [0.94-1.07],0.977622334409002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,2268,265,0.41 [0.28-0.60],5.423948720304702e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRHR,Growth hormone-releasing hormone receptor,2589,310,0.98 [0.80-1.20],0.8534224741409313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRL,Appetite-regulating hormone,2658,316,1.00 [0.89-1.12],0.99617188506245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,2304,274,1.34 [1.05-1.71],0.018780920446759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,2304,274,0.98 [0.84-1.14],0.8094043189708299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP7,GTPase IMAP family member 7,2268,265,0.75 [0.51-1.10],0.1421705022132933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP8,GTPase IMAP family member 8,2224,264,0.91 [0.70-1.17],0.4520324226197595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,2243,264,1.40 [1.14-1.72],0.0011309582342006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,2300,272,1.51 [1.08-2.12],0.0171902581454979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC3,PDZ domain-containing protein GIPC3,2307,271,0.94 [0.84-1.06],0.3367685138551433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPR,Gastric inhibitory polypeptide receptor,2244,268,1.13 [0.86-1.49],0.3696974119256548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIT1,ARF GTPase-activating protein GIT1,2244,268,0.91 [0.80-1.02],0.1110276525796185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,2224,264,1.15 [0.96-1.37],0.1278260999912318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,2545,302,1.52 [1.04-2.22],0.0310934819837673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLA,Alpha-galactosidase A,2266,263,1.21 [0.89-1.64],0.2242028104120971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLB1,Beta-galactosidase,2641,320,1.06 [0.84-1.33],0.6450488134509202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLI2,Zinc finger protein GLI2,2244,268,0.88 [0.58-1.34],0.5559119153882379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLO1,Lactoylglutathione lyase,2616,315,0.96 [0.81-1.15],0.6795800040989171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,2660,317,0.68 [0.51-0.91],0.0098156373621055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,2244,266,1.09 [0.78-1.51],0.6275917094377819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX,Glutaredoxin-1,2644,316,0.86 [0.72-1.02],0.0813220267579361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2268,265,0.92 [0.81-1.06],0.2651002613860116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2589,310,1.06 [0.87-1.29],0.5416640976708558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLYR1,Putative oxidoreductase GLYR1,2297,268,1.07 [0.87-1.32],0.5105960488278253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,2268,265,1.38 [1.03-1.84],0.0307460289547958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMFG,Glia maturation factor gamma,2304,270,0.94 [0.80-1.11],0.4523055451606342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,2692,319,0.75 [0.61-0.91],0.0038974815788926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR2,GMP reductase 2,2268,265,0.86 [0.72-1.03],0.1077660555404018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNAS,Neuroendocrine secretory protein 55,2304,274,0.98 [0.85-1.12],0.7442432309268052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2579,308,0.80 [0.68-0.94],0.0081727909791544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2262,271,1.01 [0.82-1.25],0.9142254592839564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,2670,320,0.81 [0.70-0.95],0.0091382882529431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,2243,264,0.85 [0.58-1.24],0.3887143552309062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2268,265,0.61 [0.44-0.83],0.0020278088981671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLGA3,Golgin subfamily A member 3,2304,274,0.98 [0.84-1.15],0.8433747273583594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,2678,319,1.37 [1.01-1.85],0.0403004454777515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2664,320,0.94 [0.85-1.03],0.201645061736445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GORASP2,Golgi reassembly-stacking protein 2,2307,271,0.90 [0.70-1.16],0.4368266949792514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2316,272,0.57 [0.44-0.75],3.4723736956009936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,2648,316,0.75 [0.56-1.01],0.057378316392663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BB,Platelet glycoprotein Ib beta chain,2242,265,0.89 [0.75-1.07],0.2088464802574932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2585,312,1.15 [1.05-1.27],0.0039823407410406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP5,Platelet glycoprotein V,2268,265,0.78 [0.57-1.07],0.1227591620250921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP6,Platelet glycoprotein VI,2663,320,0.95 [0.85-1.07],0.401043497168037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,2636,313,0.89 [0.82-0.96],0.0024090413772755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,2676,318,1.49 [1.09-2.05],0.0130024596876687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,2641,320,0.86 [0.73-1.03],0.0940989308443495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPD1,Glycerol-3-phosphate dehydrogenase,2297,268,0.85 [0.69-1.03],0.0990932603989236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPHA2,Glycoprotein hormone alpha-2,2307,271,1.09 [0.84-1.41],0.5081734892822627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPI,Glucose-6-phosphate isomerase,2315,273,0.85 [0.66-1.09],0.1994516967493806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2307,271,1.10 [0.93-1.30],0.2694723242149156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,2589,310,1.00 [0.73-1.37],0.9840331139129466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,2595,307,2.40 [1.72-3.35],2.519656776027049e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,2244,266,0.98 [0.79-1.22],0.8413218378890758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR158,Probable G-protein coupled receptor 158,2304,274,0.99 [0.71-1.40],0.971248710170804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR15L,Protein GPR15L,2307,271,1.10 [0.92-1.32],0.2757256929990317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,2616,315,1.17 [1.00-1.36],0.0474858923101166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,2297,268,1.26 [1.05-1.52],0.0154886491259106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRAP2,GRB2-related adapter protein 2,2658,316,0.96 [0.89-1.03],0.248865937201767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2304,270,0.93 [0.77-1.12],0.424820098898536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",2304,274,0.77 [0.56-1.06],0.1105898981376641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2244,266,0.87 [0.67-1.13],0.3035061834815835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRK5,G protein-coupled receptor kinase 5,2616,315,0.90 [0.74-1.10],0.305582974981214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,2655,319,2.69 [1.87-3.86],8.02253871504669e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRP,Gastrin-releasing peptide,2243,264,0.91 [0.74-1.13],0.3925167361186161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",2636,313,1.10 [0.94-1.29],0.2158583695591265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRSF1,G-rich sequence factor 1,2211,263,0.94 [0.81-1.09],0.4098263597346316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSAP,Gamma-secretase-activating protein,2579,308,0.98 [0.86-1.11],0.7531090993909529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,2308,273,0.57 [0.36-0.91],0.0174702180228172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",2303,271,0.56 [0.39-0.80],0.0016292660389497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,2654,316,0.83 [0.74-0.92],0.0007138086669191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,2579,308,0.82 [0.73-0.93],0.0017610747850596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTM4,Glutathione S-transferase Mu 4,2242,265,0.98 [0.84-1.16],0.8377500906046033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTP1,Glutathione S-transferase P,2569,308,1.12 [0.97-1.29],0.1307482952322937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTT2B,Glutathione S-transferase theta-2B,2300,272,1.00 [0.95-1.04],0.846998642511843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2271,266,1.09 [0.93-1.27],0.3011475624239713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTPBP2,GTP-binding protein 2,2262,271,0.95 [0.82-1.10],0.530966623477592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,2658,320,1.65 [1.30-2.10],4.238411350948048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCY2C,Heat-stable enterotoxin receptor,2271,266,0.89 [0.75-1.06],0.192952857583448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUK1,Guanylate kinase,2242,265,1.18 [0.85-1.63],0.3151761390218914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,2676,320,0.86 [0.74-0.99],0.0359957658006364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",2616,315,0.85 [0.76-0.95],0.0040225103898449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMA,Granzyme A,2692,319,1.03 [0.77-1.37],0.8319223076821556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,2664,320,0.78 [0.66-0.93],0.0046486361016469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMH,Granzyme H,2616,315,0.95 [0.83-1.09],0.4764924775322524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,H2AP,Huntingtin-interacting protein M,2224,264,0.89 [0.68-1.17],0.4045981279707736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2242,265,1.11 [0.96-1.30],0.1680732885234336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2671,318,0.85 [0.74-0.97],0.0193561530089525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAO1,Hydroxyacid oxidase 1,2676,318,0.99 [0.91-1.07],0.7292539855559282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",2670,320,0.92 [0.80-1.04],0.186683080029573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,2674,318,1.70 [1.52-1.89],1.0162301859408154e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,2670,320,1.80 [1.40-2.32],4.831901445607022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBEGF,Proheparin-binding EGF-like growth factor,2671,318,0.93 [0.81-1.05],0.2375909044251764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,2676,318,0.85 [0.72-1.00],0.0477833267293486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBZ,Hemoglobin subunit zeta,2304,270,0.98 [0.88-1.09],0.6756039459521648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCG22,Protein PBMUCL2,2242,265,0.96 [0.78-1.17],0.6726939616671703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,2692,319,0.80 [0.66-0.96],0.0149607217198119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC8,Histone deacetylase 8,2244,268,0.93 [0.73-1.18],0.5324201228560504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC9,Histone deacetylase 9,2244,266,1.04 [0.87-1.24],0.6872489648987574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDDC2,5'-deoxynucleotidase HDDC2,2307,271,0.77 [0.59-1.02],0.0682869733277162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGF,Hepatoma-derived growth factor,2670,318,0.95 [0.86-1.06],0.3905231704382118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,2300,272,1.03 [0.86-1.23],0.7734968322292073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEBP1,Heme-binding protein 1,2616,315,0.92 [0.75-1.13],0.4215400646567715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEG1,Protein HEG homolog 1,2268,265,1.29 [0.86-1.92],0.2173461914553772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPACAM2,HEPACAM family member 2,2300,272,0.79 [0.61-1.02],0.067279624772805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,2304,270,3.55 [2.27-5.55],2.7357524963720563e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEXIM1,Protein HEXIM1,2664,320,0.89 [0.78-1.01],0.0612656401473176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGF,Hepatocyte growth factor,2692,319,0.96 [0.73-1.24],0.7330942160525007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,2295,270,1.60 [1.03-2.50],0.0364026859964161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2579,308,0.90 [0.79-1.03],0.127073174718989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,2300,272,0.91 [0.78-1.07],0.2499398317841025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIF1A,Hypoxia-inducible factor 1-alpha,2244,268,0.89 [0.72-1.10],0.2958675417613989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1,Huntingtin-interacting protein 1,2242,265,0.88 [0.60-1.30],0.5308777641345896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,2297,271,1.09 [0.89-1.34],0.4211542916231523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HJV,Hemojuvelin,2304,274,1.07 [0.80-1.42],0.6551555290798727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HK2,Hexokinase-2,2616,315,1.07 [0.75-1.53],0.7043764767055066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2304,274,1.40 [0.98-2.00],0.0613291805875175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2655,319,1.42 [1.10-1.82],0.0064059459649847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2664,320,1.60 [1.21-2.13],0.0011020902985101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,2676,318,0.69 [0.54-0.87],0.0018211328113093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMCN2,Hemicentin-2,2265,264,1.11 [0.91-1.36],0.3143658623818284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2243,264,0.98 [0.76-1.27],0.9047291811749136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2242,265,0.86 [0.64-1.17],0.3459605765392262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMMR,Hyaluronan mediated motility receptor,2220,263,1.01 [0.79-1.30],0.9083656970547532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,2636,313,0.80 [0.66-0.98],0.034609981403028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,2589,310,0.93 [0.74-1.18],0.5606627441314973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNF1A,Hepatocyte nuclear factor 1-alpha,2262,271,1.02 [0.88-1.18],0.7846445100453131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNMT,Histamine N-methyltransferase,2630,319,0.97 [0.81-1.17],0.7439348771641905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2610,315,0.93 [0.81-1.06],0.2717218344580968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2304,274,0.97 [0.77-1.23],0.808652909427961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPCAL1,Hippocalcin-like protein 1,2692,319,0.96 [0.84-1.10],0.5503527786615471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPGDS,Hematopoietic prostaglandin D synthase,2579,308,0.85 [0.65-1.11],0.2291475236568055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPSE,Heparanase,2293,268,0.98 [0.87-1.11],0.7702982652912289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRAS,GTPase Hras,2265,265,0.97 [0.85-1.10],0.6113341701796534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2243,264,1.33 [0.94-1.88],0.1101507137885331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRG,Histidine-rich glycoprotein,2297,270,1.30 [0.90-1.87],0.1608861766538085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS1BP3,HCLS1-binding protein 3,2243,264,0.96 [0.84-1.10],0.5932607603972586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2636,313,0.99 [0.76-1.27],0.9076812195594514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2676,318,0.91 [0.69-1.20],0.5166063633087401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2244,268,1.13 [0.85-1.50],0.3898790858523454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,2243,264,1.01 [0.89-1.15],0.8215399834703994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2664,320,0.82 [0.65-1.04],0.096195209965584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2300,272,0.97 [0.81-1.16],0.7614409821653614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,2242,265,0.89 [0.69-1.16],0.4001439874716961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2243,264,0.96 [0.74-1.23],0.7302715878136221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSP90B1,Endoplasmin,2576,308,0.96 [0.81-1.15],0.6616910012843303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA1A,Heat shock 70 kDa protein 1A,2667,318,0.89 [0.77-1.03],0.1217687887103274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,2297,268,1.06 [0.76-1.46],0.7451041005973154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB1,Heat shock protein beta-1,2619,313,0.90 [0.79-1.04],0.158589304887348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,2676,318,1.39 [1.12-1.74],0.0034690651244153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2642,314,1.53 [1.12-2.09],0.0073446328194956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1A,5-hydroxytryptamine receptor 1A,2244,266,0.97 [0.83-1.12],0.6523201809511043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,2244,266,0.80 [0.59-1.08],0.1401321143776515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTRA2,"Serine protease HTRA2, mitochondrial",2658,318,0.93 [0.79-1.09],0.3756500788912165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,2641,313,2.08 [1.43-3.04],0.000144220797937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,2695,322,1.74 [1.18-2.56],0.0051023638812679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICA1,Islet cell autoantigen 1,2601,309,0.89 [0.78-1.01],0.0791250737238706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM1,Intercellular adhesion molecule 1,2649,316,1.14 [0.83-1.57],0.4189202267939229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,2695,322,1.68 [1.23-2.27],0.0009262603802319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,2695,322,1.86 [1.34-2.59],0.0002383010182861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM4,Intercellular adhesion molecule 4,2664,320,0.88 [0.72-1.06],0.176804077434439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM5,Intercellular adhesion molecule 5,2658,316,1.00 [0.81-1.24],0.9817152523497236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,2636,313,1.56 [0.93-2.62],0.0895831229343889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ID4,DNA-binding protein inhibitor ID-4,2271,266,1.01 [0.77-1.31],0.9660334358133444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,2589,310,1.06 [0.87-1.28],0.5651884737718706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDO1,"Indoleamine 2,3-dioxygenase 1",2243,264,0.94 [0.78-1.13],0.4974588365442303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDS,Iduronate 2-sulfatase,2692,319,0.84 [0.28-2.51],0.7585579292863611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDUA,Alpha-L-iduronidase,2676,318,1.05 [0.85-1.29],0.663954616863752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2248,266,0.99 [0.73-1.35],0.9518117912297578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2271,266,1.10 [0.87-1.39],0.4483436326844813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2271,266,0.87 [0.63-1.19],0.371872755967183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNAR1,Interferon alpha/beta receptor 1,2307,271,1.02 [0.63-1.64],0.9420198149773458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,2601,309,1.06 [0.97-1.16],0.2244498495820971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,2674,318,1.83 [1.20-2.79],0.0053374481372387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR2,Interferon gamma receptor 2,2641,320,1.18 [0.99-1.41],0.0641138012447682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,2589,310,1.13 [0.92-1.39],0.2599843845605005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL2,Interferon lambda-2,2244,266,1.10 [0.90-1.35],0.3334037396461401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNLR1,Interferon lambda receptor 1,2664,320,1.05 [0.79-1.39],0.7415842329838431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNW1,Interferon omega-1,2242,265,0.79 [0.53-1.17],0.2362165146208381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFT20,Intraflagellar transport protein 20 homolog,2262,271,1.04 [0.79-1.38],0.7607725971852729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGBP1,Immunoglobulin-binding protein 1,2304,274,0.90 [0.74-1.09],0.2700548904454505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2244,266,0.99 [0.77-1.27],0.9372735952303638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2316,272,0.96 [0.63-1.45],0.8310596875410032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,2636,313,2.05 [1.40-2.99],0.0002213613896687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2242,265,0.95 [0.72-1.27],0.7494680956358216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,2670,320,1.17 [0.77-1.76],0.4608322926396727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,2692,321,1.14 [1.05-1.23],0.0011743740307473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,2690,322,1.39 [1.20-1.60],6.910835270626098e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,2668,319,0.67 [0.53-0.84],0.0004064670784292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,2640,315,1.68 [1.42-2.00],2.873784525771541e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,2651,315,1.55 [1.19-2.01],0.001032898141571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,2695,322,1.68 [1.33-2.13],1.737553134711918e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2658,316,1.30 [1.01-1.66],0.0381171852781059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFL4,Insulin growth factor-like family member 4,2244,268,0.84 [0.69-1.03],0.0958653961929919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,2242,265,1.21 [0.99-1.49],0.0653257239983292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,2303,269,1.13 [0.72-1.78],0.5947368786938425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLON5,IgLON family member 5,2224,264,0.97 [0.83-1.13],0.6672740453871359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,2243,264,1.16 [0.90-1.50],0.2374546156287503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,2636,313,1.30 [1.05-1.61],0.0158204662113542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,2658,316,1.51 [1.16-1.98],0.0025856212173339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,2304,270,0.92 [0.81-1.03],0.1519949584843775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKBKG,NF-kappa-B essential modulator,2664,320,0.93 [0.83-1.04],0.1788702948536083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKZF2,Zinc finger protein Helios,2579,308,1.05 [0.94-1.17],0.4284437579555694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,2601,309,1.07 [0.94-1.21],0.3138210167415151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RA,Interleukin-10 receptor subunit alpha,2601,309,0.91 [0.74-1.11],0.3403499409032189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,2674,318,1.76 [1.29-2.40],0.0003556916313576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL11,Interleukin-11,2601,309,1.05 [0.89-1.22],0.5740026253422867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,2636,313,1.07 [0.95-1.21],0.2559762987271166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,2692,319,1.11 [0.93-1.31],0.2435828368881561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2601,309,1.40 [1.08-1.81],0.0120407077517998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB2,Interleukin-12 receptor subunit beta-2,2244,268,1.03 [0.77-1.38],0.8345145108379015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13,Interleukin-13,2601,309,0.84 [0.65-1.08],0.168540022357122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,2617,312,1.12 [0.76-1.66],0.5556297605114138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,2244,266,0.87 [0.58-1.31],0.5049081538443381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,2664,320,1.93 [1.46-2.54],3.163717228115936e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,2601,309,1.38 [1.06-1.81],0.0177173678611308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,2692,319,0.91 [0.72-1.14],0.4000386158201134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17A,Interleukin-17A,2596,308,1.21 [0.99-1.47],0.0634593119417051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,2601,309,1.36 [1.22-1.52],5.991402895162653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17D,Interleukin-17D,2601,309,1.20 [0.93-1.55],0.1617667578704449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,2601,309,1.05 [0.91-1.21],0.4833764311747891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,2670,320,1.06 [0.85-1.33],0.575748780483248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,2637,317,1.31 [1.09-1.57],0.0035078927348017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,2655,317,1.19 [0.95-1.47],0.1241898069668406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,2668,319,1.97 [1.50-2.58],9.979822399887471e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,2692,319,1.77 [1.36-2.32],2.987106102248664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,2626,317,0.93 [0.87-0.99],0.0216062373792992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,2601,312,1.17 [1.04-1.32],0.0088111491964026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,2601,309,1.13 [0.97-1.30],0.1142285055956453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1B,Interleukin-1 beta,2587,309,0.99 [0.84-1.17],0.8883804176960484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,2666,319,4.83 [3.50-6.67],8.835571952618715e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R2,Interleukin-1 receptor type 2,2659,317,1.47 [0.93-2.30],0.0962715277651824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RAP,Interleukin-1 receptor accessory protein,2670,320,1.23 [1.00-1.51],0.0557035202478473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,2690,322,1.49 [1.19-1.87],0.0004849974086347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL2,Interleukin-1 receptor-like 2,2601,309,1.05 [0.80-1.37],0.727618964009272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RN,Interleukin-1 receptor antagonist protein,2655,317,0.99 [0.84-1.18],0.9527605268167352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2,Interleukin-2,2601,309,1.21 [0.88-1.66],0.240059104539337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20,Interleukin-20,2601,309,0.94 [0.75-1.17],0.5564143191423566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RA,Interleukin-20 receptor subunit alpha,2601,309,1.12 [0.91-1.39],0.2946384206759954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RB,Interleukin-20 receptor subunit beta,2244,268,0.79 [0.60-1.05],0.1102165466286932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL21R,Interleukin-21 receptor,2244,268,1.05 [0.87-1.27],0.5912089737076786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,2297,268,1.01 [0.85-1.19],0.9417470261193756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,2601,309,1.11 [0.89-1.38],0.3692441750144667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL24,Interleukin-24,2601,309,0.92 [0.74-1.15],0.4648937870123067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL25,Interleukin-25,2216,263,0.95 [0.67-1.36],0.7982968933141431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,2643,315,1.67 [1.34-2.07],4.198189311505583e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RB,Interleukin-2 receptor subunit beta,2601,309,1.04 [0.79-1.37],0.7658381613394639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,2297,268,1.53 [1.12-2.07],0.0069072860074767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3,Interleukin-3,2224,264,1.15 [0.93-1.43],0.1914700525035738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31,Interleukin-31,2244,268,1.01 [0.82-1.25],0.8999908576666488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31RA,Interleukin-31 receptor subunit alpha,2235,267,0.98 [0.72-1.33],0.8748197027480732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL32,Interleukin-32,2664,320,1.00 [0.83-1.20],0.9935353747443376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL33,Interleukin-33,2601,309,0.94 [0.73-1.20],0.6099261859429193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL34,Interleukin-34,2583,309,0.87 [0.66-1.14],0.3100186823558905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36A,Interleukin-36 alpha,2244,268,0.98 [0.79-1.22],0.8797487170668843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36G,Interleukin-36 gamma,2238,268,0.99 [0.84-1.18],0.939823414339856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3RA,Interleukin-3 receptor subunit alpha,2601,309,1.32 [0.97-1.78],0.0733744021278222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4,Interleukin-4,2601,309,1.02 [0.91-1.14],0.71818937606658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,2664,320,1.92 [1.51-2.45],1.360812706114408e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5,Interleukin-5,2601,309,1.01 [0.94-1.09],0.7457802061072452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,2664,320,1.22 [1.04-1.44],0.0177392020326205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6,Interleukin-6,2636,313,0.96 [0.84-1.10],0.5549700788923096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,2646,316,1.17 [0.88-1.55],0.2737721662113067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,2658,316,2.81 [1.65-4.78],0.0001329608584648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7,Interleukin-7,2664,320,0.88 [0.75-1.03],0.1110430071190109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7R,Interleukin-7 receptor subunit alpha,2670,320,1.06 [0.88-1.28],0.5261047252950927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,2271,266,0.88 [0.69-1.11],0.2724021247694555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2585,309,0.97 [0.81-1.16],0.720410738613843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,2297,268,1.10 [0.86-1.40],0.4438237813838027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPA1,Inositol monophosphatase 1,2641,320,0.87 [0.74-1.03],0.1119361161802395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,2300,272,0.77 [0.62-0.96],0.0173781517792519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,2244,266,0.82 [0.54-1.26],0.3742797622374294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ING1,Inhibitor of growth protein 1,2584,309,0.83 [0.68-1.01],0.0679999760401219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,2268,265,1.18 [0.95-1.45],0.1332547697809799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBC,Inhibin beta C chain,2670,320,0.98 [0.76-1.27],0.8957943914902209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP1,Inositol polyphosphate 1-phosphatase,2636,313,0.90 [0.74-1.09],0.2900436869380689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2243,264,0.96 [0.78-1.18],0.6764713382268439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2304,274,0.69 [0.49-0.97],0.0325411973504133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2636,313,0.91 [0.82-1.01],0.0850059971717806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL3,Insulin-like 3,2300,272,0.96 [0.85-1.09],0.5237498955239162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,2297,268,1.48 [1.20-1.83],0.0003078876506418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,2307,271,1.13 [1.01-1.27],0.0276443389896286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,2244,268,3.30 [1.76-6.18],0.0001928332353809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,2637,320,1.02 [0.91-1.14],0.767114130957223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,2636,313,0.94 [0.78-1.12],0.481375292589944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2616,315,0.94 [0.84-1.05],0.2755302082866481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,2601,309,0.92 [0.79-1.06],0.2468240949165341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK4,Interleukin-1 receptor-associated kinase 4,2664,320,0.94 [0.86-1.04],0.2195655221759199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2551,302,0.95 [0.73-1.25],0.7305626520176951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM1,Isthmin-1,2664,320,0.82 [0.65-1.04],0.1005602532124123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,2316,272,1.28 [1.05-1.56],0.013697112581048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IST1,IST1 homolog,2290,269,0.95 [0.84-1.08],0.4242973354175897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA11,Integrin alpha-11,2664,320,0.98 [0.74-1.29],0.8715591333434485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA2,Integrin alpha-2,2268,265,0.73 [0.52-1.01],0.0581570738847898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA5,Integrin alpha-5,2670,320,1.33 [0.93-1.89],0.1209430161190164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,2664,320,0.80 [0.65-0.99],0.0381038872874139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAL,Integrin alpha-L,2244,268,0.99 [0.75-1.30],0.9497740628690258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,2670,320,1.51 [1.14-2.00],0.0037297437800126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAV,Integrin alpha-V,2676,318,0.95 [0.54-1.65],0.8527871930881156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAX,Integrin alpha-X,2271,266,0.92 [0.72-1.19],0.5447983441755234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1,Integrin beta-1,2660,319,1.41 [0.91-2.19],0.1203697585766635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP1,Integrin beta-1-binding protein 1,2579,308,1.20 [0.94-1.53],0.1436210668817835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP2,Integrin beta-1-binding protein 2,2616,315,0.96 [0.88-1.05],0.3300231278149168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,2660,317,1.92 [1.42-2.59],1.965266522971349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB5,Integrin beta-5,2658,318,1.15 [0.91-1.45],0.2339814190682475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,2601,309,2.22 [1.62-3.04],7.966030745185531e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,2676,318,1.43 [1.18-1.74],0.0002504152629722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,2316,272,1.28 [1.02-1.60],0.0313068212138805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2309,270,0.76 [0.40-1.44],0.3960292593600077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2668,319,1.94 [1.51-2.50],2.57546747607015e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2309,270,0.86 [0.53-1.38],0.5260036468282538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2297,268,1.06 [0.81-1.39],0.6725496705112417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITM2A,Integral membrane protein 2A,2664,320,1.15 [0.98-1.34],0.0888658917458069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPA,Inosine triphosphate pyrophosphatase,2242,265,0.87 [0.73-1.04],0.131131487096014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2243,264,1.07 [0.91-1.26],0.4032611739587411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2244,266,1.26 [0.98-1.62],0.0740758230892182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2589,310,0.90 [0.73-1.11],0.332949737785541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IZUMO1,Izumo sperm-egg fusion protein 1,2224,264,1.13 [0.89-1.44],0.310519903949169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,2678,319,2.69 [2.00-3.63],8.525324509003742e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,2268,265,1.08 [0.87-1.34],0.4769389995086389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,2601,309,1.02 [0.87-1.21],0.7958526752860816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2224,264,1.00 [0.81-1.23],0.9772319303019544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JPT2,Jupiter microtubule associated homolog 2,2307,271,0.94 [0.82-1.08],0.3968131101444893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JUN,Transcription factor AP-1,2601,309,1.13 [0.94-1.36],0.1964949946184306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2636,313,1.20 [0.97-1.49],0.0998691809824458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZN,Kazrin,2307,271,0.94 [0.84-1.05],0.2511384352577978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,2244,266,0.80 [0.61-1.04],0.0893581027123298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,2262,271,1.02 [0.88-1.18],0.8300283558518837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,2589,310,0.80 [0.64-1.00],0.0541979034962745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCTD5,BTB/POZ domain-containing protein KCTD5,2261,266,0.89 [0.69-1.16],0.3961604879367613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDM3A,Lysine-specific demethylase 3A,2244,268,1.02 [0.89-1.18],0.78182620020148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,2658,318,0.88 [0.61-1.26],0.486211539912962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KEL,Kell blood group glycoprotein,2589,310,1.12 [0.85-1.46],0.4254820643016852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,2224,264,0.97 [0.80-1.16],0.7136560781928147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHK,Ketohexokinase,2243,264,0.86 [0.72-1.04],0.112581162707562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,2300,272,0.85 [0.57-1.25],0.3978755716905798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549,UPF0606 protein KIAA1549,2271,266,0.94 [0.78-1.13],0.5272377396841971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549L,UPF0606 protein KIAA1549L,2271,266,0.88 [0.57-1.38],0.5854356515775467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA2013,Uncharacterized protein KIAA2013,2297,268,0.92 [0.73-1.17],0.5091168752659149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,2242,265,1.16 [0.79-1.69],0.4502805251114945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF20B,Kinesin-like protein KIF20B,2244,266,0.95 [0.82-1.11],0.5383851676945808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF22,Kinesin-like protein KIF22,2242,265,0.95 [0.86-1.05],0.3211439368039603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIFBP,KIF-binding protein,2636,313,0.97 [0.87-1.10],0.6528266386616323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2297,268,1.11 [0.98-1.26],0.1027768134368241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2579,308,1.06 [0.93-1.19],0.3869534056935952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2307,271,1.00 [0.94-1.07],0.9605704349168228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2579,308,0.99 [0.91-1.07],0.7357196363196872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2224,264,0.85 [0.71-1.03],0.0907831892814429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,2244,266,1.06 [0.86-1.31],0.5673859413159217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL2,Kin of IRRE-like protein 2,2589,310,1.09 [0.85-1.40],0.4758662096650257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIT,Mast/stem cell growth factor receptor Kit,2666,317,1.30 [0.94-1.81],0.112153675076718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,2658,316,1.38 [1.08-1.75],0.0089368849239505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,2589,310,1.23 [1.08-1.40],0.0015925718811731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLF4,Krueppel-like factor 4,2244,266,0.89 [0.67-1.19],0.440845357731499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,2304,274,1.01 [0.81-1.26],0.9185586704957648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK1,Kallikrein-1,2632,311,0.97 [0.89-1.05],0.4213106147829655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK10,Kallikrein-10,2651,317,1.06 [0.84-1.35],0.6291118355097465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,2631,315,1.98 [1.47-2.66],5.906451179370649e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK12,Kallikrein-12,2579,308,1.05 [0.97-1.13],0.2181702169389963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK13,Kallikrein-13,2586,309,0.87 [0.71-1.06],0.1739621409725456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK14,Kallikrein-14,2676,318,0.87 [0.70-1.07],0.176874267290597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK15,Kallikrein-15,2291,268,0.96 [0.75-1.22],0.7399835696460427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK3,Prostate-specific antigen,2316,272,0.92 [0.83-1.01],0.0932541313636975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,2676,318,1.60 [1.42-1.81],3.7646573913166174e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK6,Kallikrein-6,2654,318,1.23 [0.92-1.65],0.1681464146154422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,2210,256,0.72 [0.52-0.98],0.0373072983761266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK8,Kallikrein-8,2558,309,1.19 [0.91-1.54],0.2017042494432252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLKB1,Plasma kallikrein,2266,270,1.17 [0.73-1.87],0.5240531463837357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2692,319,2.47 [1.98-3.07],4.640707934703188e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2244,266,0.84 [0.67-1.06],0.1405587055308816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,2692,319,1.39 [1.14-1.71],0.0014966493460869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,2244,268,1.10 [0.90-1.34],0.3644752679591313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,2300,272,1.39 [1.07-1.80],0.0126935914981231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT14,"Keratin, type I cytoskeletal 14",2513,296,1.06 [0.76-1.49],0.7290617963161115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT17,"Keratin, type I cytoskeletal 17",2242,265,1.11 [0.84-1.47],0.4664481866609272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT18,"Keratin, type I cytoskeletal 18",2636,313,0.98 [0.88-1.08],0.6628800731806632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",2661,320,1.59 [1.41-1.80],1.4970607237672296e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT5,"Keratin, type II cytoskeletal 5",2589,310,0.97 [0.81-1.17],0.7692947008920434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT6C,"Keratin, type II cytoskeletal 6C",2242,265,1.04 [0.76-1.41],0.8018362049540566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT8,"Keratin, type II cytoskeletal 8",2244,266,1.06 [0.97-1.15],0.1918075918800447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,2657,316,0.75 [0.63-0.89],0.001321609750003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,2692,319,0.74 [0.61-0.90],0.0027868807971078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L1CAM,Neural cell adhesion molecule L1,2658,318,1.22 [0.89-1.67],0.213762640178911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2304,270,0.94 [0.82-1.07],0.3596021272281299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACRT,Extracellular glycoprotein lacritin,2286,268,1.01 [0.76-1.33],0.9601100007695178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,2658,316,0.85 [0.73-1.00],0.0456373493699218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,2636,313,1.66 [1.39-1.97],1.545208351947739e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2663,317,1.72 [1.43-2.06],5.068952698420438e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2641,320,1.06 [0.96-1.16],0.2781000979740886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA1,Laminin subunit alpha-1,2242,265,0.86 [0.66-1.12],0.2662372481561242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA4,Laminin subunit alpha-4,2674,318,1.12 [0.85-1.48],0.4184151883416356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,2243,264,1.62 [1.12-2.34],0.0105598174745885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP1,Lysosome-associated membrane glycoprotein 1,2265,266,1.37 [0.86-2.19],0.1864429619507786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP2,Lysosome-associated membrane glycoprotein 2,2584,305,0.96 [0.59-1.57],0.8829477712929817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP3,Lysosome-associated membrane glycoprotein 3,2686,319,1.08 [0.89-1.29],0.4383550708393233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,2297,268,0.68 [0.49-0.94],0.0192968446091032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAP3,Cytosol aminopeptidase,2601,309,0.81 [0.65-1.01],0.0562348037443526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LARP1,La-related protein 1,2297,268,0.98 [0.81-1.18],0.8256556697823993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT,Linker for activation of T-cells family member 1,2692,319,1.00 [0.88-1.14],0.9941448691520064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT2,Linker for activation of T-cells family member 2,2636,313,0.99 [0.91-1.07],0.7106369207077626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LATS1,Serine/threonine-protein kinase LATS1,2244,268,0.94 [0.82-1.08],0.4027601499710694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,2636,319,2.22 [1.81-2.73],1.8541749064802954e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,2668,319,1.23 [1.04-1.46],0.0163456946385764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,2678,319,0.97 [0.84-1.11],0.6440690798303172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCAT,Phosphatidylcholine-sterol acyltransferase,2315,273,0.74 [0.45-1.21],0.2276304116314318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,2304,274,1.33 [1.17-1.51],1.075288649014996e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,2581,310,1.42 [1.14-1.76],0.001745574662406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,2316,272,0.59 [0.45-0.77],9.210900580664952e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,2671,320,0.76 [0.63-0.91],0.0036000092302004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,2304,274,0.97 [0.87-1.09],0.6439949982618471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LECT2,Leukocyte cell-derived chemotaxin-2,2304,270,1.04 [0.88-1.23],0.653581007775599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,2673,318,0.96 [0.80-1.15],0.6289173283972904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEG1,Protein LEG1 homolog,2189,260,1.08 [0.92-1.27],0.34938662151885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LELP1,Late cornified envelope-like proline-rich protein 1,2244,266,0.92 [0.76-1.11],0.3918577993725913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEO1,RNA polymerase-associated protein LEO1,2304,274,1.02 [0.70-1.48],0.921885301097894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,2658,316,0.91 [0.78-1.05],0.1918883727151837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,2658,316,1.66 [1.24-2.22],0.0006548293018954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,2304,274,1.14 [0.93-1.41],0.2152700123523149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,2658,316,1.01 [0.77-1.33],0.9218673395379468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,2665,318,1.84 [1.34-2.52],0.0001728083693185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3BP,Galectin-3-binding protein,2309,270,1.04 [0.73-1.48],0.8236980632843718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,2663,317,1.73 [1.50-2.00],1.5827829125595034e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,2647,313,1.16 [0.93-1.44],0.1924386878480135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS8,Galectin-8,2678,319,1.07 [0.91-1.25],0.4413507114172933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,2667,317,1.37 [1.00-1.86],0.0472552824884774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGMN,Legumain,2674,318,1.28 [0.98-1.66],0.0664838475315172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,2579,308,0.99 [0.88-1.12],0.8938699860115891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2660,317,0.76 [0.64-0.89],0.0008349068399326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIF,Leukemia inhibitory factor,2589,310,0.99 [0.81-1.20],0.8890572046353293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,2664,320,4.59 [3.27-6.44],1.1423188806697368e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2670,320,0.91 [0.71-1.18],0.48718858498811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2316,272,1.02 [0.93-1.11],0.6584105102906672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2242,265,0.83 [0.63-1.10],0.2007034457154021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2656,314,1.39 [1.02-1.88],0.035226936920716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2304,270,1.15 [0.99-1.33],0.0747941422522908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2695,322,1.14 [0.81-1.61],0.4655178100510476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2685,322,1.60 [1.21-2.13],0.0010581843917547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2601,309,1.25 [1.00-1.56],0.0481670325057847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2695,322,1.13 [0.97-1.31],0.105043710348636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,2243,264,1.19 [1.01-1.40],0.0409584834731436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB1,Lamin-B1,2304,271,0.86 [0.71-1.05],0.1319862116813203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,2300,272,0.92 [0.61-1.38],0.6765680671455778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,2304,274,1.71 [1.31-2.22],6.443403314679949e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD2,Leiomodin-2,2244,266,0.81 [0.65-1.01],0.0560663648508184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LONP1,"Lon protease homolog, mitochondrial",2243,264,1.02 [0.89-1.17],0.7723524461969336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),2262,266,0.96 [0.90-1.02],0.1940223880436061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,2636,313,1.00 [0.80-1.23],0.965274706703503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPL,Lipoprotein lipase,2658,316,0.97 [0.79-1.19],0.7411775187065133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,2575,314,1.46 [1.26-1.70],3.5251330974416097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPP,Lipoma-preferred partner,2242,265,0.91 [0.75-1.09],0.2970465724620065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2242,265,0.91 [0.76-1.09],0.282044870828705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2262,271,0.95 [0.72-1.25],0.7171907339684436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRG1,Leucine-rich alpha-2-glycoprotein,2309,270,1.35 [0.87-2.09],0.1844401402797326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2671,318,1.51 [1.16-1.96],0.002335019109421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2237,267,0.91 [0.59-1.41],0.6859748258311633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,2636,313,1.24 [0.87-1.78],0.2312164726151406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,2658,316,1.45 [1.13-1.86],0.0038593420962747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,2262,271,0.86 [0.60-1.23],0.4038485551093473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2BP,LRP2-binding protein,2262,271,0.98 [0.84-1.14],0.7721501221680049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2678,319,0.99 [0.82-1.19],0.9125303849576938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC25,Leucine-rich repeat-containing protein 25,2636,313,1.03 [0.82-1.30],0.8078130181899186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,2307,271,1.11 [0.85-1.45],0.425444633234765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC38,Leucine-rich repeat-containing protein 38,2262,271,1.09 [0.85-1.41],0.4913767399679034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC59,Leucine-rich repeat-containing protein 59,2304,270,0.87 [0.68-1.12],0.2841237066874532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2297,268,0.87 [0.68-1.12],0.279278386743257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,2601,309,0.84 [0.66-1.07],0.1653932691688686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2262,271,1.17 [0.90-1.53],0.2432802907552976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2304,274,0.57 [0.36-0.90],0.0169418877692103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,2579,308,0.93 [0.76-1.13],0.4631218890134706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,2271,266,1.04 [0.92-1.18],0.53640143860496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSP1,Lymphocyte-specific protein 1,2664,320,0.91 [0.71-1.17],0.4743100951513611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA,Lymphotoxin-alpha,2664,320,0.90 [0.70-1.17],0.446034272417501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA4H,Leukotriene A-4 hydrolase,2676,318,0.87 [0.74-1.03],0.1070422085830039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTB,Lymphotoxin-beta,2297,268,1.24 [0.91-1.69],0.1722052843130947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2695,322,2.18 [1.67-2.85],1.2118084484134446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2579,308,1.20 [1.03-1.40],0.0164028076761706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2651,317,1.45 [1.07-1.96],0.0169101843564259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTO1,Protein LTO1 homolog,2601,309,0.98 [0.75-1.28],0.8672294410475139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LUZP2,Leucine zipper protein 2,2297,268,1.10 [0.86-1.41],0.4543347067663394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,2628,320,0.85 [0.74-0.99],0.0363353280251729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,2647,315,1.19 [0.95-1.50],0.1346263026514783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY75,Lymphocyte antigen 75,2664,320,1.26 [0.98-1.61],0.0681293750443252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,2623,312,1.71 [1.25-2.33],0.0006971779464298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY96,Lymphocyte antigen 96,2641,320,1.20 [0.92-1.55],0.1768239770406951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYAR,Cell growth-regulating nucleolar protein,2579,308,0.87 [0.71-1.08],0.2115756690343259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYN,Tyrosine-protein kinase Lyn,2636,313,1.01 [0.90-1.14],0.8537392981736565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD1,Ly6/PLAUR domain-containing protein 1,2589,310,0.91 [0.76-1.09],0.2877211378983305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,2636,315,1.49 [1.14-1.96],0.0039202842242116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2579,308,1.19 [1.05-1.35],0.0056974613198767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPLA2,Acyl-protein thioesterase 2,2244,266,0.92 [0.81-1.04],0.1678008832968616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2262,271,0.87 [0.76-0.98],0.0285134292711057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2309,270,1.38 [0.76-2.50],0.2862927438751674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYZL2,Lysozyme-like protein 2,2224,264,1.03 [0.74-1.44],0.8572412181102915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LZTFL1,Leucine zipper transcription factor-like protein 1,2268,265,0.91 [0.77-1.09],0.3073328074691886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,M6PR,Cation-dependent mannose-6-phosphate receptor,2243,264,0.77 [0.55-1.08],0.1344918927743608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2628,319,0.98 [0.81-1.18],0.8270228103189209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,2579,308,0.73 [0.55-0.97],0.0280384895458663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,2262,271,0.88 [0.69-1.13],0.309332469264676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,2271,266,1.29 [1.12-1.49],0.0004729222243609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGED1,Melanoma-associated antigen D1,2579,308,0.95 [0.77-1.18],0.6616582307582675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,2304,270,1.65 [1.23-2.22],0.0008068210873591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC4,Apical endosomal glycoprotein,2297,268,1.06 [0.86-1.29],0.5953612172394915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2243,264,1.54 [0.96-2.46],0.0720484651122885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN2B2,Epididymis-specific alpha-mannosidase,2304,270,0.92 [0.76-1.12],0.4178690099278817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2224,264,1.08 [0.85-1.37],0.510409301501474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,2674,318,0.96 [0.89-1.04],0.3135717299795568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,2658,318,1.46 [1.04-2.06],0.0279134002232751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC4,MANSC domain-containing protein 4,2242,265,0.89 [0.75-1.06],0.1840170156806036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2244,266,0.71 [0.48-1.04],0.0765480700812591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2242,265,1.00 [0.84-1.20],0.9860746883255164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2,Microtubule-associated protein 2,2300,272,1.04 [0.81-1.33],0.7578059169217881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2307,271,0.88 [0.72-1.06],0.1812723875104769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2664,320,0.98 [0.89-1.09],0.7636161710437689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2579,308,0.91 [0.82-1.02],0.1055780207050856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2636,319,0.95 [0.87-1.04],0.2778681556204226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK13,Mitogen-activated protein kinase 13,2224,264,0.99 [0.76-1.28],0.9146061609545724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK9,Mitogen-activated protein kinase 9,2664,320,0.92 [0.74-1.14],0.4501461844145962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPKAPK2,MAP kinase-activated protein kinase 2,2271,266,0.95 [0.81-1.12],0.5718972730456076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,2224,264,1.03 [0.95-1.11],0.5308383566460402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,2589,310,1.08 [0.88-1.32],0.4714435180948226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARCO,Macrophage receptor MARCO,2658,316,1.21 [0.83-1.75],0.322544417102873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",2266,263,0.93 [0.81-1.07],0.3152347346482819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MASP1,Mannan-binding lectin serine protease 1,2636,319,0.89 [0.58-1.35],0.5729590368593879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN2,Matrilin-2,2668,317,0.92 [0.67-1.27],0.6070752198828584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,2637,320,0.71 [0.53-0.94],0.0177589895512566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAVS,Mitochondrial antiviral-signaling protein,2579,308,0.90 [0.81-1.02],0.0920154614828908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAX,Protein max,2589,310,0.98 [0.89-1.08],0.6393645899550982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MB,Myoglobin,2695,322,1.05 [0.89-1.24],0.5476868176855705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MBL2,Mannose-binding protein C,2278,267,1.00 [0.90-1.11],0.9867664049988072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,2668,319,1.88 [1.46-2.43],1.0230423109090268e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2304,274,0.90 [0.67-1.21],0.4769026934775331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEMP1,Mast cell-expressed membrane protein 1,2244,268,1.01 [0.88-1.16],0.8989342669260346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,2644,315,1.03 [0.83-1.27],0.8107385984231776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCTS1,Malignant T-cell-amplified sequence 1,2307,271,1.00 [0.64-1.55],0.991763626507514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2641,320,1.13 [0.99-1.30],0.0668229414881079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",2301,272,0.70 [0.51-0.94],0.0199037091423226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,2649,317,1.51 [1.28-1.77],4.5658265450279163e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,2262,271,0.77 [0.52-1.13],0.1817920496880198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2243,264,1.00 [0.87-1.13],0.9520029363975404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED18,Mediator of RNA polymerase II transcription subunit 18,2579,308,0.94 [0.82-1.08],0.376462684532368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED21,Mediator of RNA polymerase II transcription subunit 21,2242,265,0.82 [0.62-1.09],0.1784239471539161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,2663,317,1.02 [0.81-1.30],0.8400711166850201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,2242,265,1.00 [0.66-1.52],0.9916715757429098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,2690,322,1.23 [0.76-2.00],0.3966098692196299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MELTF,Melanotransferrin,2304,270,1.06 [0.72-1.55],0.7815092094222287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MENT,Protein MENT,2268,265,0.81 [0.50-1.29],0.3709212947779309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1A,Meprin A subunit alpha,2307,271,1.01 [0.87-1.18],0.8479523170973328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,2658,316,0.94 [0.87-1.03],0.1748230125152877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,2663,317,0.44 [0.31-0.63],7.817820678440934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,2692,319,1.35 [0.94-1.94],0.1033943259266514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MESD,LRP chaperone MESD,2670,320,0.96 [0.89-1.04],0.3211961198486635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,2676,320,1.71 [1.07-2.75],0.0263486410094948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1,Methionine aminopeptidase 1,2589,310,0.88 [0.61-1.26],0.4756595308988255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2664,320,0.97 [0.86-1.10],0.6527691673623561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,2673,318,0.87 [0.72-1.05],0.137337863854571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3,Microfibril-associated glycoprotein 3,2616,315,1.01 [0.82-1.24],0.9382791544339985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,2262,271,0.76 [0.59-0.96],0.0224156787096508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,2268,265,1.70 [1.21-2.39],0.0022018926165993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP5,Microfibrillar-associated protein 5,2695,322,1.02 [0.81-1.28],0.8855254042298402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,2670,320,1.23 [1.01-1.49],0.0420282197152433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGLL,Monoglyceride lipase,2672,317,0.94 [0.84-1.05],0.2523622688852118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,2664,320,0.95 [0.88-1.04],0.2685999270797914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIA,Melanoma-derived growth regulatory protein,2658,318,0.92 [0.71-1.18],0.5150234878381474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICALL2,MICAL-like protein 2,2262,271,0.90 [0.75-1.08],0.2678596466703905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2664,320,1.09 [1.01-1.17],0.0222497497277438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,2664,318,0.83 [0.72-0.97],0.0173502292359583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,2601,309,1.30 [1.07-1.57],0.0071206311264111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2297,268,0.92 [0.82-1.03],0.1301113398052223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINK1,Misshapen-like kinase 1,2300,272,0.93 [0.82-1.06],0.2831783977273406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MITD1,MIT domain-containing protein 1,2641,320,0.94 [0.85-1.05],0.2735129503646057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MKI67,Proliferation marker protein Ki-67,2244,268,0.85 [0.61-1.17],0.3088323081861516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLLT1,Protein ENL,2224,264,0.81 [0.66-1.00],0.0518134419325413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,2664,320,1.14 [1.02-1.28],0.0232235764751338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MME,Neprilysin,2636,313,1.06 [0.94-1.20],0.3213402949432917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,2583,310,1.22 [1.09-1.37],0.0004853452346564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,2657,316,1.42 [1.22-1.66],8.656811883731802e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,2660,318,1.37 [1.16-1.63],0.0002305978458464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,2589,310,1.21 [0.89-1.65],0.224801664831917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,2304,270,1.21 [1.01-1.45],0.0394404986387128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,2670,320,1.24 [1.04-1.49],0.0197127441833786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,2613,315,1.73 [1.41-2.13],1.3649290964318853e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP8,Neutrophil collagenase,2675,319,1.02 [0.89-1.16],0.7729726104676237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP9,Matrix metalloproteinase-9,2667,320,1.01 [0.86-1.19],0.9119439750572784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2242,265,1.14 [0.90-1.43],0.2780904585125199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MN1,Transcriptional activator MN1,2262,271,0.79 [0.62-1.00],0.0504266553726813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNAT1,CDK-activating kinase assembly factor MAT1,2271,266,0.98 [0.75-1.29],0.8892438664958809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNDA,Myeloid cell nuclear differentiation antigen,2654,316,0.91 [0.83-1.01],0.0806823211575885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOCS2,Molybdopterin synthase catalytic subunit,2268,265,0.90 [0.75-1.08],0.2471351465094884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOG,Myelin-oligodendrocyte glycoprotein,2676,318,1.16 [0.89-1.51],0.2591000468483024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORC3,MORC family CW-type zinc finger protein 3,2300,272,0.78 [0.49-1.24],0.2959976295762891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,2271,266,0.70 [0.50-1.00],0.0476345391227903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L2,Mortality factor 4-like protein 2,2224,264,1.04 [0.76-1.43],0.7964400136349951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORN4,MORN repeat-containing protein 4,2224,264,0.97 [0.84-1.12],0.6887532304500974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPHOSPH8,M-phase phosphoprotein 8,2616,315,0.95 [0.83-1.08],0.4090221344590836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPI,Mannose-6-phosphate isomerase,2636,313,0.98 [0.87-1.10],0.6912927217015404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2672,317,0.97 [0.86-1.11],0.6886866005192396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPO,Myeloperoxidase,2670,320,0.97 [0.78-1.20],0.7745695178503818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,2293,268,0.74 [0.56-0.98],0.0359970765844414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,2315,273,1.76 [1.19-2.59],0.004403885630445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRI1,Methylthioribose-1-phosphate isomerase,2262,271,0.90 [0.76-1.06],0.2153557879842035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL24,"39S ribosomal protein L24, mitochondrial",2242,265,0.72 [0.49-1.04],0.07842257234487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL28,"39S ribosomal protein L28, mitochondrial",2304,274,1.01 [0.75-1.37],0.9239403443853194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",2589,310,0.66 [0.45-0.98],0.0376397812823594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",2220,263,0.90 [0.57-1.44],0.6671482580751715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2304,274,0.92 [0.78-1.09],0.3372565828485061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPS16,"28S ribosomal protein S16, mitochondrial",2244,268,0.77 [0.48-1.24],0.2847883870807913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLN,Mesothelin,2630,312,1.10 [0.93-1.29],0.2667737051436288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLNL,Mesothelin-like protein,2262,271,0.87 [0.62-1.23],0.4328561156623675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,2663,318,1.15 [1.00-1.31],0.0460499234099274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,2678,319,1.49 [1.21-1.83],0.0001388639375768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,2658,318,0.91 [0.80-1.05],0.2042737603783987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MST1,Hepatocyte growth factor-like protein,2282,270,1.02 [0.86-1.21],0.8249598388428482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,2616,315,1.08 [0.90-1.29],0.3993803221593021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTDH,Protein LYRIC,2244,268,1.00 [0.88-1.13],0.9665045549532996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2300,272,0.99 [0.64-1.55],0.979643738888825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2271,266,0.97 [0.88-1.08],0.6210765097615232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",2307,271,0.99 [0.87-1.13],0.9145606159494758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTPN,Myotrophin,2616,315,1.03 [0.75-1.41],0.8750023744290194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTR,Methionine synthase,2242,265,0.83 [0.67-1.04],0.0991864791768224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS1,Protein MTSS 1,2307,271,0.94 [0.85-1.04],0.2195219292008704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS2,Protein MTSS 2,2297,268,0.95 [0.85-1.07],0.427101428485529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTUS1,Microtubule-associated tumor suppressor 1,2271,266,0.84 [0.68-1.04],0.1045914262044025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,2589,310,1.71 [1.48-1.97],2.995969199890602e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC16,Mucin-16,2636,313,1.00 [0.94-1.05],0.8970874070248396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC2,Mucin-2,2316,272,1.07 [0.95-1.21],0.2733941627772269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUCL3,Mucin-like protein 3,2224,264,1.00 [0.76-1.31],0.9957493589287384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MVK,Mevalonate kinase,2601,309,0.99 [0.89-1.11],0.888428566559247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MXRA8,Matrix remodeling-associated protein 8,2268,265,0.69 [0.47-1.00],0.0506159818624523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",2304,270,1.09 [0.94-1.26],0.2392662663487946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC2,"Myosin-binding protein C, fast-type",2243,264,1.05 [0.92-1.19],0.4859537415824063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2304,274,0.89 [0.75-1.07],0.2298723183437567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYDGF,Myeloid-derived growth factor,2304,270,0.94 [0.83-1.06],0.3255398955778923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH4,Myosin-4,2242,265,0.96 [0.73-1.26],0.7525627874343326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH7B,Myosin-7B,2224,264,1.14 [0.85-1.54],0.3907933791701014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH9,Myosin-9,2316,272,0.99 [0.89-1.10],0.8495611061055164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2242,265,1.04 [0.82-1.33],0.7285646970445177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,2243,264,1.12 [0.96-1.30],0.1369418992960154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,2243,264,1.17 [0.95-1.44],0.150913419440405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL6B,Myosin light chain 6B,2262,271,0.96 [0.84-1.10],0.5747880324229524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2262,271,1.12 [0.93-1.35],0.2386833638618696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO6,Unconventional myosin-VI,2304,274,0.92 [0.66-1.28],0.6169020336846935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO9B,Unconventional myosin-IXb,2601,309,0.92 [0.79-1.08],0.307736880167429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOC,Myocilin,2670,320,1.09 [0.88-1.35],0.4137636164515241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM1,Myomesin-1,2244,266,0.92 [0.69-1.22],0.5548156366272392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,2242,265,1.15 [0.96-1.39],0.1368429151988362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,2268,265,1.05 [0.93-1.18],0.4443661943468681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,2670,318,1.01 [0.84-1.22],0.9035375806443644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,2579,308,0.78 [0.63-0.97],0.0243520677460392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA10,N-alpha-acetyltransferase 10,2242,265,0.88 [0.69-1.11],0.2860503358159941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA80,N-alpha-acetyltransferase 80,2262,271,0.95 [0.86-1.04],0.2503342892378641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,2630,320,1.01 [0.85-1.19],0.948881354508023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NACC1,Nucleus accumbens-associated protein 1,2297,268,0.93 [0.75-1.15],0.4839302095183168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NADK,NAD kinase,2658,316,0.96 [0.80-1.14],0.6107038352481249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGA,Alpha-N-acetylgalactosaminidase,2238,268,1.05 [0.84-1.32],0.6824112544309249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,2240,264,0.74 [0.60-0.91],0.0046525218075134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2268,265,1.42 [0.86-2.36],0.1717329585493942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAMPT,Nicotinamide phosphoribosyltransferase,2579,308,0.82 [0.67-1.02],0.0685545695836353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAP1L4,Nucleosome assembly protein 1-like 4,2303,270,0.83 [0.62-1.11],0.2113147470582629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,2300,272,0.73 [0.51-1.05],0.0917484547996427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",2304,274,1.00 [0.78-1.27],0.979552175070278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2658,318,2.11 [1.54-2.90],3.894337940999061e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBN,Nibrin,2601,309,0.85 [0.69-1.05],0.1232012769894052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM1,Neural cell adhesion molecule 1,2668,319,1.04 [0.79-1.39],0.7628645055371621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM2,Neural cell adhesion molecule 2,2670,320,0.94 [0.66-1.34],0.7311176544640774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,2678,319,0.51 [0.40-0.65],2.48997219815474e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCF2,Neutrophil cytosol factor 2,2660,320,0.90 [0.80-1.01],0.0778853996400819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCK2,Cytoplasmic protein NCK2,2674,318,0.97 [0.89-1.07],0.5592595236271309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCLN,Nicalin,2601,309,1.07 [0.89-1.30],0.467650823481563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,2661,320,1.91 [1.51-2.42],9.047378940225512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2307,271,1.81 [1.33-2.44],0.0001291737367761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,2676,318,1.68 [1.22-2.32],0.0015992502477435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDRG1,Protein NDRG1,2589,310,0.95 [0.80-1.12],0.5140805374564024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2297,268,1.04 [0.85-1.26],0.7116667049732989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2241,268,1.01 [0.72-1.41],0.970387498871513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2307,271,0.93 [0.82-1.06],0.2966748421630075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2579,308,1.10 [0.97-1.24],0.1524519699832857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEB,Nebulin,2242,265,1.13 [0.83-1.55],0.4296948645953861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,2242,265,1.01 [0.84-1.22],0.8764121763932687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN1,Nectin-1,2244,268,0.79 [0.54-1.15],0.2202164945782665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,2656,314,2.10 [1.59-2.76],1.1789996198949197e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,2658,318,1.92 [1.53-2.40],1.496918486923398e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2244,268,0.82 [0.65-1.04],0.0983624146239064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD9,Enhancer of filamentation 1,2244,268,1.02 [0.73-1.42],0.9004735740031288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,2581,309,1.89 [1.61-2.22],6.6218801511156e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEK7,Serine/threonine-protein kinase Nek7,2271,266,1.02 [0.88-1.19],0.7692893048084373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,2658,318,0.60 [0.49-0.74],9.736683809088388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL2,Protein kinase C-binding protein NELL2,2674,318,1.06 [0.76-1.47],0.73018084438061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NENF,Neudesin,2297,268,1.01 [0.90-1.12],0.915771038703189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEO1,Neogenin,2304,274,0.94 [0.58-1.54],0.8128260434446686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEXN,Nexilin,2315,273,0.90 [0.77-1.07],0.2322714966045389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,2692,319,2.89 [2.18-3.85],2.435073654945355e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFAT5,Nuclear factor of activated T-cells 5,2244,268,0.96 [0.83-1.10],0.5364242646721993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2664,320,0.93 [0.84-1.03],0.1395964120916159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2601,309,0.96 [0.82-1.12],0.6034547593590032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFE2,Transcription factor NF-E2 45 kDa subunit,2243,264,0.98 [0.83-1.15],0.7666537163601153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFIC,Nuclear factor 1 C-type,2304,274,0.93 [0.67-1.30],0.6727164692463732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,2242,265,0.90 [0.76-1.06],0.2204286603708046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,2271,266,0.92 [0.71-1.20],0.5433253081631015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKBIE,NF-kappa-B inhibitor epsilon,2579,308,0.89 [0.72-1.10],0.2694298404193063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2307,271,0.98 [0.88-1.10],0.7538016434572046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFX1,Transcriptional repressor NF-X1,2242,265,0.85 [0.71-1.02],0.0786247278456252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFYA,Nuclear transcription factor Y subunit alpha,2242,265,0.87 [0.64-1.21],0.4131594309512466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,2641,320,2.32 [1.08-4.99],0.0316543419722344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,2304,270,1.30 [0.96-1.77],0.0915378640072433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGRN,Neugrin,2300,272,0.75 [0.42-1.34],0.33243046308879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NHLRC3,NHL repeat-containing protein 3,2215,255,1.41 [0.96-2.05],0.0765493138028488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID1,Nidogen-1,2661,316,1.01 [0.77-1.33],0.9297604042374764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID2,Nidogen-2,2670,320,0.95 [0.83-1.08],0.4249094937057841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NINJ1,Ninjurin-1,2579,308,1.10 [0.93-1.30],0.2760599075910235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,2243,264,0.68 [0.52-0.88],0.0035590844090621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT2,Omega-amidase NIT2,2294,269,0.91 [0.77-1.08],0.2686266677513301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN1,Neuroligin-1,2262,271,1.02 [0.86-1.21],0.8190990833304417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN2,Neuroligin-2,2244,266,1.00 [0.76-1.31],0.9922424190777538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME1,Nucleoside diphosphate kinase A,2244,268,0.79 [0.45-1.39],0.4129292534305352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME3,Nucleoside diphosphate kinase 3,2668,317,0.86 [0.55-1.35],0.5203754331698466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMI,N-myc-interactor,2290,268,0.95 [0.80-1.12],0.5554342520163678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2641,320,0.97 [0.85-1.09],0.5831081579587359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMRK2,Nicotinamide riboside kinase 2,2224,264,0.71 [0.48-1.05],0.0887801153969468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2304,274,1.02 [0.85-1.22],0.8572883762647063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOMO1,Nodal modulator 1,2670,320,0.82 [0.54-1.23],0.3365150040199017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,2242,265,0.97 [0.87-1.09],0.6248213780473989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",2589,310,1.12 [0.95-1.31],0.1731528113023711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS2,"Nitric oxide synthase, inducible",2242,265,0.85 [0.62-1.17],0.318870942386619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",2589,310,1.18 [0.99-1.42],0.0663443188950555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,2695,322,4.73 [2.69-8.34],7.29602397829323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,2316,272,1.42 [0.90-2.23],0.1285376491415936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,2695,322,1.33 [1.01-1.75],0.0396487587118414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,2281,267,1.85 [1.32-2.58],0.0003033545649026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,2658,316,1.47 [1.14-1.90],0.0032213389407367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS1,Nephrin,2244,268,0.81 [0.57-1.15],0.2433291470370235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS2,Podocin,2244,268,1.00 [0.90-1.12],0.941792122116938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPL,N-acetylneuraminate lyase,2304,270,0.85 [0.67-1.08],0.1926037030524448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,2616,315,1.10 [1.03-1.18],0.0041246358082754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPC,C-type natriuretic peptide,2664,320,0.88 [0.75-1.04],0.1368162824759332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,2242,265,0.75 [0.53-1.05],0.0919268121834555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTN,Neuroplastin,2579,308,1.01 [0.88-1.16],0.8741724792634888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,2670,320,1.26 [1.02-1.57],0.031851976744603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX2,Neuronal pentraxin-2,2316,272,0.97 [0.70-1.36],0.8742938655785184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTXR,Neuronal pentraxin receptor,2658,316,0.86 [0.66-1.12],0.2595491475857593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,2676,318,1.21 [1.04-1.40],0.0149863225739099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,2658,316,2.21 [1.66-2.94],5.003778551865256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRGN,Neurogranin,2315,273,0.95 [0.83-1.07],0.3909128215393763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRN1,Neuritin,2304,274,0.87 [0.60-1.26],0.4512312697312364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,2671,320,2.15 [1.52-3.03],1.3750974096368526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP2,Neuropilin-2,2670,320,0.99 [0.71-1.39],0.9716223880891692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRTN,Neurturin,2601,309,0.86 [0.70-1.05],0.1372341390358259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRXN3,Neurexin-3,2262,271,0.90 [0.62-1.29],0.5575264302885761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,2678,319,0.84 [0.72-0.99],0.0337675054853008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2304,270,0.99 [0.84-1.17],0.9422249785486848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2300,272,1.05 [0.76-1.44],0.7659589628430428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,2659,319,0.91 [0.81-1.03],0.1241146291999787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5E,5'-nucleotidase,2658,318,1.02 [0.85-1.22],0.8331606077168785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,2664,320,1.31 [1.02-1.68],0.0344867418186785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF4,Neurotrophin-4,2579,308,1.04 [0.79-1.39],0.763722223599845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK2,BDNF/NT-3 growth factors receptor,2658,316,1.37 [0.94-1.98],0.0999450578902471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK3,NT-3 growth factor receptor,2678,319,1.44 [0.93-2.22],0.1027880699259887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2658,316,1.14 [1.05-1.22],0.0007314114415458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUB1,NEDD8 ultimate buster 1,2664,320,0.96 [0.85-1.08],0.4769201669924235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2297,268,1.01 [0.90-1.14],0.8633231913845946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,2672,318,1.12 [0.86-1.45],0.4019046719983923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDC,Nuclear migration protein nudC,2692,319,0.90 [0.77-1.06],0.1969625772174104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2243,264,1.00 [0.59-1.70],0.9968794401411312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2242,265,0.79 [0.60-1.04],0.0898151928061886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT16,U8 snoRNA-decapping enzyme,2304,271,1.00 [0.88-1.15],0.9712353854527224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2636,313,0.87 [0.73-1.05],0.1611928600871571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,2670,320,0.88 [0.71-1.08],0.218673533340625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUMB,Protein numb homolog,2244,268,0.91 [0.79-1.05],0.2100180358891924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUP50,Nuclear pore complex protein Nup50,2242,265,0.95 [0.63-1.45],0.8186221514852299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPE4,NXPE family member 4,2242,265,1.02 [0.70-1.48],0.9143493141588468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,2589,310,0.72 [0.55-0.94],0.0163483853286907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH3,Neurexophilin-3,2244,268,0.88 [0.60-1.30],0.5337036235084962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OBP2B,Odorant-binding protein 2b,2634,319,0.92 [0.78-1.09],0.3401744932210564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,2304,274,1.16 [0.90-1.49],0.2559471277831011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ODAM,Odontogenic ameloblast-associated protein,2583,309,1.04 [0.87-1.24],0.6612771304981323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OFD1,Oral-facial-digital syndrome 1 protein,2271,266,0.85 [0.69-1.05],0.132412945403779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGA,Protein O-GlcNAcase,2307,271,0.97 [0.82-1.15],0.7253883416249809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGFR,Opioid growth factor receptor,2636,313,0.81 [0.59-1.11],0.1816279857687975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,2670,320,1.46 [1.19-1.78],0.0002610163269982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2271,266,1.03 [0.85-1.25],0.7642883995448156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLFM4,Olfactomedin-4,2185,256,1.07 [0.97-1.17],0.1794866931617186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLR1,Oxidized low-density lipoprotein receptor 1,2635,316,1.03 [0.88-1.21],0.6924863806695597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,2674,318,0.60 [0.49-0.75],2.3137422803287306e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,2636,313,0.80 [0.69-0.92],0.0013641624142119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMP,Olfactory marker protein,2244,266,0.96 [0.73-1.25],0.7487191967089988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPHN1,Oligophrenin-1,2300,272,0.92 [0.83-1.03],0.146910833738844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPLAH,5-oxoprolinase,2243,264,1.06 [0.89-1.26],0.515338050372073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPTC,Opticin,2636,313,0.92 [0.73-1.16],0.4761856841525675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ORM1,Alpha-1-acid glycoprotein 1,2302,269,0.84 [0.47-1.48],0.5365545334601505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,2300,272,0.60 [0.40-0.90],0.0142149568849846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,2668,317,1.12 [0.85-1.48],0.4246081917964581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSM,Oncostatin-M,2653,320,0.98 [0.85-1.13],0.7936171803182415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,2671,320,2.04 [1.28-3.25],0.0026407250794298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSTN,Osteocrin,2262,271,1.05 [0.80-1.38],0.7234326466566241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTOA,Otoancorin,2244,266,0.94 [0.75-1.17],0.557673085974504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD6B,Deubiquitinase OTUD6B,2307,271,0.86 [0.70-1.06],0.1490812727777037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD7B,OTU domain-containing protein 7B,2304,274,0.98 [0.81-1.18],0.833672334701803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2243,264,0.94 [0.80-1.11],0.4807294745515945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXT,Oxytocin-neurophysin 1,2678,319,0.98 [0.92-1.05],0.6244667337847285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,2641,317,1.02 [0.79-1.31],0.8987379166950722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PACS2,Phosphofurin acidic cluster sorting protein 2,2242,265,0.95 [0.78-1.16],0.6093824112638047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI2,Protein-arginine deiminase type-2,2601,309,1.12 [0.95-1.31],0.1767466924609322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,2583,309,0.84 [0.73-0.97],0.0161976199792352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAEP,Glycodelin,2641,320,1.01 [0.92-1.11],0.8320250149085565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2304,274,1.02 [0.92-1.12],0.7225041588225207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2271,266,0.97 [0.75-1.24],0.8023042745409708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2616,315,1.07 [0.90-1.28],0.4427330996848265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,2243,264,0.99 [0.74-1.33],0.969009515659393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2221,264,0.89 [0.71-1.12],0.3158054028464868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,2589,310,0.90 [0.76-1.06],0.2043565284543015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALLD,Palladin,2244,268,0.96 [0.69-1.32],0.7843785739823832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,2295,269,1.23 [0.87-1.74],0.2508413801617639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,2300,272,1.31 [1.00-1.71],0.0509366513332818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM3,Paralemmin-3,2242,265,1.06 [0.90-1.24],0.4867553087438805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,2681,319,0.91 [0.65-1.26],0.5631664877312801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAMR1,Inactive serine protease PAMR1,2670,320,0.82 [0.58-1.17],0.282572038859651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,2601,309,0.67 [0.54-0.83],0.0003695077650171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARD3,Partitioning defective 3 homolog,2271,266,0.88 [0.74-1.04],0.1446288019418024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,2670,320,0.83 [0.67-1.01],0.0631703304682791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARP1,Poly [ADP-ribose] polymerase 1,2664,320,0.87 [0.72-1.05],0.1461893482038403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAXX,Protein PAXX,2268,265,0.81 [0.62-1.06],0.1230232098951031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,2224,264,0.85 [0.59-1.23],0.3855156095097154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,2589,310,0.76 [0.63-0.91],0.0037262462546439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2307,271,1.11 [0.74-1.65],0.6196537789791534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCARE,Photoreceptor cilium actin regulator,2244,266,0.91 [0.78-1.06],0.2426302412647037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2263,264,0.72 [0.57-0.89],0.0030109770382767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBP2,Poly(rC)-binding protein 2,2304,274,0.95 [0.80-1.12],0.5130969339640565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,2678,319,1.76 [1.14-2.70],0.0107001149011699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,2304,274,1.56 [1.03-2.36],0.0376083465780709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,2658,316,1.41 [1.12-1.77],0.0036278666738726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,2307,271,1.71 [1.30-2.25],0.0001365969488461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,2307,271,0.67 [0.49-0.93],0.0155155956904724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDHB15,Protocadherin beta-15,2297,268,1.27 [0.95-1.68],0.1056530395742296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCNA,Proliferating cell nuclear antigen,2224,264,1.01 [0.84-1.20],0.9537310990024698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,2297,268,0.93 [0.73-1.20],0.5897439352275708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2695,322,1.33 [1.05-1.69],0.020265643883496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,2307,271,0.94 [0.80-1.11],0.4628382170355722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,2304,270,0.96 [0.85-1.08],0.4769109194252471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,2673,318,1.33 [1.07-1.65],0.0106315107014184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,2636,313,2.32 [1.79-3.01],2.552252875408677e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,2678,319,0.90 [0.75-1.07],0.2313614406904523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,2658,316,1.10 [0.94-1.28],0.2329187666722367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCL2,Phosducin-like protein 2,2224,264,0.99 [0.78-1.25],0.9394459745411368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2224,264,1.08 [0.87-1.34],0.4859946213502533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2242,265,0.98 [0.79-1.21],0.8512836316060013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2268,265,0.96 [0.86-1.07],0.4463203997065411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFA,Platelet-derived growth factor subunit A,2695,322,0.98 [0.86-1.11],0.733578320979168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFB,Platelet-derived growth factor subunit B,2674,318,0.97 [0.87-1.08],0.5945864583068232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFC,Platelet-derived growth factor C,2579,308,0.89 [0.62-1.28],0.5310008644402744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,2658,316,1.76 [1.28-2.42],0.0005251015892027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRB,Platelet-derived growth factor receptor beta,2695,322,1.20 [0.90-1.59],0.2087639503011065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA2,Protein disulfide-isomerase A2,2224,264,0.85 [0.62-1.17],0.3149193974180184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA3,Protein disulfide-isomerase A3,2268,265,0.76 [0.47-1.25],0.2800877721086194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA4,Protein disulfide-isomerase A4,2316,272,0.91 [0.75-1.11],0.3610282092893844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA5,Protein disulfide-isomerase A5,2224,264,0.91 [0.74-1.11],0.3471200768386633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM5,PDZ and LIM domain protein 5,2304,274,0.96 [0.87-1.05],0.3654213292741792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM7,PDZ and LIM domain protein 7,2674,318,0.97 [0.90-1.06],0.5296851597322267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2579,308,1.09 [0.91-1.31],0.3573699549533883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDRG1,p53 and DNA damage-regulated protein 1,2262,271,0.84 [0.65-1.09],0.1944807738208315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2224,264,1.04 [0.87-1.25],0.6324820090035557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZD2,PDZ domain-containing protein 2,2242,265,0.84 [0.68-1.04],0.117192871732559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2244,268,1.03 [0.82-1.30],0.7768751765525566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,2695,322,1.88 [1.23-2.88],0.0037743093499251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,2670,320,0.86 [0.71-1.03],0.0913959883946223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECAM1,Platelet endothelial cell adhesion molecule,2670,320,0.94 [0.68-1.29],0.6984289848136915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,2243,264,0.69 [0.43-1.10],0.1205463576928257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PENK,Proenkephalin-A,2268,265,1.06 [0.75-1.50],0.7373427088877929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,2315,273,0.50 [0.34-0.73],0.0003990738665787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,2244,268,0.89 [0.81-0.98],0.0203355666648198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PF4,Platelet factor 4,2296,270,0.97 [0.86-1.10],0.6696955471466504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN2,Prefoldin subunit 2,2589,310,1.08 [0.89-1.31],0.4233998214227251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,2224,264,0.97 [0.76-1.23],0.787558473176915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN6,Prefoldin subunit 6,2262,271,1.05 [0.87-1.26],0.6191338684979039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2634,313,0.92 [0.81-1.05],0.2357504834894541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGA4,Pepsin A-4,2315,273,1.11 [0.97-1.28],0.1133466690176361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2304,270,0.92 [0.74-1.15],0.4842025744838927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,2692,319,1.90 [1.36-2.65],0.0001799290176927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP1,Peptidoglycan recognition protein 1,2685,322,1.11 [0.89-1.37],0.3631660757344419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2282,268,1.45 [0.96-2.20],0.0773337341662535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP4,Peptidoglycan recognition protein 4,2242,265,1.07 [0.87-1.31],0.519874934952361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGM2,Phosphoglucomutase-2,2262,271,0.84 [0.66-1.07],0.1519301541307708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGR,Progesterone receptor,2244,268,1.03 [0.91-1.16],0.6697158020486388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHACTR2,Phosphatase and actin regulator 2,2304,274,0.95 [0.86-1.06],0.3667040417689718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2307,271,1.22 [0.98-1.52],0.0694577424282823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB2,Pleckstrin homology-like domain family B member 2,2224,264,1.04 [0.92-1.18],0.4911351035702695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2641,320,1.20 [0.88-1.64],0.245726377447404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2268,265,0.82 [0.63-1.07],0.146887372803152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI16,Peptidase inhibitor 16,2315,273,0.99 [0.62-1.59],0.9759185710201866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,2627,316,1.25 [1.07-1.46],0.003870480250271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2304,274,0.92 [0.79-1.07],0.2898817451625111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,2630,313,1.76 [1.40-2.20],1.1091536683369543e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2664,320,0.80 [0.68-0.95],0.0096459233872762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2670,320,2.66 [2.05-3.45],1.8383582618865472e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2244,268,0.92 [0.74-1.15],0.4837394078064859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2670,320,1.69 [1.34-2.13],7.203141542417653e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2658,316,1.38 [1.15-1.66],0.0005083726193733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2268,265,0.84 [0.71-0.99],0.0353818410023136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PITHD1,PITH domain-containing protein 1,2221,264,0.98 [0.85-1.13],0.8093400829536623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,2304,270,2.56 [1.72-3.83],4.258367741740331e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD2,Polycystin-2,2242,265,0.96 [0.78-1.19],0.7242476060581213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKLR,Pyruvate kinase PKLR,2665,317,0.86 [0.74-1.01],0.0593234954035316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKN3,Serine/threonine-protein kinase N3,2271,266,0.97 [0.82-1.14],0.6748949601424699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,2641,320,1.56 [1.31-1.85],4.2053851133198454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G15,Phospholipase A2 group XV,2658,318,1.16 [0.84-1.62],0.3685823727796747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G1B,Phospholipase A2,2693,322,1.05 [0.87-1.27],0.616810329056921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G2A,"Phospholipase A2, membrane associated",2657,315,0.97 [0.80-1.16],0.7320781518995068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G4A,Cytosolic phospholipase A2,2674,318,0.95 [0.85-1.06],0.3769739462776189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,2670,320,0.44 [0.35-0.55],5.414098897931027e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,2690,322,0.71 [0.59-0.84],0.0001008983986441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAU,Urokinase-type plasminogen activator,2670,320,0.75 [0.54-1.05],0.0918283620474656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,2651,317,1.74 [1.25-2.42],0.0010090481325961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",2300,272,0.71 [0.58-0.87],0.0008083462633825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2244,268,0.88 [0.65-1.20],0.4151385345028253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2300,272,0.94 [0.83-1.05],0.2738744771530403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,2300,272,1.05 [0.89-1.23],0.5893744580436023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLG,Plasminogen,2256,265,1.45 [0.86-2.46],0.1676187983044495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN1,Perilipin-1,2589,310,0.83 [0.62-1.11],0.2042587996235893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,2658,316,1.05 [0.83-1.32],0.680243208155346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,2658,316,0.82 [0.70-0.95],0.0096268009483043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLSCR3,Phospholipid scramblase 3,2295,271,1.08 [0.87-1.33],0.475721898493158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLTP,Phospholipid transfer protein,2685,321,1.04 [0.81-1.33],0.7508255233481949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC1,Plexin domain-containing protein 1,2579,308,1.13 [0.83-1.53],0.439044331828213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC2,Plexin domain-containing protein 2,2300,272,1.11 [0.75-1.66],0.6042691975586736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNA4,Plexin-A4,2664,320,0.99 [0.87-1.12],0.8168195110054908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,2686,320,3.70 [2.82-4.86],4.9324503865200675e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB3,Plexin-B3,2647,313,0.86 [0.70-1.07],0.1808053057829666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2644,311,1.02 [0.97-1.08],0.3968367304341558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMCH,Pro-MCH,2242,265,0.92 [0.78-1.09],0.3452635327161986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMM2,Phosphomannomutase 2,2242,265,0.94 [0.76-1.15],0.540805743433711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMS1,PMS1 protein homolog 1,2262,271,0.93 [0.73-1.18],0.5285864028541514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMVK,Phosphomevalonate kinase,2588,310,0.94 [0.87-1.03],0.1970662178496821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIP,Pancreatic triacylglycerol lipase,2315,273,1.11 [0.96-1.28],0.1597535793776906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,2300,272,1.09 [0.96-1.23],0.1726472167989435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP2,Pancreatic lipase-related protein 2,2663,317,0.98 [0.95-1.01],0.1645190478210297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA1,Paraneoplastic antigen Ma1,2243,264,0.99 [0.81-1.22],0.9446065438822894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA2,Paraneoplastic antigen Ma2,2244,266,0.96 [0.73-1.27],0.7915477679928334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2601,309,1.05 [0.97-1.15],0.2325020379250044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL,Podocalyxin,2636,313,0.91 [0.48-1.72],0.7754492338479801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL2,Podocalyxin-like protein 2,2658,318,1.22 [0.87-1.70],0.2503373806759989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,2244,268,1.58 [1.27-1.96],3.235194147279368e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,2244,268,0.89 [0.59-1.35],0.5935002608029378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2636,313,1.11 [0.86-1.44],0.4049334617812176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,2243,264,1.02 [0.87-1.20],0.7756414297652865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,2315,273,0.57 [0.38-0.84],0.0048984591999724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON2,Serum paraoxonase/arylesterase 2,2616,315,0.90 [0.69-1.19],0.4688785134041864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,2674,318,0.86 [0.64-1.16],0.3256280950946811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POSTN,Periostin,2316,272,0.86 [0.64-1.17],0.3399101620339968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPBP,Platelet basic protein,2294,270,0.98 [0.86-1.13],0.827231210536572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,2678,319,0.73 [0.59-0.91],0.0049478209176289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,2666,318,0.97 [0.88-1.08],0.5778292923279389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,2271,266,0.95 [0.77-1.17],0.6062420525796318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2316,272,0.93 [0.77-1.13],0.4619872861075249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPL,Periplakin,2244,268,0.95 [0.66-1.35],0.7638564190523438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1A,Protein phosphatase 1A,2579,308,0.98 [0.72-1.33],0.8870891628534496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1B,Protein phosphatase 1B,2244,268,0.84 [0.65-1.08],0.1668221100877963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1F,Protein phosphatase 1F,2304,270,0.90 [0.72-1.12],0.3588668240920043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,2636,313,0.84 [0.71-0.99],0.0350208748052716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2297,268,0.92 [0.80-1.07],0.2689410783742685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2658,318,0.95 [0.86-1.05],0.3362440301145314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2271,266,0.88 [0.73-1.06],0.1756247622033238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2304,274,0.95 [0.82-1.10],0.5042395431323983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2304,274,1.52 [1.19-1.93],0.0006343278003102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R2,Protein phosphatase inhibitor 2,2658,316,0.92 [0.81-1.04],0.1920037173278955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R9B,Neurabin-2,2692,319,0.99 [0.90-1.10],0.8907347607090593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2307,271,0.99 [0.90-1.09],0.7703119682679773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,2641,320,0.96 [0.76-1.22],0.7313235882133846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPT1,Palmitoyl-protein thioesterase 1,2262,271,0.91 [0.76-1.08],0.2822970098179631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,2645,313,1.22 [1.11-1.33],1.683317317930855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,2579,308,0.87 [0.71-1.06],0.1663149324582111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAME,Melanoma antigen preferentially expressed in tumors,2224,264,0.92 [0.56-1.52],0.7495223442850529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,2316,272,1.77 [1.29-2.44],0.0004297968210225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRC1,Protein regulator of cytokinesis 1,2297,268,0.80 [0.58-1.10],0.1641351157364485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,2679,320,1.78 [1.37-2.30],1.5437421458175527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX1,Peroxiredoxin-1,2586,317,0.92 [0.82-1.03],0.1273522306880008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,2282,271,0.77 [0.64-0.94],0.0092248151490347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2601,309,1.03 [0.90-1.19],0.6420127568400525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX5,"Peroxiredoxin-5, mitochondrial",2692,319,0.88 [0.76-1.03],0.1067717388666077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,2676,318,0.84 [0.71-0.99],0.0333892699771776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,2601,309,1.23 [0.89-1.72],0.2097897031139963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,2663,317,1.56 [1.03-2.37],0.0365791745450451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,2316,272,1.17 [0.94-1.44],0.1589419566853334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG3,Proteoglycan 3,2316,272,0.97 [0.77-1.21],0.7915483046720325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2601,309,0.98 [0.81-1.18],0.818401349348824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2262,271,0.93 [0.64-1.36],0.7155817311318196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2658,316,0.93 [0.82-1.05],0.2200173515284684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2294,268,0.94 [0.80-1.09],0.4058154094143125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKCQ,Protein kinase C theta type,2601,309,1.00 [0.79-1.26],0.9982283345643694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKD2,Serine/threonine-protein kinase D2,2242,265,1.12 [0.84-1.49],0.4380578409118832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKG1,cGMP-dependent protein kinase 1,2268,265,0.95 [0.86-1.04],0.270296120509384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2579,308,0.97 [0.84-1.13],0.7298676017250414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,2678,319,1.13 [1.00-1.29],0.0476235770574298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRND,Prion-like protein doppel,2300,272,0.94 [0.75-1.18],0.6115754094962506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROC,Vitamin K-dependent protein C,2666,317,0.94 [0.65-1.36],0.7297927119366767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROCR,Endothelial protein C receptor,2242,265,1.11 [0.77-1.61],0.5659135808292878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROK1,Prokineticin-1,2664,320,1.01 [0.84-1.21],0.915059764320319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROS1,Vitamin K-dependent protein S,2309,270,0.77 [0.50-1.21],0.2632980653931592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR4,Proline-rich protein 4,2249,263,1.09 [0.93-1.27],0.3014070916164247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR5,Proline-rich protein 5,2244,268,1.09 [0.87-1.36],0.4456843489681543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,2243,264,1.19 [0.90-1.57],0.2273881735454302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS2,Trypsin-2,2668,319,1.09 [0.95-1.26],0.2166883549515597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,2244,268,1.41 [1.05-1.89],0.0206122439119428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,2653,316,1.69 [1.34-2.14],1.224465505353844e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,2300,272,0.60 [0.46-0.79],0.0002031929321208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,2652,317,1.85 [1.47-2.33],1.2720920800357638e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2589,310,0.94 [0.86-1.02],0.1452292855758716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,2676,318,1.60 [1.08-2.37],0.0191857060966029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTN3,Myeloblastin,2597,309,0.92 [0.75-1.12],0.4019196406651836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRUNE2,Protein prune homolog 2,2271,266,0.82 [0.54-1.23],0.3319081183424872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,2300,271,1.85 [1.24-2.76],0.002772220544559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAPL1,Proactivator polypeptide-like 1,2307,271,0.92 [0.74-1.15],0.4536159900984783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSCA,Prostate stem cell antigen,2307,271,1.00 [0.95-1.04],0.8280969290490934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2641,320,1.20 [1.09-1.32],0.000177642817812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSIP1,PC4 and SFRS1-interacting protein,2664,320,0.95 [0.82-1.11],0.5357326960793759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMA1,Proteasome subunit alpha type-1,2579,308,1.02 [0.80-1.29],0.8937910874519677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMC3,26S proteasome regulatory subunit 6A,2224,264,0.85 [0.57-1.28],0.4421244880348773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,2304,274,0.92 [0.73-1.17],0.5148881182750359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,2262,271,1.03 [0.82-1.30],0.778162089894205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,2636,313,0.80 [0.66-0.96],0.0160200757712239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,2639,320,0.71 [0.54-0.94],0.0183127797801488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,2628,317,0.82 [0.61-1.09],0.1650661045496942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,2664,320,0.74 [0.61-0.91],0.0038701705066015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG4,Proteasome assembly chaperone 4,2244,268,0.86 [0.70-1.06],0.158373714197998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,2664,320,1.14 [1.03-1.27],0.0129529319957128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,2579,308,1.04 [0.88-1.22],0.6647597681094761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2197,256,0.96 [0.86-1.08],0.5206836389424805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2589,310,0.79 [0.57-1.10],0.1618142535216292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,2639,314,1.74 [1.36-2.23],9.876376952373976e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGES2,Prostaglandin E synthase 2,2230,267,0.94 [0.76-1.17],0.578928825597305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGR1,Prostaglandin reductase 1,2304,270,0.93 [0.82-1.05],0.2625246845442457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,2262,271,0.84 [0.74-0.96],0.0126928239277394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2664,320,1.23 [1.00-1.50],0.0467050621847297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,2589,310,1.37 [1.05-1.79],0.0186095521315036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTN,Pleiotrophin,2616,315,0.86 [0.70-1.05],0.1453423262102835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,2244,268,0.81 [0.64-1.04],0.0989764913799222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2641,320,0.94 [0.82-1.07],0.3322256044809931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2672,317,0.97 [0.87-1.08],0.5944753130917095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2241,268,0.96 [0.70-1.32],0.8094318087700398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2304,270,1.77 [1.23-2.56],0.0021270688049845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,2316,272,1.13 [0.69-1.86],0.6334823510591933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2695,322,1.57 [1.13-2.19],0.0076439637155918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2307,271,1.35 [1.10-1.67],0.0044123450877153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2307,271,1.21 [0.73-2.01],0.4543202347041367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,2658,319,1.43 [0.98-2.10],0.0641548528065309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2631,318,1.38 [1.06-1.80],0.0179184262869477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,2300,272,0.81 [0.61-1.09],0.1666138245304998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,2695,322,1.17 [0.81-1.70],0.3965106647619059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2304,270,0.75 [0.52-1.09],0.1304665597781444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2268,265,0.80 [0.65-0.98],0.0314744400667926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,2579,307,0.81 [0.69-0.96],0.0143443964306376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTTG1,Securin,2271,266,0.81 [0.59-1.11],0.1854700215401936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,2664,320,1.24 [1.00-1.54],0.0480927241223397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVALB,Parvalbumin alpha,2666,318,0.97 [0.89-1.06],0.565682659770363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,2678,319,1.51 [1.21-1.88],0.0002814198356728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXDNL,Peroxidasin-like protein,2297,268,0.90 [0.71-1.14],0.3879695340099973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,2589,310,0.84 [0.68-1.04],0.1043307902153983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYDC1,Pyrin domain-containing protein 1,2243,264,1.02 [0.75-1.38],0.8927146157401437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,2242,265,1.35 [1.23-1.48],6.576085861558403e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PZP,Pregnancy zone protein,2309,270,0.75 [0.54-1.04],0.0823213422322663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,2647,316,0.69 [0.54-0.88],0.0031250241664441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,2667,320,2.14 [1.50-3.07],3.2236239045661745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QSOX1,Sulfhydryl oxidase 1,2259,264,1.19 [0.88-1.61],0.2568002517395338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB10,Ras-related protein Rab-10,2304,270,0.83 [0.67-1.05],0.1181452976499965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB11FIP3,Rab11 family-interacting protein 3,2304,270,0.96 [0.87-1.07],0.4758882995374143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB27B,Ras-related protein Rab-27B,2304,270,0.90 [0.78-1.04],0.1485640935001289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB2B,Ras-related protein Rab-2B,2297,268,0.89 [0.73-1.08],0.2413133092666409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB33A,Ras-related protein Rab-33A,2242,265,0.95 [0.80-1.14],0.6134029105412667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB37,Ras-related protein Rab-37,2601,309,1.01 [0.90-1.15],0.8176473977390701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB39B,Ras-related protein Rab-39B,2242,265,0.88 [0.76-1.03],0.1076104103520117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2244,266,1.07 [0.87-1.32],0.505814288108001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB44,Ras-related protein Rab-44,2297,268,0.86 [0.65-1.13],0.2696024701066483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,2664,320,0.72 [0.58-0.89],0.0021633993610363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6B,Ras-related protein Rab-6B,2589,310,1.07 [0.87-1.32],0.531571215196456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEP1,Rab GTPase-binding effector protein 1,2268,265,0.89 [0.76-1.04],0.1355509658308503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEPK,Rab9 effector protein with kelch motifs,2579,308,1.02 [0.86-1.21],0.824237408299577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,2601,309,0.84 [0.70-1.00],0.0452719508191328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAC3,Ras-related C3 botulinum toxin substrate 3,2262,271,1.13 [0.97-1.32],0.113368926637322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD23B,UV excision repair protein RAD23 homolog B,2579,308,0.96 [0.77-1.19],0.6861411787481029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD51,DNA repair protein RAD51 homolog 1,2271,266,1.14 [0.92-1.42],0.2300833088584236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALB,Ras-related protein Ral-B,2244,268,0.88 [0.59-1.32],0.5348165933499351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALY,RNA-binding protein Raly,2297,268,0.99 [0.77-1.27],0.9351300991244031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP1,Ran-specific GTPase-activating protein,2243,264,0.79 [0.63-1.00],0.0537384698501553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,2244,266,0.73 [0.49-1.07],0.1095586788825837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANGAP1,Ran GTPase-activating protein 1,2579,308,0.99 [0.80-1.22],0.9161049697478482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAP1A,Ras-related protein Rap-1A,2244,268,0.91 [0.75-1.11],0.3544597058458385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,2271,266,0.96 [0.76-1.20],0.7032906473270601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,2579,308,1.54 [1.15-2.06],0.0041318575978228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,2671,320,1.15 [0.95-1.38],0.1572888646386906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASA1,Ras GTPase-activating protein 1,2589,310,1.17 [0.87-1.57],0.2935155741067098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2224,264,1.00 [0.77-1.31],0.9928408888651165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASSF2,Ras association domain-containing protein 2,2579,308,0.97 [0.82-1.15],0.7327417866005452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,2304,274,1.74 [1.33-2.27],4.996350554412822e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,2603,318,0.67 [0.58-0.76],1.4770629871403743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM17,Splicing factor 45,2304,274,0.98 [0.84-1.15],0.8029122657512064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM19,Probable RNA-binding protein 19,2242,265,0.97 [0.72-1.30],0.822975023161346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM25,RNA-binding protein 25,2224,264,1.03 [0.80-1.34],0.8005870408510247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,2262,271,1.05 [0.89-1.24],0.5631004991766894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,2636,313,1.25 [1.12-1.40],0.0001150845240051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP5,Retinol-binding protein 5,2636,313,1.02 [0.87-1.19],0.840522001875219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,2307,271,1.17 [0.99-1.37],0.0634488427851907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS,RNA-binding protein with multiple splicing,2244,268,1.05 [0.87-1.27],0.6143464720996481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS2,RNA-binding protein with multiple splicing 2,2243,264,0.96 [0.86-1.08],0.545162243625456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCC1,Regulator of chromosome condensation,2297,268,1.01 [0.79-1.28],0.945824973646469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,2616,315,0.84 [0.64-1.10],0.202888348581953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2243,264,1.29 [0.75-2.20],0.3537805652672099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REEP4,Receptor expression-enhancing protein 4,2304,274,0.92 [0.76-1.11],0.3584389994721315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,2642,315,2.00 [1.72-2.33],4.349247353812957e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,2695,322,1.62 [1.40-1.87],1.2458868493885095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,2695,322,1.46 [1.28-1.67],3.4892515214940064e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,2297,268,0.99 [0.73-1.33],0.9216586040017376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,2668,317,2.07 [1.78-2.40],1.3474796756271365e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELB,Transcription factor RelB,2244,268,0.83 [0.63-1.10],0.200557530861054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2670,320,1.38 [1.02-1.86],0.0395834152231621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,2658,316,1.47 [1.34-1.60],1.5941851246165485e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REPS1,RalBP1-associated Eps domain-containing protein 1,2244,268,0.98 [0.71-1.36],0.8958465433761121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REST,RE1-silencing transcription factor,2224,264,1.00 [0.71-1.41],0.9897263797032516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2636,313,1.20 [0.92-1.55],0.1784509759057153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RETN,Resistin,2664,321,1.18 [0.96-1.45],0.1242443596471248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REXO2,"Oligoribonuclease, mitochondrial",2242,265,0.75 [0.54-1.03],0.0792347918660116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RFC4,Replication factor C subunit 4,2297,268,0.83 [0.48-1.44],0.5150867111358763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGCC,Regulator of cell cycle RGCC,2304,274,0.91 [0.78-1.05],0.2008163301258481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2271,266,1.27 [1.09-1.49],0.0021066815097944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,2678,319,1.59 [1.19-2.13],0.0015513947303296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,2678,319,1.49 [1.08-2.05],0.0139678828934256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS10,Regulator of G-protein signaling 10,2304,274,0.90 [0.73-1.10],0.2917877093351098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,2601,309,0.86 [0.72-1.03],0.0955677347356967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RHOC,Rho-related GTP-binding protein RhoC,2630,320,0.98 [0.90-1.06],0.589642215810926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RICTOR,Rapamycin-insensitive companion of mTOR,2244,268,0.94 [0.71-1.25],0.679691794441557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2268,265,0.89 [0.72-1.10],0.2764941308447149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,2671,318,0.84 [0.71-0.98],0.0292755953409283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILPL2,RILP-like protein 2,2304,270,0.95 [0.84-1.06],0.354652368074538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2242,265,1.04 [0.88-1.23],0.6164365923998268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,2304,274,1.30 [1.05-1.61],0.013978225700283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN2,Prorelaxin H2,2263,265,0.87 [0.69-1.09],0.2115573052386647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,2315,273,1.82 [1.22-2.71],0.0034896367414964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,2243,264,1.30 [1.03-1.63],0.0249851019549222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE3,Eosinophil cationic protein,2649,316,0.96 [0.88-1.05],0.3893920302833653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,2232,262,1.46 [0.99-2.15],0.0558292917488714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,2297,270,1.56 [1.26-1.94],4.842531749205959e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASEH2A,Ribonuclease H2 subunit A,2304,274,0.78 [0.60-1.03],0.081783374985111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,2687,322,2.28 [1.64-3.18],1.0666711986277435e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,2243,264,2.22 [1.59-3.12],3.5245312360580286e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF168,E3 ubiquitin-protein ligase RNF168,2244,268,0.90 [0.66-1.24],0.5302353368312076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF31,E3 ubiquitin-protein ligase RNF31,2244,268,0.92 [0.66-1.27],0.6104511555641268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF4,E3 ubiquitin-protein ligase RNF4,2271,266,0.87 [0.71-1.07],0.1954983001848175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF41,E3 ubiquitin-protein ligase NRDP1,2579,308,0.88 [0.75-1.04],0.1267586697924224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF43,E3 ubiquitin-protein ligase RNF43,2271,266,0.98 [0.78-1.23],0.8604094198689654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,2243,264,0.84 [0.72-0.99],0.0380899289204056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,2668,317,1.41 [0.97-2.04],0.0687873170690345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO2,Roundabout homolog 2,2678,319,0.95 [0.64-1.42],0.8088271982128157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO4,Roundabout homolog 4,2243,264,1.63 [0.85-3.12],0.1436417642087013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2658,316,1.40 [1.05-1.85],0.019769236968939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RP2,Protein XRP2,2636,313,0.90 [0.71-1.13],0.350307614629392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPA2,Replication protein A 32 kDa subunit,2244,268,0.94 [0.64-1.37],0.7334969147256893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPE,Ribulose-phosphate 3-epimerase,2271,266,0.91 [0.77-1.08],0.3018956738400393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,2262,271,0.91 [0.68-1.22],0.5190635077182911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPL14,60S ribosomal protein L14,2243,264,0.92 [0.66-1.29],0.6407740683355814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPS10,40S ribosomal protein S10,2242,265,1.04 [0.76-1.42],0.817990418862175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRAS,Ras-related protein R-Ras,2262,271,0.98 [0.90-1.08],0.7134411829177078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,2579,308,1.07 [0.89-1.28],0.4871989406629675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2579,308,0.94 [0.81-1.09],0.4066804751893537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRP15,RRP15-like protein,2244,266,0.94 [0.83-1.08],0.4069780216685382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO1,R-spondin-1,2641,320,1.21 [0.90-1.63],0.2134943069184679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,2676,318,1.70 [1.24-2.33],0.0009691898558691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTBDN,Retbindin,2636,313,1.01 [0.73-1.41],0.9297577591308752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTKN2,Rhotekin-2,2242,265,1.11 [0.89-1.38],0.3493745596076755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2304,274,0.99 [0.87-1.12],0.8236892511160474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,2676,318,2.00 [1.53-2.62],3.948880303302855e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RUVBL1,RuvB-like 1,2579,308,0.98 [0.88-1.08],0.6684605376800412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RWDD1,RWD domain-containing protein 1,2678,319,0.89 [0.76-1.05],0.1767996229076341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RYR1,Ryanodine receptor 1,2242,265,1.02 [0.75-1.40],0.89578292445915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A11,Protein S100-A11,2631,314,0.93 [0.76-1.15],0.5228924989644856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A12,Protein S100-A12,2608,312,0.92 [0.80-1.05],0.2204737203486476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A13,Protein S100-A13,2244,268,0.71 [0.51-1.00],0.050747793047394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,2304,274,0.76 [0.60-0.97],0.026314578454072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,2583,309,0.83 [0.69-0.99],0.0334245041070187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A3,Protein S100-A3,2297,268,1.01 [0.80-1.28],0.907543053738634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,2658,318,0.83 [0.70-0.99],0.0391702824854703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,2304,274,0.71 [0.56-0.91],0.0066369009083426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,2616,315,1.25 [1.09-1.43],0.0015900488243417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,2309,270,0.39 [0.20-0.76],0.0056369417621161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAFB2,Scaffold attachment factor B2,2304,274,1.17 [0.77-1.78],0.4622787591916313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAG,S-arrestin,2244,266,1.08 [0.85-1.39],0.5190165610773715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,2664,320,0.98 [0.85-1.13],0.7569979819394436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAP18,Histone deacetylase complex subunit SAP18,2271,266,1.11 [0.96-1.29],0.1594081035152863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SARG,Specifically androgen-regulated gene protein,2298,270,1.00 [0.90-1.11],0.957702563892229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,2242,265,1.24 [0.95-1.62],0.1211727596235108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT1,Diamine acetyltransferase 1,2242,265,1.00 [0.77-1.29],0.9881432290477888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,2271,266,0.97 [0.82-1.14],0.6814839603212062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SATB1,DNA-binding protein SATB1,2304,274,0.80 [0.50-1.27],0.3373872585295723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SBSN,Suprabasin,2313,272,0.98 [0.72-1.33],0.8983077551364431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCAMP3,Secretory carrier-associated membrane protein 3,2636,313,0.97 [0.86-1.10],0.62915431477989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,2678,319,2.65 [1.99-3.52],1.8347540931806405e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB1,Scavenger receptor class B member 1,2589,310,1.16 [0.98-1.37],0.0772792180845131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,2591,318,1.97 [1.55-2.52],4.568085765837818e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,2695,322,1.12 [0.89-1.40],0.3321670049163335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,2678,319,2.23 [1.68-2.95],2.6145691189291736e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,2667,318,2.48 [1.93-3.20],2.2521159896677997e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,2668,317,0.92 [0.69-1.22],0.5740031872171407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,2663,317,1.18 [0.99-1.41],0.0715232457919721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB2A2,Mammaglobin-A,2242,265,1.05 [0.68-1.62],0.8292085505705522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A1,Secretoglobin family 3A member 1,2268,265,0.89 [0.57-1.39],0.5961934247577453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A2,Secretoglobin family 3A member 2,2672,317,1.07 [0.96-1.20],0.2097666417727274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,2601,309,1.74 [1.47-2.05],6.389190327484939e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCIN,Adseverin,2244,266,0.98 [0.84-1.16],0.8482759995637709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,2671,318,0.82 [0.67-0.99],0.0381854762832298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2A,Sodium channel protein type 2 subunit alpha,2244,266,0.99 [0.77-1.26],0.9212877580848696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2B,Sodium channel subunit beta-2,2262,271,0.94 [0.60-1.46],0.7760754112912553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3A,Sodium channel protein type 3 subunit alpha,2262,271,0.88 [0.62-1.25],0.4838016581290214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3B,Sodium channel subunit beta-3,2244,266,1.02 [0.78-1.34],0.8739477657449054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,2243,264,1.35 [1.06-1.72],0.0158435636943987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCP2,Non-specific lipid-transfer protein,2579,308,1.05 [0.91-1.20],0.5127338150230689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,2238,263,1.05 [0.82-1.33],0.716800126980045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRG1,Scrapie-responsive protein 1,2304,270,0.76 [0.50-1.15],0.19966417229979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRIB,Protein scribble homolog,2243,264,1.06 [0.93-1.21],0.3942903747175915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRN1,Secernin-1,2664,320,0.92 [0.77-1.11],0.4086690539466913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,2262,271,1.50 [1.20-1.86],0.0002769712206447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC1,Syndecan-1,2658,316,1.00 [0.79-1.28],0.9696565309511412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,2658,316,0.75 [0.62-0.91],0.0042109528658339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDCCAG8,Serologically defined colon cancer antigen 8,2297,268,0.95 [0.86-1.06],0.38486730249798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDHB,Succinate dehydrogenase,2307,271,1.02 [0.84-1.24],0.8594660490380505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDK2,Protein sidekick-2,2268,265,0.89 [0.65-1.21],0.4425471363348296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEC31A,Protein transport protein Sec31A,2243,264,0.98 [0.84-1.14],0.771907400125287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,2243,264,1.52 [1.09-2.12],0.0133356694039352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,2695,322,1.35 [1.13-1.61],0.0009055669856637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELENOP,Selenoprotein P,2309,270,1.26 [0.78-2.05],0.3456651210381735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,2309,270,0.55 [0.33-0.92],0.0235095298213803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELP,P-selectin,2668,319,1.03 [0.87-1.23],0.7043907744290142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELPLG,P-selectin glycoprotein ligand 1,2664,320,1.35 [0.97-1.87],0.0764113855029767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,2658,316,1.54 [1.09-2.18],0.0135684933927946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,2268,265,1.21 [0.96-1.52],0.1095177631949067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4C,Semaphorin-4C,2636,313,1.15 [0.88-1.50],0.2953513058832632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4D,Semaphorin-4D,2678,319,0.93 [0.67-1.30],0.686312284525064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA6C,Semaphorin-6C,2244,268,1.15 [0.76-1.73],0.5027820747775562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,2690,322,2.04 [1.55-2.68],4.345865394795571e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN3,Neuronal-specific septin-3,2304,274,0.95 [0.83-1.10],0.5130468472675708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN7,Septin-7,2271,266,0.97 [0.78-1.21],0.7715462866683056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,2293,272,1.35 [0.97-1.88],0.0763368532381138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN9,Septin-9,2636,313,0.90 [0.64-1.27],0.5491166539521692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,2271,267,0.83 [0.19-3.70],0.8076922663145225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA11,Serpin A11,2695,322,0.90 [0.71-1.13],0.3465740160158799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,2598,309,0.96 [0.88-1.04],0.2837241006714164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA3,Alpha-1-antichymotrypsin,2300,269,0.72 [0.33-1.56],0.4048281880978965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA4,Kallistatin,2263,265,1.41 [0.86-2.32],0.1729341082506932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA5,Plasma serine protease inhibitor,2271,266,0.83 [0.55-1.25],0.3740479563575255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,2309,270,2.47 [1.22-5.03],0.0124960075222571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA7,Thyroxine-binding globulin,2309,270,0.78 [0.41-1.47],0.4444357275555105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA9,Serpin A9,2628,312,1.02 [0.90-1.17],0.7230636014624205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB1,Leukocyte elastase inhibitor,2661,318,0.94 [0.84-1.05],0.2657323490814072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB5,Serpin B5,2616,315,0.98 [0.80-1.21],0.8834146345214622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB6,Serpin B6,2669,318,1.00 [0.85-1.19],0.9590641021450474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB8,Serpin B8,2692,319,0.89 [0.75-1.06],0.1919671893965544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB9,Serpin B9,2641,320,0.87 [0.64-1.18],0.3612536853106312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,2304,270,2.15 [1.00-4.61],0.048706826681616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPIND1,Heparin cofactor 2,2304,270,1.14 [0.78-1.69],0.4967060168575491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,2695,322,0.92 [0.80-1.06],0.2613746054425367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE2,Glia-derived nexin,2304,270,0.92 [0.77-1.11],0.3870038993441399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF1,Pigment epithelium-derived factor,2276,268,1.14 [0.73-1.77],0.5608128611595713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF2,Alpha-2-antiplasmin,2264,269,1.02 [0.44-2.37],0.9578829797282123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPING1,Plasma protease C1 inhibitor,2304,270,1.66 [0.91-3.03],0.0957061270012437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINH1,Serpin H1,2271,266,0.97 [0.89-1.07],0.5560756192493561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,2266,263,0.67 [0.44-1.03],0.0655018380414224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI2,Serpin I2,2307,271,1.16 [0.97-1.39],0.1098614527411274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2589,310,0.89 [0.76-1.05],0.1697821654651163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2633,319,0.55 [0.39-0.78],0.0006843013450537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,2262,271,0.85 [0.58-1.23],0.3843814258017487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,2658,318,1.56 [1.12-2.18],0.0091905463399075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L2,Seizure 6-like protein 2,2636,313,1.20 [0.81-1.77],0.3576892611284217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,2636,313,0.84 [0.73-0.97],0.0184057717319252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,2632,319,1.17 [0.94-1.47],0.1682007800746555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP4,Secreted frizzled-related protein 4,2268,265,0.83 [0.63-1.11],0.2060770456389583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,2579,308,1.20 [1.02-1.40],0.0291616698871794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA2,Pulmonary surfactant-associated protein A2,2579,308,0.87 [0.72-1.06],0.1813331282052901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPD,Pulmonary surfactant-associated protein D,2658,316,1.09 [0.94-1.26],0.2622629565895532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SGSH,N-sulphoglucosamine sulphohydrolase,2271,267,0.99 [0.81-1.22],0.933379919545722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2B3,SH2B adapter protein 3,2579,308,0.94 [0.85-1.04],0.2272948956589497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2D1A,SH2 domain-containing protein 1A,2664,320,0.92 [0.77-1.10],0.3438135022526121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2244,266,0.97 [0.79-1.18],0.7421582864068256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BP1,SH3 domain-binding protein 1,2307,271,0.93 [0.74-1.18],0.5644610354665354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,2260,266,1.17 [1.02-1.35],0.0261429543286933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,2300,272,0.89 [0.75-1.06],0.1954529636701726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,2315,273,0.83 [0.67-1.04],0.0998088882205657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHC1,SHC-transforming protein 1,2224,264,1.07 [0.96-1.19],0.2125781332543014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHD,SH2 domain-containing adapter protein D,2236,265,1.03 [0.90-1.18],0.6555032415942894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHH,Sonic hedgehog protein,2244,268,1.04 [0.80-1.35],0.7871484531962742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,2316,272,1.50 [1.04-2.15],0.0310142548449765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",2672,317,0.92 [0.82-1.04],0.1883332116693279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHPK,Sedoheptulokinase,2271,266,0.96 [0.71-1.29],0.7876397447048361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIAE,Sialate O-acetylesterase,2655,318,1.17 [0.95-1.43],0.1476047740470133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,2674,318,1.55 [1.23-1.96],0.0002061177336708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2664,320,1.66 [1.28-2.14],0.000106229784253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,2589,310,1.01 [0.89-1.15],0.8409910295013117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,2670,320,0.99 [0.92-1.07],0.7853986438664307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2676,318,2.51 [1.88-3.36],4.89780018959486e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,2658,316,1.65 [1.18-2.32],0.003810267347647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,2243,264,1.07 [0.84-1.35],0.6036982150646854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,2674,318,1.19 [0.87-1.63],0.269205577172775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIL1,Nucleotide exchange factor SIL1,2243,264,0.93 [0.63-1.37],0.7048194663289943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2668,318,1.19 [0.99-1.44],0.0580200893145279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,2656,317,1.56 [1.28-1.90],9.319725416570253e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,2244,268,1.03 [0.89-1.20],0.6485419357072908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,2636,313,0.89 [0.79-1.00],0.0567554272154642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2589,310,0.99 [0.82-1.20],0.9237041168276428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,2601,309,1.20 [1.00-1.43],0.0523743286309062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP1,Src kinase-associated phosphoprotein 1,2636,319,1.00 [0.87-1.16],0.9575811234532644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP2,Src kinase-associated phosphoprotein 2,2674,318,0.96 [0.87-1.06],0.419211971617822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKIV2L,Helicase SKI2W,2242,265,0.95 [0.68-1.32],0.7415711384168577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLA2,Src-like-adapter 2,2304,274,0.97 [0.87-1.09],0.6391681158190305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,2601,309,1.43 [1.20-1.71],5.495714922190227e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF6,SLAM family member 6,2579,308,1.26 [0.98-1.62],0.0728102617574873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,2664,320,1.32 [1.12-1.55],0.000765845597872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,2579,308,1.25 [1.03-1.51],0.0219788135869206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC12A2,Solute carrier family 12 member 2,2242,265,1.60 [0.99-2.58],0.0526656356590379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,2297,268,0.90 [0.72-1.13],0.3646410326654796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,2589,310,1.16 [0.97-1.39],0.0939902649437073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,2262,271,1.09 [0.85-1.40],0.5000583802845863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC27A4,Long-chain fatty acid transport protein 4,2589,310,0.89 [0.76-1.05],0.1673789704140287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC28A1,Sodium/nucleoside cotransporter 1,2224,264,1.09 [0.90-1.33],0.3755033830138573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,2224,264,0.90 [0.67-1.19],0.445911368946976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,2589,310,1.31 [1.03-1.67],0.0262235770716008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A5,Zinc transporter ZIP5,2664,320,1.06 [0.89-1.26],0.4997701122199475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC44A4,Choline transporter-like protein 4,2262,271,0.92 [0.75-1.12],0.3971460339451761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,2316,272,1.04 [0.81-1.33],0.7797280656788346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC51B,Organic solute transporter subunit beta,2242,265,0.88 [0.73-1.06],0.1840376175778074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2268,265,0.94 [0.82-1.08],0.4010313145564548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2307,271,1.13 [0.92-1.39],0.2571004173728817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2224,264,1.23 [1.03-1.48],0.0227035523835024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIT2,Slit homolog 2 protein,2589,310,0.99 [0.81-1.20],0.8818534613187559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,2244,268,0.63 [0.44-0.89],0.0097843466717699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,2676,318,1.50 [1.19-1.90],0.0005968047521017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,2616,315,1.65 [1.32-2.07],1.3864897924597037e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLK,STE20-like serine/threonine-protein kinase,2271,266,0.97 [0.82-1.15],0.7284807238784172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLMAP,Sarcolemmal membrane-associated protein,2307,271,1.03 [0.90-1.18],0.6822234560304565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2301,271,1.02 [0.72-1.44],0.9269719867032612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD1,Mothers against decapentaplegic homolog 1,2579,308,0.94 [0.83-1.06],0.312432164410078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD2,Mothers against decapentaplegic homolog 2,2297,268,0.92 [0.78-1.09],0.3219670014774364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD3,Mothers against decapentaplegic homolog 3,2297,268,0.89 [0.71-1.12],0.3098120800197636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,2636,313,0.56 [0.34-0.91],0.0198744897017071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,2589,310,1.05 [0.91-1.21],0.4981319083265637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMC3,Structural maintenance of chromosomes protein 3,2224,264,1.00 [0.78-1.27],0.9801923487442348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,2307,271,0.86 [0.71-1.06],0.1543601726501128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,2676,318,1.21 [0.90-1.63],0.2128852030439551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,2674,318,1.57 [1.24-1.97],0.0001527995673013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,2668,317,1.20 [1.00-1.45],0.0553210735705079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD3,Sphingomyelin phosphodiesterase 3,2244,268,1.07 [0.87-1.32],0.5218436601897032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2667,318,0.98 [0.85-1.14],0.8132376842321767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2297,268,0.81 [0.67-0.98],0.0318525338291659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMS,Spermine synthase,2244,266,0.98 [0.81-1.19],0.8207585016634134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMTN,Smoothelin,2296,272,0.98 [0.87-1.11],0.7900310084915603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP23,Synaptosomal-associated protein 23,2658,316,0.93 [0.83-1.03],0.1737630849587838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP25,Synaptosomal-associated protein 25,2244,266,0.97 [0.76-1.23],0.7954686984626355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP29,Synaptosomal-associated protein 29,2658,318,0.93 [0.84-1.04],0.1942714631929511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,2304,274,0.75 [0.62-0.92],0.0055361009186985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,2268,265,0.85 [0.76-0.93],0.0009756458827689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,2641,320,1.30 [1.12-1.51],0.0005302008475384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2243,264,1.58 [1.11-2.25],0.010676465183728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',2300,272,1.00 [0.79-1.27],0.9898384873453928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNU13,NHP2-like protein 1,2242,265,1.12 [0.95-1.34],0.1855471243473338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,2268,265,0.75 [0.60-0.93],0.0103509686575344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX18,Sorting nexin-18,2307,271,1.23 [0.95-1.58],0.1156636693911106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX2,Sorting nexin-2,2297,268,1.06 [0.93-1.20],0.3939325567941858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,2243,264,1.00 [0.67-1.51],0.9826132635124474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,2658,316,0.91 [0.78-1.05],0.2029540568043321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],2607,311,0.81 [0.66-1.01],0.0581467852941783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",2670,320,0.79 [0.62-0.99],0.0430252607421824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD3,Extracellular superoxide dismutase,2315,273,0.93 [0.78-1.12],0.4622304408649657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORBS1,Sorbin and SH3 domain-containing protein 1,2304,274,1.02 [0.77-1.35],0.8803292160156384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,2579,308,1.39 [1.08-1.78],0.0096037440709214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,2665,317,0.78 [0.69-0.88],0.0001050437824553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORT1,Sortilin,2656,314,0.99 [0.77-1.27],0.9205623652840642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOST,Sclerostin,2656,314,1.17 [0.91-1.50],0.2116511793372585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2262,271,0.82 [0.62-1.09],0.1722746625033541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX2,Transcription factor SOX-2,2300,273,0.78 [0.47-1.29],0.3283672862421194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,2262,271,1.19 [0.77-1.85],0.4366149237983572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2304,274,0.89 [0.59-1.33],0.5569656680377135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPAG1,Sperm-associated antigen 1,2304,274,1.14 [0.93-1.39],0.2170115878051916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARC,SPARC,2658,318,1.05 [0.91-1.21],0.4955093622170843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARCL1,SPARC-like protein 1,2655,317,1.11 [0.77-1.61],0.5765853556328704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPART,Spartin,2268,265,0.89 [0.76-1.04],0.1416969741860569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPESP1,Sperm equatorial segment protein 1,2304,270,1.06 [0.75-1.49],0.7563621894852004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,2670,320,2.13 [1.80-2.53],3.456071292712457e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,2268,265,1.36 [1.02-1.81],0.033769837833765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,2664,320,1.73 [1.53-1.96],1.6521183398283761e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK5,Serine protease inhibitor Kazal-type 5,2670,320,1.28 [0.98-1.68],0.071608210970701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK6,Serine protease inhibitor Kazal-type 6,2676,318,1.10 [0.91-1.33],0.307394549579626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK8,Serine protease inhibitor Kazal-type 8,2242,265,1.24 [0.94-1.64],0.1342847232707565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,2660,317,1.39 [0.99-1.94],0.0574031914361904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,2674,318,1.62 [1.28-2.04],5.348716478557378e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,2307,271,1.01 [0.94-1.09],0.6979606072628236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,2641,320,0.42 [0.30-0.60],1.3983342362394305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,2668,317,2.07 [1.60-2.68],3.008084562388505e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,2645,312,1.73 [1.32-2.26],6.937306677702747e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPP1,Osteopontin,2690,322,0.90 [0.73-1.11],0.3251681297659633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2244,268,0.88 [0.65-1.18],0.3827568352891622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRING1,SREBP regulating gene protein,2224,264,1.04 [0.85-1.26],0.7052851665589315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,2271,266,0.99 [0.85-1.14],0.8761543730648983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR3,Small proline-rich protein 3,2300,272,1.09 [0.92-1.29],0.3247674940315635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRY2,Protein sprouty homolog 2,2601,309,0.94 [0.84-1.05],0.2850314520068212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2244,266,0.94 [0.64-1.37],0.7517021308026177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTLC1,Serine palmitoyltransferase 1,2300,272,0.91 [0.66-1.25],0.5588776919691908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRC,Proto-oncogene tyrosine-protein kinase Src,2653,316,0.97 [0.89-1.06],0.5032447809665411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRP14,Signal recognition particle 14 kDa protein,2636,313,0.87 [0.74-1.04],0.124005699408131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPK2,SRSF protein kinase 2,2664,320,0.95 [0.84-1.06],0.354956319342499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPX,Sushi repeat-containing protein SRPX,2304,270,1.22 [0.90-1.63],0.1966819153113542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSB,Lupus La protein,2589,310,1.02 [0.88-1.19],0.7795632081325102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2244,268,0.94 [0.68-1.31],0.7232129930687803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2656,314,0.91 [0.84-0.98],0.0090905328923264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2668,319,0.98 [0.79-1.23],0.8861878743787517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,2224,264,1.12 [0.74-1.71],0.5932950626379156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,2307,271,0.85 [0.67-1.08],0.1819629319306367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,2268,265,0.74 [0.60-0.92],0.0064287654625083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2636,313,1.52 [1.29-1.80],7.502976238130345e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2695,322,1.20 [0.87-1.65],0.270686933453761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2244,268,0.85 [0.64-1.13],0.2625581553858507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAB2,Stabilin-2,2316,272,0.79 [0.52-1.19],0.2593265880496003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAM,Signal transducing adapter molecule 1,2297,268,0.69 [0.48-1.00],0.0505119496397037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAMBP,STAM-binding protein,2636,319,0.87 [0.74-1.02],0.0823964258741831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT2,Signal transducer and activator of transcription 2,2244,268,0.93 [0.80-1.09],0.3744017702439871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,2636,313,0.93 [0.86-1.00],0.0435808516579396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2224,264,1.05 [0.89-1.25],0.555044359265938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,2678,319,1.24 [1.02-1.51],0.0349530448628144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,2666,320,1.54 [1.03-2.30],0.0374966754925455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STEAP4,Metalloreductase STEAP4,2244,266,1.00 [0.84-1.19],0.9817578071887256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STIP1,Stress-induced-phosphoprotein 1,2664,318,0.87 [0.74-1.02],0.0942982299891481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK11,Serine/threonine-protein kinase STK11,2616,315,0.91 [0.80-1.05],0.2128820284462044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK24,Serine/threonine-protein kinase 24,2589,310,0.95 [0.80-1.12],0.5310516321624792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK4,Serine/threonine-protein kinase 4,2658,316,0.89 [0.80-1.00],0.0574675721035099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STOML2,"Stomatin-like protein 2, mitochondrial",2224,264,0.93 [0.81-1.06],0.2619310701801915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX16,Syntaxin-16,2579,308,1.03 [0.86-1.24],0.7467769268264952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX1B,Syntaxin-1B,2262,271,0.98 [0.72-1.33],0.9082988499313946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX3,Syntaxin-3,2300,272,0.83 [0.58-1.18],0.3004509432614962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX4,Syntaxin-4,2636,313,1.01 [0.85-1.19],0.9247450329125506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX5,Syntaxin-5,2244,268,1.10 [0.85-1.41],0.4799749163781103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX6,Syntaxin-6,2579,308,1.01 [0.86-1.19],0.8975255033368067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX7,Syntaxin-7,2244,268,1.09 [0.85-1.40],0.4852832883050064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX8,Syntaxin-8,2664,320,0.98 [0.80-1.21],0.8768262205367107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP1,Syntaxin-binding protein 1,2304,274,0.95 [0.82-1.10],0.4719861152737791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP3,Syntaxin-binding protein 3,2579,308,0.90 [0.70-1.15],0.3959276355915738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGP1,SURP and G-patch domain-containing protein 1,2307,271,0.97 [0.73-1.30],0.8403989253399801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGT1,Protein SGT1 homolog,2579,308,0.92 [0.81-1.05],0.2315450020708444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT1A1,Sulfotransferase 1A1,2678,319,0.96 [0.89-1.04],0.3283419349711922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT2A1,Bile salt sulfotransferase,2664,320,0.96 [0.83-1.11],0.5486265322193551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF1,Formylglycine-generating enzyme,2244,268,1.12 [0.96-1.30],0.1539564054620651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2678,319,1.08 [0.88-1.31],0.4681990709191013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUOX,"Sulfite oxidase, mitochondrial",2304,274,0.87 [0.73-1.04],0.1353389790328452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD1,Sushi domain-containing protein 1,2616,315,0.93 [0.76-1.14],0.4685167272404753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,2670,320,1.72 [1.24-2.37],0.0010892131104111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD4,Sushi domain-containing protein 4,2297,268,0.96 [0.72-1.28],0.7687349058747113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,2260,264,1.09 [0.79-1.51],0.5828660866390754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SV2A,Synaptic vesicle glycoprotein 2A,2262,271,1.13 [0.95-1.34],0.1767435634778622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SWAP70,Switch-associated protein 70,2307,271,0.89 [0.64-1.24],0.4763295763340869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,2268,265,0.80 [0.65-0.99],0.0393581957981473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2244,266,0.95 [0.76-1.18],0.6251923368224981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYT1,Synaptotagmin-1,2300,272,0.88 [0.63-1.23],0.4592733260464283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYTL4,Synaptotagmin-like protein 4,2304,270,0.94 [0.80-1.10],0.4132582069653742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2271,266,0.95 [0.85-1.07],0.3994630290028302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACC3,Transforming acidic coiled-coil-containing protein 3,2636,313,0.96 [0.88-1.05],0.3648355431842169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,2336,276,2.46 [1.77-3.43],1.0384990485492233e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TADA3,Transcriptional adapter 3,2297,268,0.77 [0.57-1.04],0.093673353816844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,2636,313,1.48 [1.17-1.87],0.0010470167233674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAGLN3,Transgelin-3,2224,264,1.03 [0.84-1.26],0.7786934997194742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TALDO1,Transaldolase,2311,272,0.82 [0.62-1.08],0.1526563961280445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TANK,TRAF family member-associated NF-kappa-B activator,2601,309,0.87 [0.75-1.00],0.0567663806418863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAP1,Antigen peptide transporter 1,2271,266,0.99 [0.82-1.19],0.9144348408569218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARBP2,RISC-loading complex subunit TARBP2,2589,310,0.93 [0.81-1.06],0.2791129185466107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2262,271,1.01 [0.85-1.20],0.9037549090076747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2297,268,0.80 [0.57-1.12],0.1938077738468621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAX1BP1,Tax1-binding protein 1,2300,272,0.92 [0.76-1.12],0.4038410027657897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,2589,310,0.84 [0.66-1.06],0.1382176008738174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D23,TBC1 domain family member 23,2636,313,0.95 [0.85-1.06],0.3480344963421377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D5,TBC1 domain family member 5,2664,320,0.92 [0.81-1.05],0.2364688060022415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCA,Tubulin-specific chaperone A,2268,265,0.91 [0.79-1.05],0.1971985325998857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCB,Tubulin-folding cofactor B,2641,320,0.94 [0.85-1.04],0.2382811900401944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCC,Tubulin-specific chaperone C,2641,320,0.94 [0.83-1.07],0.3732849752784757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,2579,308,0.97 [0.86-1.10],0.6607739410157396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBR1,T-box brain protein 1,2262,271,0.88 [0.68-1.14],0.3332738311001518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2640,319,0.85 [0.77-0.94],0.0008672748622343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1B,T-cell leukemia/lymphoma protein 1B,2616,315,1.00 [0.88-1.14],0.9711000638642272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN1,Transcobalamin-1,2259,267,0.74 [0.53-1.04],0.0848171143909755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,2690,322,2.38 [1.76-3.22],2.0289735829500583e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCOF1,Treacle protein,2304,270,1.13 [0.80-1.60],0.4959687024706497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,2271,266,0.83 [0.64-1.07],0.1473594944375774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCTN3,Tectonic-3,2304,270,0.93 [0.64-1.34],0.6798564933602242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDGF1,Teratocarcinoma-derived growth factor 1,2589,310,1.03 [0.97-1.10],0.3634987322841553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDO2,"Tryptophan 2,3-dioxygenase",2262,271,0.76 [0.55-1.06],0.1029349838594813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,2297,268,1.00 [0.85-1.17],0.9922277835236214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDRKH,Tudor and KH domain-containing protein,2589,310,0.93 [0.82-1.05],0.244794795313001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEF,Thyrotroph embryonic factor,2242,265,0.79 [0.58-1.07],0.1248005090893373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,2658,318,1.60 [1.06-2.42],0.0257761067098864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TERF1,Telomeric repeat-binding factor 1,2244,268,0.91 [0.60-1.39],0.6650354115508922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TET2,Methylcytosine dioxygenase TET2,2265,265,0.93 [0.81-1.06],0.2787819722125276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX101,Testis-expressed protein 101,2262,271,1.06 [0.88-1.28],0.5467678356074916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX33,Testis-expressed protein 33,2271,266,0.97 [0.72-1.31],0.8586062924994865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TF,Serotransferrin,2309,270,1.43 [0.84-2.45],0.1903206797168687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFAP2A,Transcription factor AP-2-alpha,2244,266,1.05 [0.86-1.27],0.653923563321803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,2657,319,1.40 [1.27-1.54],2.899610156468427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,2672,317,1.61 [1.40-1.85],1.6251812398022542e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,2649,318,1.76 [1.50-2.07],2.585707090143091e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI,Tissue factor pathway inhibitor,2656,316,0.88 [0.65-1.20],0.4303245465351943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI2,Tissue factor pathway inhibitor 2,2654,317,1.12 [0.90-1.40],0.315646037632338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,2668,320,1.30 [1.02-1.66],0.033057101329584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TG,Thyroglobulin,2297,268,0.99 [0.89-1.10],0.8429827064024219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,2664,320,1.31 [1.08-1.59],0.0061472567421818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB1,Transforming growth factor beta-1 proprotein,2686,319,1.05 [0.82-1.34],0.7025562547713837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB2,Transforming growth factor beta-2 proprotein,2297,268,0.99 [0.79-1.25],0.9650781385042744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2646,316,0.65 [0.46-0.92],0.0161678000568254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR1,TGF-beta receptor type-1,2244,268,1.13 [0.65-1.97],0.6608433784161296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,2658,318,1.87 [1.51-2.32],1.3417871321168985e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,2695,322,1.33 [0.96-1.83],0.0877777300875327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,2650,314,0.87 [0.77-1.00],0.0433208025117212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2315,273,1.82 [1.21-2.71],0.0036993786680062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,2221,264,0.87 [0.74-1.01],0.0755756803997905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,2658,316,1.62 [1.21-2.18],0.0011602746795314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,2670,320,1.27 [1.03-1.55],0.0225614439093131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS4,Thrombospondin-4,2661,316,0.92 [0.75-1.14],0.4561267597217737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,2649,314,0.58 [0.43-0.78],0.0002873580794852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THPO,Thrombopoietin,2616,315,1.06 [0.83-1.35],0.6599018938262837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THRAP3,Thyroid hormone receptor-associated protein 3,2242,265,0.89 [0.78-1.02],0.0868886064143008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THSD1,Thrombospondin type-1 domain-containing protein 1,2230,266,1.10 [0.79-1.53],0.5814343066128554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THTPA,Thiamine-triphosphatase,2293,268,0.97 [0.85-1.12],0.6893535140023697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,2678,319,1.48 [1.08-2.04],0.0147075996955672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIA1,Nucleolysin TIA-1 isoform p40,2588,310,0.95 [0.88-1.03],0.2435306864456465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,2695,322,1.36 [1.05-1.77],0.0213337487908261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2584,309,0.94 [0.75-1.17],0.5607746163814863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2271,266,1.20 [0.98-1.48],0.0747173493390982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2668,319,0.73 [0.58-0.91],0.0046038764509676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2304,270,0.87 [0.65-1.17],0.3648880400765834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2300,272,0.96 [0.84-1.10],0.5478070359538577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,2626,314,1.89 [1.41-2.55],2.5897611927804204e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,2304,270,1.24 [0.85-1.79],0.2602741976366801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP3,Metalloproteinase inhibitor 3,2674,318,1.01 [0.94-1.09],0.7554044619623212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP4,Metalloproteinase inhibitor 4,2670,320,1.08 [0.84-1.38],0.5362518764411047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2652,314,2.03 [1.33-3.10],0.0011227630889926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJAP1,Tight junction-associated protein 1,2658,318,0.91 [0.81-1.02],0.1166726134322133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJP3,Tight junction protein ZO-3,2244,266,1.03 [0.79-1.36],0.8085091200240297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TK1,"Thymidine kinase, cytosolic",2271,266,0.86 [0.65-1.13],0.2649417071151824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR1,Toll-like receptor 1,2244,268,1.40 [0.92-2.12],0.1148670609897036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR2,Toll-like receptor 2,2271,266,1.32 [0.79-2.21],0.2897376741955789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR3,Toll-like receptor 3,2692,319,1.10 [0.94-1.28],0.2525604077502097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR4,Toll-like receptor 4,2244,268,0.95 [0.62-1.45],0.8141911581444584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2262,271,0.90 [0.72-1.13],0.35992491600436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED1,Transmembrane emp24 domain-containing protein 1,2271,266,1.10 [0.89-1.37],0.3857016849819846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED10,Transmembrane emp24 domain-containing protein 10,2242,265,1.03 [0.79-1.35],0.820685567014262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED4,Transmembrane emp24 domain-containing protein 4,2242,265,0.83 [0.64-1.07],0.1522769506773167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED8,Protein TMED8,2307,271,0.94 [0.84-1.06],0.3140263297338665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM106A,Transmembrane protein 106A,2297,268,0.97 [0.82-1.15],0.7436063700255673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM132A,Transmembrane protein 132A,2243,264,1.05 [0.88-1.26],0.6019789520813421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM25,Transmembrane protein 25,2304,274,1.24 [0.97-1.59],0.0882996486598653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMOD4,Tropomodulin-4,2224,264,0.96 [0.70-1.31],0.7954241756261696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11B,Transmembrane protease serine 11B,2244,266,0.95 [0.80-1.13],0.5630737882157506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11D,Transmembrane protease serine 11D,2293,272,1.19 [0.90-1.58],0.2261173213769648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,2636,313,1.35 [1.21-1.51],4.9607425159403086e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS5,Transmembrane protease serine 5,2631,319,1.14 [0.88-1.48],0.3116040015258638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,2670,320,1.03 [0.90-1.17],0.6679219766505322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,2668,319,1.06 [0.87-1.29],0.5490901127023065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,2614,315,1.29 [1.03-1.63],0.0284897331742756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2307,271,0.91 [0.72-1.14],0.4061453866356489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2601,309,0.93 [0.71-1.22],0.5838755666725763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2268,265,0.91 [0.76-1.10],0.345968652955829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2641,320,1.75 [1.40-2.19],8.47366455030315e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2641,320,1.38 [1.21-1.57],2.105787497288551e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2671,318,1.06 [0.86-1.31],0.5750631894631648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2692,319,2.02 [1.65-2.47],6.4200237102900594e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2663,317,1.66 [1.23-2.24],0.0008806506724308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2658,318,1.89 [1.48-2.42],3.1649987278613945e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2668,317,1.56 [1.22-1.99],0.0003511027586706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2601,309,1.35 [1.09-1.67],0.0061546661324073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2668,317,2.06 [1.60-2.65],2.148923356749332e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2268,265,1.21 [0.91-1.60],0.1865609145338009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2676,318,1.57 [1.24-2.00],0.0002135523063158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2670,320,2.46 [1.90-3.17],7.01346362319154e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2670,320,1.44 [1.22-1.69],1.243062567367112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2678,319,1.80 [1.30-2.48],0.0003799815088312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2686,319,1.96 [1.57-2.44],2.3296914259488317e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2641,320,1.23 [1.05-1.45],0.0124572240937149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2678,319,1.30 [1.05-1.60],0.0155372601543538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2641,320,1.49 [1.23-1.80],3.104393028214851e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,2692,319,0.72 [0.50-1.05],0.0876394946768598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2664,320,0.79 [0.67-0.94],0.0060365637641072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2692,319,0.59 [0.41-0.83],0.0028621435808409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2674,318,2.11 [1.50-2.95],1.5170945740192528e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2694,322,1.12 [0.79-1.58],0.5173266959969696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,2641,320,0.97 [0.82-1.16],0.7675170736737302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2316,272,1.11 [0.82-1.49],0.5069967681169597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNIP1,TNFAIP3-interacting protein 1,2300,272,0.95 [0.83-1.09],0.465396085141684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNN,Tenascin-N,2316,272,1.06 [0.81-1.39],0.6802054464055245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",2616,315,0.89 [0.80-0.99],0.0340351660011703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNPO1,Transportin-1,2271,266,1.12 [0.80-1.58],0.4995846305792304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNR,Tenascin-R,2641,320,1.15 [0.92-1.45],0.2201667856280025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,2670,320,0.50 [0.35-0.70],8.307219195540958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2304,270,0.97 [0.83-1.14],0.7354132827396689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1,DNA topoisomerase 1,2307,271,1.06 [0.97-1.16],0.2111502818296614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1MT,"DNA topoisomerase I, mitochondrial",2224,264,0.84 [0.65-1.09],0.1961583472505131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP2B,DNA topoisomerase 2-beta,2244,268,0.95 [0.82-1.10],0.5070633167972448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOR1AIP1,Torsin-1A-interacting protein 1,2243,264,1.07 [0.87-1.33],0.5105190885016659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,2579,308,0.99 [0.79-1.25],0.9394676969495532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53BP1,TP53-binding protein 1,2244,268,1.03 [0.89-1.18],0.7309834475098879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,2216,259,0.73 [0.57-0.92],0.0077819098110075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,2616,315,1.20 [0.90-1.60],0.207320332721245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP73,Tumor protein p73,2262,271,0.83 [0.58-1.19],0.3127067921237301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPBGL,Trophoblast glycoprotein-like,2262,271,0.81 [0.58-1.12],0.1987731713044219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPD52L2,Tumor protein D54,2268,265,0.94 [0.84-1.04],0.2355785335072452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,2304,270,0.34 [0.23-0.51],1.3718055174055876e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPM3,Tropomyosin alpha-3 chain,2242,265,1.09 [0.84-1.41],0.5186402176011482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,2579,308,0.85 [0.73-0.98],0.0305483245461567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,2644,316,1.37 [1.14-1.66],0.0010870552530652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP2,Tubulin polymerization-promoting protein family member 2,2271,266,1.07 [0.91-1.26],0.4301057039957847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP3,Tubulin polymerization-promoting protein family member 3,2589,310,0.74 [0.54-1.01],0.0596337893796288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPR,Nucleoprotein TPR,2242,265,0.90 [0.70-1.15],0.3987534976098668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPRKB,EKC/KEOPS complex subunit TPRKB,2224,264,0.95 [0.78-1.15],0.6034661453797936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,2688,319,1.26 [1.03-1.55],0.0246704803394467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSD1,Tryptase delta,2304,274,1.27 [0.94-1.72],0.1254098826700067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSG1,Tryptase gamma,2244,268,0.88 [0.56-1.39],0.5917842682456584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPT1,Translationally-controlled tumor protein,2601,309,1.05 [0.90-1.22],0.5422417072438364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,2664,320,0.86 [0.74-1.00],0.0438197867755718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",2244,268,0.91 [0.67-1.24],0.5569232964333697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2242,265,0.93 [0.72-1.19],0.560661358197011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2271,266,0.94 [0.81-1.08],0.3506733124454672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREH,Trehalase,2316,272,1.05 [0.90-1.22],0.5506837379594796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREM2,Triggering receptor expressed on myeloid cells 2,2663,317,1.05 [0.88-1.24],0.6069821510149243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML1,Trem-like transcript 1 protein,2315,273,0.93 [0.74-1.16],0.5074061324937001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML2,Trem-like transcript 2 protein,2670,320,1.11 [0.85-1.46],0.4490896982959962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,2676,318,1.01 [0.86-1.19],0.9302934756096308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,2664,320,0.87 [0.76-1.00],0.0469199586627099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,2268,266,0.85 [0.70-1.03],0.0949320583224099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2307,271,0.95 [0.85-1.06],0.3468441427669168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM26,Tripartite motif-containing protein 26,2224,264,0.92 [0.74-1.15],0.4772302352424146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM40,E3 ubiquitin ligase TRIM40,2262,271,0.90 [0.77-1.05],0.1731877129439314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM5,Tripartite motif-containing protein 5,2664,320,0.97 [0.86-1.08],0.5688961672615049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,2297,268,0.89 [0.78-1.02],0.0949983167476404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,2242,265,0.90 [0.70-1.15],0.3924341568615684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC1,Hamartin,2244,268,0.91 [0.76-1.10],0.3482790708731416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC22D1,TSC22 domain family protein 1,2304,274,1.00 [0.83-1.19],0.959529179713803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,2658,316,0.83 [0.72-0.96],0.0121153748312634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSLP,Thymic stromal lymphopoietin,2616,315,1.10 [0.95-1.27],0.1912822855223815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSNAX,Translin-associated protein X,2242,265,0.83 [0.60-1.14],0.2527688357448557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,2616,315,1.00 [0.89-1.13],0.9754951079105864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN15,Tetraspanin-15,2242,265,1.14 [0.93-1.40],0.2114738988680595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN7,Tetraspanin-7,2244,266,0.86 [0.75-1.00],0.056222747986094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN8,Tetraspanin-8,2307,271,0.98 [0.87-1.10],0.7749939032695844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPYL1,Testis-specific Y-encoded-like protein 1,2244,268,0.88 [0.65-1.19],0.400214543938638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TST,Thiosulfate sulfurtransferase,2587,310,0.98 [0.85-1.13],0.7771911921250483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,2262,271,0.91 [0.72-1.16],0.4614809696194545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,2242,265,1.03 [0.86-1.23],0.7589676095920964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTR,Transthyretin,2284,268,1.13 [0.72-1.76],0.5940534451733395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,2244,266,0.83 [0.53-1.30],0.412214674843105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TWF2,Twinfilin-2,2316,272,0.97 [0.85-1.12],0.7184202927935388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXK,Tyrosine-protein kinase TXK,2271,266,1.01 [0.87-1.17],0.9198090261041908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXLNA,Alpha-taxilin,2641,320,0.95 [0.85-1.07],0.3778517086248499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXN,Thioredoxin,2276,268,0.85 [0.64-1.15],0.2945785325745641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC15,Thioredoxin domain-containing protein 15,2658,318,0.86 [0.61-1.21],0.3974626238684268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,2678,319,1.09 [0.95-1.26],0.2204780942352129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC9,Thioredoxin domain-containing protein 9,2300,272,0.86 [0.68-1.08],0.1815384943428335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNL1,Thioredoxin-like protein 1,2241,265,0.99 [0.88-1.12],0.8985226191961728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2670,320,0.82 [0.66-1.02],0.0778380408843305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYMP,Thymidine phosphorylase,2641,314,0.91 [0.78-1.06],0.2148802729832182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,2658,316,1.25 [0.89-1.77],0.2012251074149739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2244,268,1.37 [1.13-1.65],0.0012106371929945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,2636,313,0.85 [0.63-1.14],0.2854590261473696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,2297,268,0.99 [0.64-1.53],0.9750769606074042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2304,270,0.93 [0.76-1.14],0.4783909962896071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2244,268,1.05 [0.85-1.30],0.6430102821353277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBQLN3,Ubiquilin-3,2242,265,0.86 [0.70-1.07],0.1701766113001045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBXN1,UBX domain-containing protein 1,2268,265,0.86 [0.72-1.02],0.0909580930258338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2307,271,0.97 [0.89-1.05],0.4060394934427462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,2242,265,1.06 [0.95-1.19],0.2725688680479018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,2242,265,1.29 [0.89-1.86],0.1764027959547255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,2641,320,1.50 [1.19-1.89],0.0005991875263951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,2687,320,0.84 [0.71-1.00],0.0483090475682586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC5D,Netrin receptor UNC5D,2244,268,1.08 [0.71-1.65],0.7208637415840893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC79,Protein unc-79 homolog,2224,264,1.05 [0.85-1.30],0.6661589809024051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNG,Uracil-DNA glycosylase,2297,268,0.88 [0.61-1.26],0.4719543230069517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,2304,270,0.92 [0.82-1.03],0.1440418512714611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3A,Uroplakin-3a,2244,266,0.91 [0.72-1.13],0.3899385574732942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3BL1,Uroplakin-3b-like protein 1,2267,265,0.96 [0.75-1.21],0.7055476775438507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROD,Uroporphyrinogen decarboxylase,2268,265,0.86 [0.72-1.04],0.1134683880175268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,2262,271,0.91 [0.75-1.10],0.3103664371222403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USO1,General vesicular transport factor p115,2636,313,0.96 [0.85-1.07],0.4552940189267001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,2297,268,0.95 [0.80-1.12],0.5095769401120809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2300,272,1.36 [1.02-1.82],0.0340474647199203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,2242,265,1.07 [0.94-1.21],0.2843281507421674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,2616,315,0.95 [0.85-1.06],0.3812193292795801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UXS1,UDP-glucuronic acid decarboxylase 1,2579,308,1.07 [0.90-1.28],0.4495245879822164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP5,Vesicle-associated membrane protein 5,2616,315,1.05 [0.88-1.25],0.6010872121927737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP8,Vesicle-associated membrane protein 8,2244,268,0.95 [0.83-1.09],0.503244852512114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,2664,320,0.96 [0.86-1.09],0.5431877353893539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,2620,313,1.94 [1.39-2.72],0.0001044520019233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASP,Vasodilator-stimulated phosphoprotein,2315,273,0.91 [0.78-1.07],0.2500276511044364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2636,313,0.94 [0.57-1.54],0.8115657971679758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAV3,Guanine nucleotide exchange factor VAV3,2244,266,0.99 [0.87-1.11],0.8133075917961121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,2666,317,2.16 [1.58-2.96],1.5956036012523776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAN,Versican core protein,2678,319,1.11 [0.80-1.54],0.5436114351098199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCPKMT,Protein-lysine methyltransferase METTL21D,2224,264,0.99 [0.86-1.15],0.911469117884192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFA,Vascular endothelial growth factor A,2682,318,1.12 [0.95-1.33],0.1862622668927746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFB,Vascular endothelial growth factor B,2244,268,0.75 [0.51-1.12],0.1603300987353666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFC,Vascular endothelial growth factor C,2658,318,1.03 [0.87-1.22],0.7514986135941423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,2686,318,1.74 [1.38-2.20],3.6553606694625305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VGF,Neurosecretory protein VGF,2304,274,0.95 [0.66-1.37],0.7730692018882053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIM,Vimentin,2616,315,1.00 [0.92-1.09],0.9563598240397816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,2243,264,1.35 [0.79-2.32],0.2733396756552229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIT,Vitrin,2304,270,0.83 [0.62-1.11],0.2134016296503886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2636,313,1.19 [1.02-1.39],0.0282814801181292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,2315,273,0.98 [0.84-1.14],0.814950106780229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN2,Vascular non-inflammatory molecule 2,2636,313,1.09 [0.88-1.35],0.418128620057888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,2271,266,0.94 [0.79-1.14],0.5473241148640614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,2636,313,0.90 [0.79-1.03],0.1175760338152866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS4B,Vacuolar protein sorting-associated protein 4B,2297,268,0.99 [0.87-1.12],0.8169651311579986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,2636,313,0.92 [0.81-1.05],0.2052001619582512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,2297,268,1.19 [0.89-1.60],0.2431351503646159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2242,265,1.23 [0.87-1.72],0.2440069954598222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2297,268,1.44 [1.25-1.66],4.587993996261711e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2666,320,1.96 [1.58-2.41],4.798559041273039e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2654,316,1.08 [0.92-1.26],0.3337926490377597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,2300,272,0.67 [0.50-0.89],0.0068041510175977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,2589,310,0.93 [0.76-1.13],0.4634082585133735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,2271,266,0.95 [0.70-1.29],0.7329739493682709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2616,315,1.28 [1.10-1.50],0.0019077022574176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2678,319,0.92 [0.80-1.07],0.272882788283758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2579,308,1.43 [1.09-1.86],0.0088790777554116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2268,265,0.88 [0.71-1.09],0.2348842970742988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA1,von Willebrand factor A domain-containing protein 1,2673,318,1.05 [0.83-1.33],0.6952473834532411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA5A,von Willebrand factor A domain-containing protein 5A,2224,264,1.05 [0.92-1.21],0.4763943123015512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,2632,319,1.39 [1.11-1.74],0.0047586232062924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,2304,274,1.17 [0.92-1.48],0.1934638321624153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWF,von Willebrand factor,2695,322,1.00 [0.88-1.14],0.9870600615663488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",2670,320,0.91 [0.71-1.18],0.4803251591225544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WAS,Wiskott-Aldrich syndrome protein,2601,309,1.02 [0.87-1.19],0.8143768953926421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,2616,315,0.92 [0.83-1.03],0.1473504362747623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,2589,310,0.92 [0.82-1.03],0.1501063039400304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASHC3,WASH complex subunit 3,2300,272,0.95 [0.82-1.11],0.5468570015090963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASL,Neural Wiskott-Aldrich syndrome protein,2244,268,0.97 [0.79-1.20],0.7929984494728489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,2297,268,0.83 [0.59-1.17],0.2810635871396592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC1,WAP four-disulfide core domain protein 1,2255,261,1.09 [0.89-1.34],0.4071378831734488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,2672,318,1.10 [0.94-1.28],0.2198419607175134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,2523,292,1.80 [1.47-2.21],1.7249140297573675e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2633,319,0.89 [0.71-1.12],0.3110578744821236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2668,317,1.23 [0.92-1.65],0.1596785712969719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,2676,318,0.52 [0.39-0.70],1.0973266386430263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,2601,309,2.06 [1.57-2.72],2.623691735337515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2641,320,0.80 [0.66-0.98],0.0271398715808707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,2676,318,1.25 [1.07-1.47],0.0046951966769939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,2681,322,1.63 [1.25-2.13],0.0002938761717677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XIAP,E3 ubiquitin-protein ligase XIAP,2244,268,0.97 [0.80-1.19],0.801773089866367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2658,318,0.91 [0.83-0.99],0.0294343580181415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XRCC4,DNA repair protein XRCC4,2589,310,0.88 [0.66-1.16],0.3617013175222489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,2300,272,1.79 [1.23-2.60],0.0022214567040301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2307,271,0.97 [0.90-1.06],0.525784457302714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YES1,Tyrosine-protein kinase Yes,2636,313,0.98 [0.90-1.06],0.5830623080474411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,2297,268,0.77 [0.52-1.12],0.1726818093969465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,2242,265,0.78 [0.64-0.94],0.0081003498383125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YTHDF3,YTH domain-containing family protein 3,2601,309,0.97 [0.86-1.09],0.5699401973959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YWHAQ,14-3-3 protein theta,2268,265,0.90 [0.76-1.06],0.1966740693480404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YY1,Transcriptional repressor protein YY1,2244,268,0.84 [0.54-1.30],0.4423312297891291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBP1,Z-DNA-binding protein 1,2244,268,0.90 [0.66-1.22],0.4978180433313308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,2579,308,0.85 [0.74-0.98],0.0292653704731523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,2616,315,0.89 [0.70-1.14],0.3491768086840456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,2242,265,0.86 [0.70-1.07],0.1737646492136783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZFYVE19,Abscission/NoCut checkpoint regulator,2307,271,0.94 [0.82-1.07],0.3366447700629364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZHX2,Zinc fingers and homeoboxes protein 2,2300,272,0.99 [0.70-1.38],0.9373546863185682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF174,Zinc finger protein 174,2244,268,0.73 [0.49-1.09],0.122658977856021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF75D,Zinc finger protein 75D,2271,266,1.02 [0.85-1.24],0.8159489024413867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF830,Zinc finger protein 830,2297,268,1.15 [0.99-1.32],0.061088076502014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRD2,Protein ZNRD2,2307,271,1.04 [0.89-1.22],0.6098716736526562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2297,268,1.00 [0.80-1.24],0.9866287320393556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP3,Zona pellucida sperm-binding protein 3,2243,264,1.01 [0.97-1.06],0.5768119265300689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP4,Zona pellucida sperm-binding protein 4,2224,264,1.00 [0.70-1.42],0.995656616859339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZPR1,Zinc finger protein ZPR1,2244,266,0.99 [0.87-1.13],0.8878208175970776
